id	sid	tid	token	lemma	pos
aiua-12833	1	1	stesura	stesura	PROPN
aiua-12833	1	2	seveso	seveso	PROPN
aiua-12833	1	3	archivio	archivio	PROPN
aiua-12833	1	4	italiano	italiano	X
aiua-12833	1	5	di	di	X
aiua-12833	1	6	urologia	urologia	PROPN
aiua-12833	1	7	e	e	PROPN
aiua-12833	1	8	andrologia	andrologia	NOUN
aiua-12833	1	9	2024	2024	NUM
aiua-12833	1	10	;	;	PUNCT
aiua-12833	1	11	96(4):12833	96(4):12833	NUM
aiua-12833	1	12	1	1	NUM
aiua-12833	1	13	meta	meta	ADJ
aiua-12833	1	14	-	-	PUNCT
aiua-12833	1	15	analysis	analysis	NOUN
aiua-12833	1	16	introduction	introduction	NOUN
aiua-12833	1	17	parkinson	parkinson	NOUN
aiua-12833	1	18	's	's	PART
aiua-12833	1	19	disease	disease	NOUN
aiua-12833	1	20	(	(	PUNCT
aiua-12833	1	21	pd	pd	NOUN
aiua-12833	1	22	)	)	PUNCT
aiua-12833	1	23	is	be	AUX
aiua-12833	1	24	one	one	NUM
aiua-12833	1	25	of	of	ADP
aiua-12833	1	26	the	the	DET
aiua-12833	1	27	most	most	ADV
aiua-12833	1	28	common	common	ADJ
aiua-12833	1	29	neurodegenerative	neurodegenerative	ADJ
aiua-12833	1	30	diseases	disease	NOUN
aiua-12833	1	31	,	,	PUNCT
aiua-12833	1	32	primarily	primarily	ADV
aiua-12833	1	33	caused	cause	VERB
aiua-12833	1	34	by	by	ADP
aiua-12833	1	35	the	the	DET
aiua-12833	1	36	degeneration	degeneration	NOUN
aiua-12833	1	37	of	of	ADP
aiua-12833	1	38	dopamine	dopamine	NOUN
aiua-12833	1	39	-	-	PUNCT
aiua-12833	1	40	producing	produce	VERB
aiua-12833	1	41	neurons	neuron	NOUN
aiua-12833	1	42	and	and	CCONJ
aiua-12833	1	43	α	α	NOUN
aiua-12833	1	44	-	-	PUNCT
aiua-12833	1	45	synuclein	synuclein	NOUN
aiua-12833	1	46	accumulation	accumulation	NOUN
aiua-12833	1	47	in	in	ADP
aiua-12833	1	48	the	the	DET
aiua-12833	1	49	substantia	substantia	NOUN
aiua-12833	1	50	nigra	nigra	NOUN
aiua-12833	1	51	and	and	CCONJ
aiua-12833	1	52	the	the	DET
aiua-12833	1	53	formation	formation	NOUN
aiua-12833	1	54	of	of	ADP
aiua-12833	1	55	lewy	lewy	ADJ
aiua-12833	1	56	bodies	body	NOUN
aiua-12833	1	57	.	.	PUNCT
aiua-12833	2	1	however	however	ADV
aiua-12833	2	2	,	,	PUNCT
aiua-12833	2	3	various	various	ADJ
aiua-12833	2	4	mechanisms	mechanism	NOUN
aiua-12833	2	5	and	and	CCONJ
aiua-12833	2	6	pathway	pathway	NOUN
aiua-12833	2	7	dysfunctions	dysfunction	NOUN
aiua-12833	2	8	contribute	contribute	VERB
aiua-12833	2	9	to	to	ADP
aiua-12833	2	10	parkinson	parkinson	NOUN
aiua-12833	2	11	's	's	PART
aiua-12833	2	12	disease	disease	NOUN
aiua-12833	2	13	pathogenesis	pathogenesis	NOUN
aiua-12833	2	14	,	,	PUNCT
aiua-12833	2	15	including	include	VERB
aiua-12833	2	16	oxidative	oxidative	ADJ
aiua-12833	2	17	stress	stress	NOUN
aiua-12833	2	18	,	,	PUNCT
aiua-12833	2	19	malfunctioning	malfunction	VERB
aiua-12833	2	20	mitochondria	mitochondria	NOUN
aiua-12833	2	21	,	,	PUNCT
aiua-12833	2	22	cellular	cellular	ADJ
aiua-12833	2	23	calcium	calcium	NOUN
aiua-12833	2	24	imbalance	imbalance	NOUN
aiua-12833	2	25	,	,	PUNCT
aiua-12833	2	26	neuroinflammation	neuroinflammation	NOUN
aiua-12833	2	27	,	,	PUNCT
aiua-12833	2	28	and	and	CCONJ
aiua-12833	2	29	other	other	ADJ
aiua-12833	2	30	neurotransmitter	neurotransmitter	NOUN
aiua-12833	2	31	system	system	NOUN
aiua-12833	2	32	abnormalities	abnormality	NOUN
aiua-12833	2	33	(	(	PUNCT
aiua-12833	2	34	1	1	NUM
aiua-12833	2	35	,	,	PUNCT
aiua-12833	2	36	2	2	NUM
aiua-12833	2	37	)	)	PUNCT
aiua-12833	2	38	.	.	PUNCT
aiua-12833	3	1	the	the	DET
aiua-12833	3	2	main	main	ADJ
aiua-12833	3	3	symptoms	symptom	NOUN
aiua-12833	3	4	of	of	ADP
aiua-12833	3	5	this	this	DET
aiua-12833	3	6	disease	disease	NOUN
aiua-12833	3	7	include	include	VERB
aiua-12833	3	8	bradykinesia	bradykinesia	NOUN
aiua-12833	3	9	,	,	PUNCT
aiua-12833	3	10	rigidity	rigidity	NOUN
aiua-12833	3	11	,	,	PUNCT
aiua-12833	3	12	tremors	tremor	NOUN
aiua-12833	3	13	,	,	PUNCT
aiua-12833	3	14	and	and	CCONJ
aiua-12833	3	15	postural	postural	ADJ
aiua-12833	3	16	instability	instability	NOUN
aiua-12833	3	17	(	(	PUNCT
aiua-12833	3	18	3	3	NUM
aiua-12833	3	19	)	)	PUNCT
aiua-12833	3	20	.	.	PUNCT
aiua-12833	4	1	the	the	DET
aiua-12833	4	2	risk	risk	NOUN
aiua-12833	4	3	of	of	ADP
aiua-12833	4	4	pd	pd	PROPN
aiua-12833	4	5	increases	increase	NOUN
aiua-12833	4	6	almost	almost	ADV
aiua-12833	4	7	exponentially	exponentially	ADV
aiua-12833	4	8	with	with	ADP
aiua-12833	4	9	age	age	NOUN
aiua-12833	4	10	,	,	PUNCT
aiua-12833	4	11	with	with	ADP
aiua-12833	4	12	most	most	ADJ
aiua-12833	4	13	patients	patient	NOUN
aiua-12833	4	14	being	be	AUX
aiua-12833	4	15	over	over	ADP
aiua-12833	4	16	65	65	NUM
aiua-12833	4	17	years	year	NOUN
aiua-12833	4	18	old	old	ADJ
aiua-12833	4	19	.	.	PUNCT
aiua-12833	5	1	globally	globally	ADV
aiua-12833	5	2	,	,	PUNCT
aiua-12833	5	3	the	the	DET
aiua-12833	5	4	incidence	incidence	NOUN
aiua-12833	5	5	and	and	CCONJ
aiua-12833	5	6	prevalence	prevalence	NOUN
aiua-12833	5	7	of	of	ADP
aiua-12833	5	8	this	this	DET
aiua-12833	5	9	disease	disease	NOUN
aiua-12833	5	10	from	from	ADP
aiua-12833	5	11	1990	1990	NUM
aiua-12833	5	12	to	to	ADP
aiua-12833	5	13	2019	2019	NUM
aiua-12833	5	14	have	have	AUX
aiua-12833	5	15	been	be	AUX
aiua-12833	5	16	reported	report	VERB
aiua-12833	5	17	to	to	PART
aiua-12833	5	18	be	be	AUX
aiua-12833	5	19	13.43	13.43	NUM
aiua-12833	5	20	and	and	CCONJ
aiua-12833	5	21	106.28	106.28	NUM
aiua-12833	5	22	per	per	ADP
aiua-12833	5	23	100.000	100.000	NUM
aiua-12833	5	24	population	population	NOUN
aiua-12833	5	25	,	,	PUNCT
aiua-12833	5	26	respectively	respectively	ADV
aiua-12833	5	27	,	,	PUNCT
aiua-12833	5	28	with	with	ADP
aiua-12833	5	29	a	a	DET
aiua-12833	5	30	rising	rise	VERB
aiua-12833	5	31	global	global	ADJ
aiua-12833	5	32	trend	trend	NOUN
aiua-12833	5	33	in	in	ADP
aiua-12833	5	34	the	the	DET
aiua-12833	5	35	burden	burden	NOUN
aiua-12833	5	36	of	of	ADP
aiua-12833	5	37	pd	pd	PROPN
aiua-12833	5	38	(	(	PUNCT
aiua-12833	5	39	4	4	NUM
aiua-12833	5	40	)	)	PUNCT
aiua-12833	5	41	.	.	PUNCT
aiua-12833	6	1	since	since	SCONJ
aiua-12833	6	2	there	there	PRON
aiua-12833	6	3	is	be	VERB
aiua-12833	6	4	currently	currently	ADV
aiua-12833	6	5	no	no	DET
aiua-12833	6	6	definitive	definitive	ADJ
aiua-12833	6	7	cure	cure	NOUN
aiua-12833	6	8	for	for	ADP
aiua-12833	6	9	pd	pd	PROPN
aiua-12833	6	10	,	,	PUNCT
aiua-12833	6	11	symptom	symptom	NOUN
aiua-12833	6	12	control	control	NOUN
aiua-12833	6	13	–	–	PUNCT
aiua-12833	6	14	primarily	primarily	ADV
aiua-12833	6	15	through	through	ADP
aiua-12833	6	16	dopamine	dopamine	NOUN
aiua-12833	6	17	agonists	agonist	NOUN
aiua-12833	6	18	and	and	CCONJ
aiua-12833	6	19	dopamine	dopamine	NOUN
aiua-12833	6	20	replacement	replacement	NOUN
aiua-12833	6	21	therapy	therapy	NOUN
aiua-12833	6	22	–	–	PUNCT
aiua-12833	6	23	remains	remain	VERB
aiua-12833	6	24	the	the	DET
aiua-12833	6	25	only	only	ADJ
aiua-12833	6	26	treatment	treatment	NOUN
aiua-12833	6	27	approach	approach	NOUN
aiua-12833	6	28	(	(	PUNCT
aiua-12833	6	29	5	5	NUM
aiua-12833	6	30	)	)	PUNCT
aiua-12833	6	31	.	.	PUNCT
aiua-12833	7	1	levodopa	levodopa	NOUN
aiua-12833	7	2	is	be	AUX
aiua-12833	7	3	one	one	NUM
aiua-12833	7	4	of	of	ADP
aiua-12833	7	5	the	the	DET
aiua-12833	7	6	most	most	ADV
aiua-12833	7	7	effective	effective	ADJ
aiua-12833	7	8	drugs	drug	NOUN
aiua-12833	7	9	,	,	PUNCT
aiua-12833	7	10	having	having	AUX
aiua-12833	7	11	been	be	AUX
aiua-12833	7	12	used	use	VERB
aiua-12833	7	13	in	in	ADP
aiua-12833	7	14	pd	pd	NOUN
aiua-12833	7	15	treatment	treatment	NOUN
aiua-12833	7	16	for	for	ADP
aiua-12833	7	17	over	over	ADP
aiua-12833	7	18	five	five	NUM
aiua-12833	7	19	decades	decade	NOUN
aiua-12833	7	20	(	(	PUNCT
aiua-12833	7	21	6	6	NUM
aiua-12833	7	22	)	)	PUNCT
aiua-12833	7	23	.	.	PUNCT
aiua-12833	8	1	the	the	DET
aiua-12833	8	2	metabolism	metabolism	NOUN
aiua-12833	8	3	of	of	ADP
aiua-12833	8	4	this	this	DET
aiua-12833	8	5	drug	drug	NOUN
aiua-12833	8	6	occurs	occur	VERB
aiua-12833	8	7	through	through	ADP
aiua-12833	8	8	four	four	NUM
aiua-12833	8	9	pathways	pathway	NOUN
aiua-12833	8	10	:	:	PUNCT
aiua-12833	8	11	decarboxylation	decarboxylation	NOUN
aiua-12833	8	12	,	,	PUNCT
aiua-12833	8	13	o	o	NOUN
aiua-12833	8	14	-	-	NOUN
aiua-12833	8	15	methylation	methylation	NOUN
aiua-12833	8	16	,	,	PUNCT
aiua-12833	8	17	transamination	transamination	NOUN
aiua-12833	8	18	,	,	PUNCT
aiua-12833	8	19	and	and	CCONJ
aiua-12833	8	20	oxidation	oxidation	NOUN
aiua-12833	8	21	(	(	PUNCT
aiua-12833	8	22	7	7	NUM
aiua-12833	8	23	)	)	PUNCT
aiua-12833	8	24	.	.	PUNCT
aiua-12833	9	1	seventy	seventy	NUM
aiua-12833	9	2	percent	percent	NOUN
aiua-12833	9	3	of	of	ADP
aiua-12833	9	4	oral	oral	ADJ
aiua-12833	9	5	levodopa	levodopa	NOUN
aiua-12833	9	6	is	be	AUX
aiua-12833	9	7	metabolized	metabolize	VERB
aiua-12833	9	8	by	by	ADP
aiua-12833	9	9	the	the	DET
aiua-12833	9	10	enzyme	enzyme	NOUN
aiua-12833	9	11	aaad	aaad	NOUN
aiua-12833	9	12	(	(	PUNCT
aiua-12833	9	13	aromatic	aromatic	ADJ
aiua-12833	9	14	amino	amino	NOUN
aiua-12833	9	15	-	-	PUNCT
aiua-12833	9	16	acid	acid	NOUN
aiua-12833	9	17	decarboxylase	decarboxylase	NOUN
aiua-12833	9	18	)	)	PUNCT
aiua-12833	9	19	in	in	ADP
aiua-12833	9	20	the	the	DET
aiua-12833	9	21	gut	gut	NOUN
aiua-12833	9	22	and	and	CCONJ
aiua-12833	9	23	liver	liver	NOUN
aiua-12833	9	24	(	(	PUNCT
aiua-12833	9	25	8)	8)	NUM
aiua-12833	9	26	.	.	PUNCT
aiua-12833	9	27	to	to	PART
aiua-12833	9	28	increase	increase	VERB
aiua-12833	9	29	the	the	DET
aiua-12833	9	30	drug	drug	NOUN
aiua-12833	9	31	's	's	PART
aiua-12833	9	32	half	half	ADJ
aiua-12833	9	33	-	-	PUNCT
aiua-12833	9	34	life	life	NOUN
aiua-12833	9	35	and	and	CCONJ
aiua-12833	9	36	concentration	concentration	NOUN
aiua-12833	9	37	levels	level	NOUN
aiua-12833	9	38	,	,	PUNCT
aiua-12833	9	39	dopa	dopa	NOUN
aiua-12833	9	40	decarboxylase	decarboxylase	NOUN
aiua-12833	9	41	inhibitors	inhibitor	NOUN
aiua-12833	9	42	(	(	PUNCT
aiua-12833	9	43	dci	dci	PROPN
aiua-12833	9	44	)	)	PUNCT
aiua-12833	9	45	such	such	ADJ
aiua-12833	9	46	as	as	ADP
aiua-12833	9	47	carbidopa	carbidopa	NOUN
aiua-12833	9	48	and	and	CCONJ
aiua-12833	9	49	benserazide	benserazide	NOUN
aiua-12833	9	50	are	be	AUX
aiua-12833	9	51	prescribed	prescribe	VERB
aiua-12833	9	52	alongside	alongside	ADP
aiua-12833	9	53	levodopa	levodopa	NOUN
aiua-12833	9	54	(	(	PUNCT
aiua-12833	9	55	9	9	NUM
aiua-12833	9	56	)	)	PUNCT
aiua-12833	9	57	.	.	PUNCT
aiua-12833	10	1	the	the	DET
aiua-12833	10	2	main	main	ADJ
aiua-12833	10	3	side	side	NOUN
aiua-12833	10	4	effects	effect	NOUN
aiua-12833	10	5	of	of	ADP
aiua-12833	10	6	pd	pd	NOUN
aiua-12833	10	7	medications	medication	NOUN
aiua-12833	10	8	include	include	VERB
aiua-12833	10	9	gastrointestinal	gastrointestinal	ADJ
aiua-12833	10	10	issues	issue	NOUN
aiua-12833	10	11	like	like	ADP
aiua-12833	10	12	nausea	nausea	NOUN
aiua-12833	10	13	and	and	CCONJ
aiua-12833	10	14	psychiatric	psychiatric	ADJ
aiua-12833	10	15	disorders	disorder	NOUN
aiua-12833	10	16	such	such	ADJ
aiua-12833	10	17	as	as	ADP
aiua-12833	10	18	psychosis	psychosis	NOUN
aiua-12833	10	19	and	and	CCONJ
aiua-12833	10	20	dyskinesia	dyskinesia	NOUN
aiua-12833	10	21	(	(	PUNCT
aiua-12833	10	22	10	10	NUM
aiua-12833	10	23	)	)	PUNCT
aiua-12833	10	24	.	.	PUNCT
aiua-12833	11	1	a	a	DET
aiua-12833	11	2	recent	recent	ADJ
aiua-12833	11	3	retrospective	retrospective	ADJ
aiua-12833	11	4	study	study	NOUN
aiua-12833	11	5	by	by	ADP
aiua-12833	11	6	gremke	gremke	PROPN
aiua-12833	11	7	et	et	PROPN
aiua-12833	11	8	al	al	PROPN
aiua-12833	11	9	.	.	PROPN
aiua-12833	11	10	indicated	indicate	VERB
aiua-12833	11	11	that	that	SCONJ
aiua-12833	11	12	the	the	DET
aiua-12833	11	13	incidence	incidence	NOUN
aiua-12833	11	14	of	of	ADP
aiua-12833	11	15	urinary	urinary	ADJ
aiua-12833	11	16	tract	tract	NOUN
aiua-12833	11	17	infection	infection	NOUN
aiua-12833	11	18	(	(	PUNCT
aiua-12833	11	19	uti	uti	PROPN
aiua-12833	11	20	)	)	PUNCT
aiua-12833	11	21	during	during	ADP
aiua-12833	11	22	one	one	NUM
aiua-12833	11	23	year	year	NOUN
aiua-12833	11	24	of	of	ADP
aiua-12833	11	25	treatment	treatment	NOUN
aiua-12833	11	26	with	with	ADP
aiua-12833	11	27	dci	dci	PROPN
aiua-12833	11	28	drugs	drug	NOUN
aiua-12833	11	29	exceeds	exceed	VERB
aiua-12833	11	30	ten	ten	NUM
aiua-12833	11	31	percent	percent	NOUN
aiua-12833	11	32	(	(	PUNCT
aiua-12833	11	33	11	11	NUM
aiua-12833	11	34	)	)	PUNCT
aiua-12833	11	35	.	.	PUNCT
aiua-12833	12	1	urinary	urinary	ADJ
aiua-12833	12	2	tract	tract	NOUN
aiua-12833	12	3	infection	infection	NOUN
aiua-12833	12	4	(	(	PUNCT
aiua-12833	12	5	uti	uti	PROPN
aiua-12833	12	6	)	)	PUNCT
aiua-12833	12	7	is	be	AUX
aiua-12833	12	8	a	a	DET
aiua-12833	12	9	common	common	ADJ
aiua-12833	12	10	factor	factor	NOUN
aiua-12833	12	11	in	in	ADP
aiua-12833	12	12	worsening	worsen	VERB
aiua-12833	12	13	the	the	DET
aiua-12833	12	14	neurological	neurological	ADJ
aiua-12833	12	15	status	status	NOUN
aiua-12833	12	16	of	of	ADP
aiua-12833	12	17	patients	patient	NOUN
aiua-12833	12	18	with	with	ADP
aiua-12833	12	19	pd	pd	PROPN
aiua-12833	12	20	.	.	PROPN
aiua-12833	12	21	uti	uti	PROPN
aiua-12833	12	22	can	can	AUX
aiua-12833	12	23	be	be	AUX
aiua-12833	12	24	one	one	NUM
aiua-12833	12	25	of	of	ADP
aiua-12833	12	26	the	the	DET
aiua-12833	12	27	leading	lead	VERB
aiua-12833	12	28	causes	cause	NOUN
aiua-12833	12	29	of	of	ADP
aiua-12833	12	30	delirium	delirium	NOUN
aiua-12833	12	31	,	,	PUNCT
aiua-12833	12	32	decreased	decrease	VERB
aiua-12833	12	33	functionalobjectives	functionalobjective	NOUN
aiua-12833	12	34	:	:	PUNCT
aiua-12833	12	35	parkinson	parkinson	NOUN
aiua-12833	12	36	’s	’s	PART
aiua-12833	12	37	disease	disease	NOUN
aiua-12833	12	38	is	be	AUX
aiua-12833	12	39	the	the	DET
aiua-12833	12	40	most	most	ADV
aiua-12833	12	41	common	common	ADJ
aiua-12833	12	42	neurodegenerative	neurodegenerative	ADJ
aiua-12833	12	43	disease	disease	NOUN
aiua-12833	12	44	.	.	PUNCT
aiua-12833	13	1	combining	combine	VERB
aiua-12833	13	2	levodopa	levodopa	NOUN
aiua-12833	13	3	with	with	ADP
aiua-12833	13	4	other	other	ADJ
aiua-12833	13	5	drugs	drug	NOUN
aiua-12833	13	6	,	,	PUNCT
aiua-12833	13	7	including	include	VERB
aiua-12833	13	8	decarboxylase	decarboxylase	NOUN
aiua-12833	13	9	inhibitors	inhibitor	NOUN
aiua-12833	13	10	(	(	PUNCT
aiua-12833	13	11	dci	dci	PROPN
aiua-12833	13	12	)	)	PUNCT
aiua-12833	13	13	is	be	AUX
aiua-12833	13	14	its	its	PRON
aiua-12833	13	15	most	most	ADV
aiua-12833	13	16	effective	effective	ADJ
aiua-12833	13	17	treatment	treatment	NOUN
aiua-12833	13	18	.	.	PUNCT
aiua-12833	14	1	urinary	urinary	ADJ
aiua-12833	14	2	tract	tract	NOUN
aiua-12833	14	3	infection	infection	NOUN
aiua-12833	14	4	(	(	PUNCT
aiua-12833	14	5	uti	uti	PROPN
aiua-12833	14	6	)	)	PUNCT
aiua-12833	14	7	is	be	AUX
aiua-12833	14	8	the	the	DET
aiua-12833	14	9	most	most	ADV
aiua-12833	14	10	common	common	ADJ
aiua-12833	14	11	cause	cause	NOUN
aiua-12833	14	12	of	of	ADP
aiua-12833	14	13	hospitalization	hospitalization	NOUN
aiua-12833	14	14	in	in	ADP
aiua-12833	14	15	parkinson	parkinson	NOUN
aiua-12833	14	16	’s	’s	PART
aiua-12833	14	17	patients	patient	NOUN
aiua-12833	14	18	,	,	PUNCT
aiua-12833	14	19	making	make	VERB
aiua-12833	14	20	it	it	PRON
aiua-12833	14	21	crucial	crucial	ADJ
aiua-12833	14	22	to	to	PART
aiua-12833	14	23	find	find	VERB
aiua-12833	14	24	an	an	DET
aiua-12833	14	25	appropriate	appropriate	ADJ
aiua-12833	14	26	treatment	treatment	NOUN
aiua-12833	14	27	to	to	PART
aiua-12833	14	28	reduce	reduce	VERB
aiua-12833	14	29	the	the	DET
aiua-12833	14	30	incidence	incidence	NOUN
aiua-12833	14	31	of	of	ADP
aiua-12833	14	32	this	this	DET
aiua-12833	14	33	complication	complication	NOUN
aiua-12833	14	34	.	.	PUNCT
aiua-12833	15	1	this	this	DET
aiua-12833	15	2	study	study	NOUN
aiua-12833	15	3	aimed	aim	VERB
aiua-12833	15	4	to	to	PART
aiua-12833	15	5	investigate	investigate	VERB
aiua-12833	15	6	utis	utis	NOUN
aiua-12833	15	7	in	in	ADP
aiua-12833	15	8	parkinson	parkinson	NOUN
aiua-12833	15	9	’s	’s	PART
aiua-12833	15	10	patients	patient	NOUN
aiua-12833	15	11	using	use	VERB
aiua-12833	15	12	levodopa	levodopa	NOUN
aiua-12833	15	13	with	with	ADP
aiua-12833	15	14	dci	dci	PROPN
aiua-12833	15	15	supplements	supplement	NOUN
aiua-12833	15	16	.	.	PUNCT
aiua-12833	16	1	methods	method	NOUN
aiua-12833	16	2	:	:	PUNCT
aiua-12833	16	3	in	in	ADP
aiua-12833	16	4	this	this	DET
aiua-12833	16	5	systematic	systematic	ADJ
aiua-12833	16	6	review	review	NOUN
aiua-12833	16	7	and	and	CCONJ
aiua-12833	16	8	meta	meta	ADJ
aiua-12833	16	9	-	-	PUNCT
aiua-12833	16	10	analysis	analysis	NOUN
aiua-12833	16	11	,	,	PUNCT
aiua-12833	16	12	databases	database	NOUN
aiua-12833	16	13	such	such	ADJ
aiua-12833	16	14	as	as	ADP
aiua-12833	16	15	pubmed	pubmed	PROPN
aiua-12833	16	16	,	,	PUNCT
aiua-12833	16	17	scopus	scopus	PROPN
aiua-12833	16	18	,	,	PUNCT
aiua-12833	16	19	embase	embase	NOUN
aiua-12833	16	20	,	,	PUNCT
aiua-12833	16	21	cochrane	cochrane	NOUN
aiua-12833	16	22	,	,	PUNCT
aiua-12833	16	23	and	and	CCONJ
aiua-12833	16	24	web	web	NOUN
aiua-12833	16	25	of	of	ADP
aiua-12833	16	26	science	science	NOUN
aiua-12833	16	27	were	be	AUX
aiua-12833	16	28	searched	search	VERB
aiua-12833	16	29	up	up	ADP
aiua-12833	16	30	to	to	ADP
aiua-12833	16	31	march	march	PROPN
aiua-12833	16	32	2024	2024	NUM
aiua-12833	16	33	.	.	PUNCT
aiua-12833	17	1	only	only	ADV
aiua-12833	17	2	randomized	randomize	VERB
aiua-12833	17	3	controlled	control	VERB
aiua-12833	17	4	trials	trial	NOUN
aiua-12833	17	5	involving	involve	VERB
aiua-12833	17	6	parkinson	parkinson	NOUN
aiua-12833	17	7	’s	’s	PART
aiua-12833	17	8	patients	patient	NOUN
aiua-12833	17	9	were	be	AUX
aiua-12833	17	10	included	include	VERB
aiua-12833	17	11	in	in	ADP
aiua-12833	17	12	the	the	DET
aiua-12833	17	13	present	present	ADJ
aiua-12833	17	14	study	study	NOUN
aiua-12833	17	15	.	.	PUNCT
aiua-12833	18	1	parkinson	parkinson	NOUN
aiua-12833	18	2	’s	’s	PART
aiua-12833	18	3	patients	patient	NOUN
aiua-12833	18	4	who	who	PRON
aiua-12833	18	5	used	use	VERB
aiua-12833	18	6	levodopa	levodopa	NOUN
aiua-12833	18	7	along	along	ADP
aiua-12833	18	8	with	with	ADP
aiua-12833	18	9	carbidopa	carbidopa	NOUN
aiua-12833	18	10	or	or	CCONJ
aiua-12833	18	11	benserazide	benserazide	NOUN
aiua-12833	18	12	were	be	AUX
aiua-12833	18	13	considered	consider	VERB
aiua-12833	18	14	the	the	DET
aiua-12833	18	15	intervention	intervention	NOUN
aiua-12833	18	16	group	group	NOUN
aiua-12833	18	17	,	,	PUNCT
aiua-12833	18	18	while	while	SCONJ
aiua-12833	18	19	those	those	PRON
aiua-12833	18	20	who	who	PRON
aiua-12833	18	21	used	use	VERB
aiua-12833	18	22	levodopa	levodopa	NOUN
aiua-12833	18	23	with	with	ADP
aiua-12833	18	24	another	another	DET
aiua-12833	18	25	drug	drug	NOUN
aiua-12833	18	26	were	be	AUX
aiua-12833	18	27	considered	consider	VERB
aiua-12833	18	28	the	the	DET
aiua-12833	18	29	control	control	NOUN
aiua-12833	18	30	group	group	NOUN
aiua-12833	18	31	.	.	PUNCT
aiua-12833	19	1	results	result	NOUN
aiua-12833	19	2	:	:	PUNCT
aiua-12833	19	3	nine	nine	NUM
aiua-12833	19	4	interventional	interventional	ADJ
aiua-12833	19	5	studies	study	NOUN
aiua-12833	19	6	were	be	AUX
aiua-12833	19	7	ultimately	ultimately	ADV
aiua-12833	19	8	analyzed	analyze	VERB
aiua-12833	19	9	.	.	PUNCT
aiua-12833	20	1	the	the	DET
aiua-12833	20	2	relative	relative	ADJ
aiua-12833	20	3	risk	risk	NOUN
aiua-12833	20	4	(	(	PUNCT
aiua-12833	20	5	rr	rr	NOUN
aiua-12833	20	6	)	)	PUNCT
aiua-12833	20	7	of	of	ADP
aiua-12833	20	8	uti	uti	PROPN
aiua-12833	20	9	in	in	ADP
aiua-12833	20	10	patients	patient	NOUN
aiua-12833	20	11	taking	take	VERB
aiua-12833	20	12	dci	dci	PROPN
aiua-12833	20	13	was	be	AUX
aiua-12833	20	14	26	26	NUM
aiua-12833	20	15	%	%	NOUN
aiua-12833	20	16	lower	low	ADJ
aiua-12833	20	17	than	than	ADP
aiua-12833	20	18	those	those	PRON
aiua-12833	20	19	who	who	PRON
aiua-12833	20	20	did	do	VERB
aiua-12833	20	21	not	not	PART
aiua-12833	20	22	(	(	PUNCT
aiua-12833	20	23	rr	rr	NOUN
aiua-12833	20	24	treatment	treatment	NOUN
aiua-12833	20	25	/	/	SYM
aiua-12833	20	26	control	control	NOUN
aiua-12833	20	27	=	=	NOUN
aiua-12833	20	28	0.74	0.74	NUM
aiua-12833	20	29	,	,	PUNCT
aiua-12833	20	30	95	95	NUM
aiua-12833	20	31	%	%	NOUN
aiua-12833	20	32	ci	ci	NOUN
aiua-12833	20	33	:	:	PUNCT
aiua-12833	20	34	0.58	0.58	NUM
aiua-12833	20	35	-	-	SYM
aiua-12833	20	36	0.95	0.95	NUM
aiua-12833	20	37	,	,	PUNCT
aiua-12833	20	38	p	p	X
aiua-12833	20	39	=	=	NOUN
aiua-12833	20	40	0.019	0.019	NUM
aiua-12833	20	41	)	)	PUNCT
aiua-12833	20	42	.	.	PUNCT
aiua-12833	21	1	furthermore	furthermore	ADV
aiua-12833	21	2	,	,	PUNCT
aiua-12833	21	3	observations	observation	NOUN
aiua-12833	21	4	at	at	ADP
aiua-12833	21	5	different	different	ADJ
aiua-12833	21	6	times	time	NOUN
aiua-12833	21	7	of	of	ADP
aiua-12833	21	8	follow	follow	NOUN
aiua-12833	21	9	-	-	PUNCT
aiua-12833	21	10	up	up	NOUN
aiua-12833	21	11	showed	show	VERB
aiua-12833	21	12	that	that	SCONJ
aiua-12833	21	13	at	at	ADP
aiua-12833	21	14	13	13	NUM
aiua-12833	21	15	-	-	SYM
aiua-12833	21	16	24	24	NUM
aiua-12833	21	17	weeks	week	NOUN
aiua-12833	21	18	and	and	CCONJ
aiua-12833	21	19	at	at	ADP
aiua-12833	21	20	>	>	SYM
aiua-12833	21	21	24	24	NUM
aiua-12833	21	22	weeks	week	NOUN
aiua-12833	21	23	of	of	ADP
aiua-12833	21	24	treatment	treatment	NOUN
aiua-12833	21	25	with	with	ADP
aiua-12833	21	26	dci	dci	PROPN
aiua-12833	21	27	,	,	PUNCT
aiua-12833	21	28	there	there	PRON
aiua-12833	21	29	was	be	VERB
aiua-12833	21	30	a	a	DET
aiua-12833	21	31	reduction	reduction	NOUN
aiua-12833	21	32	in	in	ADP
aiua-12833	21	33	the	the	DET
aiua-12833	21	34	incidence	incidence	NOUN
aiua-12833	21	35	of	of	ADP
aiua-12833	21	36	uti	uti	PROPN
aiua-12833	21	37	(	(	PUNCT
aiua-12833	21	38	rr	rr	PROPN
aiua-12833	21	39	=	=	SYM
aiua-12833	21	40	0.68	0.68	NUM
aiua-12833	21	41	,	,	PUNCT
aiua-12833	21	42	95	95	NUM
aiua-12833	21	43	%	%	NOUN
aiua-12833	21	44	ci	ci	NOUN
aiua-12833	21	45	:	:	PUNCT
aiua-12833	21	46	0.46	0.46	NUM
aiua-12833	21	47	-	-	SYM
aiua-12833	21	48	1.01	1.01	NUM
aiua-12833	21	49	and	and	CCONJ
aiua-12833	21	50	rr	rr	NOUN
aiua-12833	21	51	=	=	NOUN
aiua-12833	21	52	0.77	0.77	NUM
aiua-12833	21	53	,	,	PUNCT
aiua-12833	21	54	95	95	NUM
aiua-12833	21	55	%	%	NOUN
aiua-12833	21	56	ci	ci	NOUN
aiua-12833	21	57	:	:	PUNCT
aiua-12833	21	58	0.58	0.58	NUM
aiua-12833	21	59	-	-	SYM
aiua-12833	21	60	1.0	1.0	NUM
aiua-12833	21	61	,	,	PUNCT
aiua-12833	21	62	respectively	respectively	ADV
aiua-12833	21	63	)	)	PUNCT
aiua-12833	21	64	.	.	PUNCT
aiua-12833	22	1	on	on	ADP
aiua-12833	22	2	the	the	DET
aiua-12833	22	3	contrary	contrary	NOUN
aiua-12833	22	4	,	,	PUNCT
aiua-12833	22	5	there	there	PRON
aiua-12833	22	6	was	be	VERB
aiua-12833	22	7	an	an	DET
aiua-12833	22	8	increase	increase	NOUN
aiua-12833	22	9	of	of	ADP
aiua-12833	22	10	the	the	DET
aiua-12833	22	11	risk	risk	NOUN
aiua-12833	22	12	of	of	ADP
aiua-12833	22	13	uti	uti	PROPN
aiua-12833	22	14	in	in	ADP
aiua-12833	22	15	the	the	DET
aiua-12833	22	16	first	first	ADJ
aiua-12833	22	17	12	12	NUM
aiua-12833	22	18	weeks	week	NOUN
aiua-12833	22	19	of	of	ADP
aiua-12833	22	20	treatment	treatment	NOUN
aiua-12833	22	21	with	with	ADP
aiua-12833	22	22	dci	dci	PROPN
aiua-12833	22	23	(	(	PUNCT
aiua-12833	22	24	rr	rr	NOUN
aiua-12833	22	25	=	=	SYM
aiua-12833	22	26	1.11	1.11	NUM
aiua-12833	22	27	,	,	PUNCT
aiua-12833	22	28	95	95	NUM
aiua-12833	22	29	%	%	NOUN
aiua-12833	22	30	ci	ci	NOUN
aiua-12833	22	31	:	:	PUNCT
aiua-12833	22	32	0.37	0.37	NUM
aiua-12833	22	33	-	-	SYM
aiua-12833	22	34	3.33	3.33	NUM
aiua-12833	22	35	)	)	PUNCT
aiua-12833	22	36	.	.	PUNCT
aiua-12833	23	1	conclusions	conclusion	NOUN
aiua-12833	23	2	:	:	PUNCT
aiua-12833	23	3	the	the	DET
aiua-12833	23	4	results	result	NOUN
aiua-12833	23	5	of	of	ADP
aiua-12833	23	6	this	this	DET
aiua-12833	23	7	study	study	NOUN
aiua-12833	23	8	indicated	indicate	VERB
aiua-12833	23	9	that	that	SCONJ
aiua-12833	23	10	using	use	VERB
aiua-12833	23	11	dci	dci	PROPN
aiua-12833	23	12	drugs	drug	NOUN
aiua-12833	23	13	is	be	AUX
aiua-12833	23	14	associated	associate	VERB
aiua-12833	23	15	with	with	ADP
aiua-12833	23	16	a	a	DET
aiua-12833	23	17	reduced	reduce	VERB
aiua-12833	23	18	relative	relative	ADJ
aiua-12833	23	19	risk	risk	NOUN
aiua-12833	23	20	of	of	ADP
aiua-12833	23	21	developing	develop	VERB
aiua-12833	23	22	utis	utis	NOUN
aiua-12833	23	23	.	.	PUNCT
aiua-12833	24	1	the	the	DET
aiua-12833	24	2	beneficial	beneficial	ADJ
aiua-12833	24	3	effect	effect	NOUN
aiua-12833	24	4	of	of	ADP
aiua-12833	24	5	the	the	DET
aiua-12833	24	6	drug	drug	NOUN
aiua-12833	24	7	showed	show	VERB
aiua-12833	24	8	after	after	ADP
aiua-12833	24	9	12	12	NUM
aiua-12833	24	10	weeks	week	NOUN
aiua-12833	24	11	of	of	ADP
aiua-12833	24	12	treatment	treatment	NOUN
aiua-12833	24	13	after	after	ADP
aiua-12833	24	14	an	an	DET
aiua-12833	24	15	initial	initial	ADJ
aiua-12833	24	16	negative	negative	ADJ
aiua-12833	24	17	effect	effect	NOUN
aiua-12833	24	18	on	on	ADP
aiua-12833	24	19	the	the	DET
aiua-12833	24	20	risk	risk	NOUN
aiua-12833	24	21	of	of	ADP
aiua-12833	24	22	uti	uti	PROPN
aiua-12833	24	23	.	.	PUNCT
aiua-12833	25	1	key	key	ADJ
aiua-12833	25	2	words	word	NOUN
aiua-12833	25	3	:	:	PUNCT
aiua-12833	25	4	parkinson	parkinson	NOUN
aiua-12833	25	5	’s	’s	PART
aiua-12833	25	6	disease	disease	NOUN
aiua-12833	25	7	;	;	PUNCT
aiua-12833	25	8	urinary	urinary	ADJ
aiua-12833	25	9	tract	tract	NOUN
aiua-12833	25	10	infections	infection	NOUN
aiua-12833	25	11	;	;	PUNCT
aiua-12833	25	12	carbidopa	carbidopa	ADV
aiua-12833	25	13	;	;	PUNCT
aiua-12833	25	14	beneserazide	beneserazide	ADJ
aiua-12833	25	15	;	;	PUNCT
aiua-12833	25	16	dopa	dopa	NOUN
aiua-12833	25	17	-	-	PUNCT
aiua-12833	25	18	decarboxylase	decarboxylase	NOUN
aiua-12833	25	19	inhibitors	inhibitor	NOUN
aiua-12833	25	20	;	;	PUNCT
aiua-12833	25	21	systematic	systematic	ADJ
aiua-12833	25	22	review	review	NOUN
aiua-12833	25	23	;	;	PUNCT
aiua-12833	25	24	meta	meta	ADJ
aiua-12833	25	25	-	-	PUNCT
aiua-12833	25	26	analysis	analysis	NOUN
aiua-12833	25	27	.	.	PUNCT
aiua-12833	25	28	submitted	submit	VERB
aiua-12833	25	29	22	22	NUM
aiua-12833	25	30	july	july	PROPN
aiua-12833	25	31	2024	2024	NUM
aiua-12833	25	32	;	;	PUNCT
aiua-12833	25	33	accepted	accept	VERB
aiua-12833	25	34	2	2	NUM
aiua-12833	25	35	august	august	PROPN
aiua-12833	25	36	2024	2024	NUM
aiua-12833	25	37	effect	effect	NOUN
aiua-12833	25	38	of	of	ADP
aiua-12833	25	39	dopa	dopa	NOUN
aiua-12833	25	40	decarboxylase	decarboxylase	NOUN
aiua-12833	25	41	inhibitor	inhibitor	NOUN
aiua-12833	25	42	supplements	supplement	NOUN
aiua-12833	25	43	on	on	ADP
aiua-12833	25	44	the	the	DET
aiua-12833	25	45	incidence	incidence	NOUN
aiua-12833	25	46	of	of	ADP
aiua-12833	25	47	urinary	urinary	ADJ
aiua-12833	25	48	tract	tract	NOUN
aiua-12833	25	49	infections	infection	NOUN
aiua-12833	25	50	in	in	ADP
aiua-12833	25	51	parkinson	parkinson	NOUN
aiua-12833	25	52	’s	’s	PART
aiua-12833	25	53	disease	disease	NOUN
aiua-12833	25	54	patients	patient	NOUN
aiua-12833	25	55	:	:	PUNCT
aiua-12833	25	56	a	a	DET
aiua-12833	25	57	systematic	systematic	ADJ
aiua-12833	25	58	review	review	NOUN
aiua-12833	25	59	and	and	CCONJ
aiua-12833	25	60	meta	meta	NOUN
aiua-12833	25	61	-	-	PUNCT
aiua-12833	25	62	analysis	analysis	NOUN
aiua-12833	25	63	of	of	ADP
aiua-12833	25	64	randomized	randomized	ADJ
aiua-12833	25	65	controlled	control	VERB
aiua-12833	25	66	trials	trial	NOUN
aiua-12833	25	67	ismaeel	ismaeel	VERB
aiua-12833	25	68	alshoaibi	alshoaibi	ADV
aiua-12833	25	69	1	1	NUM
aiua-12833	25	70	,	,	PUNCT
aiua-12833	25	71	basheer	basheer	NOUN
aiua-12833	25	72	abdo	abdo	PROPN
aiua-12833	25	73	1	1	NUM
aiua-12833	25	74	,	,	PUNCT
aiua-12833	25	75	mohammed	mohammed	PROPN
aiua-12833	25	76	abdullah	abdullah	PROPN
aiua-12833	25	77	1	1	NUM
aiua-12833	25	78	,	,	PUNCT
aiua-12833	25	79	khaled	khale	VERB
aiua-12833	25	80	alzanen	alzanen	PROPN
aiua-12833	25	81	1	1	NUM
aiua-12833	25	82	,	,	PUNCT
aiua-12833	25	83	mohammed	mohammed	PROPN
aiua-12833	25	84	alhakamy	alhakamy	PROPN
aiua-12833	25	85	1	1	NUM
aiua-12833	25	86	,	,	PUNCT
aiua-12833	25	87	mamoon	mamoon	NOUN
aiua-12833	25	88	al	al	PROPN
aiua-12833	25	89	-	-	PUNCT
aiua-12833	25	90	namer	namer	PROPN
aiua-12833	25	91	1	1	NUM
aiua-12833	25	92	,	,	PUNCT
aiua-12833	25	93	abdulghani	abdulghani	PROPN
aiua-12833	25	94	al	al	PROPN
aiua-12833	25	95	-	-	PUNCT
aiua-12833	25	96	hagri	hagri	ADJ
aiua-12833	25	97	2	2	NUM
aiua-12833	25	98	,	,	PUNCT
aiua-12833	25	99	morshed	morshed	ADJ
aiua-12833	25	100	salah	salah	PROPN
aiua-12833	25	101	3	3	NUM
aiua-12833	25	102	,	,	PUNCT
aiua-12833	25	103	afrah	afrah	PROPN
aiua-12833	25	104	salem	salem	PROPN
aiua-12833	25	105	1	1	NUM
aiua-12833	25	106	,	,	PUNCT
aiua-12833	25	107	mohammed	mohammed	PROPN
aiua-12833	25	108	almogahed	almogahe	VERB
aiua-12833	25	109	1	1	NUM
aiua-12833	25	110	,	,	PUNCT
aiua-12833	25	111	ibrahim	ibrahim	NOUN
aiua-12833	25	112	alnadhari	alnadhari	ADJ
aiua-12833	25	113	4	4	NUM
aiua-12833	25	114	,	,	PUNCT
aiua-12833	25	115	faisal	faisal	PROPN
aiua-12833	25	116	ahmed	ahme	VERB
aiua-12833	25	117	5	5	NUM
aiua-12833	25	118	1	1	NUM
aiua-12833	25	119	department	department	NOUN
aiua-12833	25	120	of	of	ADP
aiua-12833	25	121	internal	internal	ADJ
aiua-12833	25	122	medicine	medicine	NOUN
aiua-12833	25	123	,	,	PUNCT
aiua-12833	25	124	school	school	NOUN
aiua-12833	25	125	of	of	ADP
aiua-12833	25	126	medicine	medicine	NOUN
aiua-12833	25	127	,	,	PUNCT
aiua-12833	25	128	ibb	ibb	PROPN
aiua-12833	25	129	university	university	NOUN
aiua-12833	25	130	,	,	PUNCT
aiua-12833	25	131	ibb	ibb	NOUN
aiua-12833	25	132	,	,	PUNCT
aiua-12833	25	133	yemen	yemen	PROPN
aiua-12833	25	134	;	;	PUNCT
aiua-12833	25	135	2	2	NUM
aiua-12833	25	136	student	student	NOUN
aiua-12833	25	137	research	research	NOUN
aiua-12833	25	138	committee	committee	NOUN
aiua-12833	25	139	,	,	PUNCT
aiua-12833	25	140	faculty	faculty	NOUN
aiua-12833	25	141	of	of	ADP
aiua-12833	25	142	medicine	medicine	NOUN
aiua-12833	25	143	and	and	CCONJ
aiua-12833	25	144	health	health	NOUN
aiua-12833	25	145	sciences	science	NOUN
aiua-12833	25	146	,	,	PUNCT
aiua-12833	25	147	sana'a	sana'a	DET
aiua-12833	25	148	university	university	NOUN
aiua-12833	25	149	,	,	PUNCT
aiua-12833	25	150	sana'a	sana'a	PROPN
aiua-12833	25	151	,	,	PUNCT
aiua-12833	25	152	yemen	yemen	PROPN
aiua-12833	25	153	;	;	PUNCT
aiua-12833	25	154	3	3	NUM
aiua-12833	25	155	urology	urology	NOUN
aiua-12833	25	156	section	section	NOUN
aiua-12833	25	157	,	,	PUNCT
aiua-12833	25	158	surgery	surgery	NOUN
aiua-12833	25	159	department	department	NOUN
aiua-12833	25	160	,	,	PUNCT
aiua-12833	25	161	hazm	hazm	PROPN
aiua-12833	25	162	mebaireek	mebaireek	PROPN
aiua-12833	25	163	general	general	ADJ
aiua-12833	25	164	hospital	hospital	NOUN
aiua-12833	25	165	,	,	PUNCT
aiua-12833	25	166	hamad	hamad	PROPN
aiua-12833	25	167	medical	medical	PROPN
aiua-12833	25	168	corporation	corporation	PROPN
aiua-12833	25	169	,	,	PUNCT
aiua-12833	25	170	doha	doha	PROPN
aiua-12833	25	171	,	,	PUNCT
aiua-12833	25	172	qatar	qatar	PROPN
aiua-12833	25	173	.	.	PUNCT
aiua-12833	26	1	4	4	NUM
aiua-12833	26	2	department	department	NOUN
aiua-12833	26	3	of	of	ADP
aiua-12833	26	4	surgery	surgery	NOUN
aiua-12833	26	5	,	,	PUNCT
aiua-12833	26	6	school	school	NOUN
aiua-12833	26	7	of	of	ADP
aiua-12833	26	8	medicine	medicine	NOUN
aiua-12833	26	9	,	,	PUNCT
aiua-12833	26	10	qatar	qatar	PROPN
aiua-12833	26	11	university	university	PROPN
aiua-12833	26	12	,	,	PUNCT
aiua-12833	26	13	doha	doha	PROPN
aiua-12833	26	14	,	,	PUNCT
aiua-12833	26	15	qatar	qatar	PROPN
aiua-12833	26	16	;	;	PUNCT
aiua-12833	26	17	5	5	NUM
aiua-12833	26	18	department	department	NOUN
aiua-12833	26	19	of	of	ADP
aiua-12833	26	20	urology	urology	NOUN
aiua-12833	26	21	,	,	PUNCT
aiua-12833	26	22	school	school	NOUN
aiua-12833	26	23	of	of	ADP
aiua-12833	26	24	medicine	medicine	NOUN
aiua-12833	26	25	,	,	PUNCT
aiua-12833	26	26	ibb	ibb	PROPN
aiua-12833	26	27	university	university	NOUN
aiua-12833	26	28	,	,	PUNCT
aiua-12833	26	29	ibb	ibb	NOUN
aiua-12833	26	30	,	,	PUNCT
aiua-12833	26	31	yemen	yemen	PROPN
aiua-12833	26	32	.	.	PUNCT
aiua-12833	27	1	doi	doi	NOUN
aiua-12833	27	2	:	:	PUNCT
aiua-12833	27	3	10.4081	10.4081	NUM
aiua-12833	27	4	/	/	SYM
aiua-12833	27	5	aiua.2024.12833	aiua.2024.12833	NOUN
aiua-12833	27	6	summary	summary	NOUN
aiua-12833	27	7	archivio	archivio	NOUN
aiua-12833	27	8	italiano	italiano	X
aiua-12833	27	9	di	di	X
aiua-12833	27	10	urologia	urologia	PROPN
aiua-12833	27	11	e	e	PROPN
aiua-12833	27	12	andrologia	andrologia	NOUN
aiua-12833	27	13	2024	2024	NUM
aiua-12833	27	14	;	;	PUNCT
aiua-12833	27	15	96(4):12833	96(4):12833	NUM
aiua-12833	27	16	i.	i.	PROPN
aiua-12833	27	17	alshoaibi	alshoaibi	PROPN
aiua-12833	27	18	,	,	PUNCT
aiua-12833	27	19	b.	b.	PROPN
aiua-12833	27	20	abdo	abdo	PROPN
aiua-12833	27	21	,	,	PUNCT
aiua-12833	27	22	m.	m.	PROPN
aiua-12833	27	23	abdullah	abdullah	PROPN
aiua-12833	27	24	,	,	PUNCT
aiua-12833	27	25	et	et	PROPN
aiua-12833	27	26	al	al	PROPN
aiua-12833	27	27	.	.	PROPN
aiua-12833	27	28	2	2	NUM
aiua-12833	27	29	ity	ity	PROPN
aiua-12833	27	30	,	,	PUNCT
aiua-12833	27	31	falls	fall	VERB
aiua-12833	27	32	,	,	PUNCT
aiua-12833	27	33	and	and	CCONJ
aiua-12833	27	34	hospitalizations	hospitalization	NOUN
aiua-12833	27	35	in	in	ADP
aiua-12833	27	36	these	these	DET
aiua-12833	27	37	patients	patient	NOUN
aiua-12833	27	38	(	(	PUNCT
aiua-12833	27	39	12	12	NUM
aiua-12833	27	40	)	)	PUNCT
aiua-12833	27	41	.	.	PUNCT
aiua-12833	28	1	various	various	ADJ
aiua-12833	28	2	clinical	clinical	ADJ
aiua-12833	28	3	features	feature	NOUN
aiua-12833	28	4	of	of	ADP
aiua-12833	28	5	pd	pd	PROPN
aiua-12833	28	6	,	,	PUNCT
aiua-12833	28	7	including	include	VERB
aiua-12833	28	8	autonomic	autonomic	ADJ
aiua-12833	28	9	dysfunction	dysfunction	NOUN
aiua-12833	28	10	,	,	PUNCT
aiua-12833	28	11	urodynamic	urodynamic	ADJ
aiua-12833	28	12	changes	change	NOUN
aiua-12833	28	13	,	,	PUNCT
aiua-12833	28	14	weakness	weakness	NOUN
aiua-12833	28	15	,	,	PUNCT
aiua-12833	28	16	cognitive	cognitive	ADJ
aiua-12833	28	17	impairment	impairment	NOUN
aiua-12833	28	18	,	,	PUNCT
aiua-12833	28	19	and	and	CCONJ
aiua-12833	28	20	the	the	DET
aiua-12833	28	21	need	need	NOUN
aiua-12833	28	22	for	for	ADP
aiua-12833	28	23	bladder	bladder	NOUN
aiua-12833	28	24	catheterization	catheterization	NOUN
aiua-12833	28	25	,	,	PUNCT
aiua-12833	28	26	contribute	contribute	VERB
aiua-12833	28	27	to	to	ADP
aiua-12833	28	28	the	the	DET
aiua-12833	28	29	increased	increase	VERB
aiua-12833	28	30	risk	risk	NOUN
aiua-12833	28	31	of	of	ADP
aiua-12833	28	32	uti	uti	PROPN
aiua-12833	28	33	(	(	PUNCT
aiua-12833	28	34	13	13	NUM
aiua-12833	28	35	)	)	PUNCT
aiua-12833	28	36	.	.	PUNCT
aiua-12833	29	1	moreover	moreover	ADV
aiua-12833	29	2	,	,	PUNCT
aiua-12833	29	3	untreated	untreated	ADJ
aiua-12833	29	4	uti	uti	PROPN
aiua-12833	29	5	can	can	AUX
aiua-12833	29	6	lead	lead	VERB
aiua-12833	29	7	to	to	ADP
aiua-12833	29	8	urosepsis	urosepsis	NOUN
aiua-12833	29	9	,	,	PUNCT
aiua-12833	29	10	a	a	DET
aiua-12833	29	11	major	major	ADJ
aiua-12833	29	12	complication	complication	NOUN
aiua-12833	29	13	in	in	ADP
aiua-12833	29	14	pd	pd	PROPN
aiua-12833	29	15	.	.	PUNCT
aiua-12833	30	1	the	the	DET
aiua-12833	30	2	use	use	NOUN
aiua-12833	30	3	of	of	ADP
aiua-12833	30	4	clean	clean	ADJ
aiua-12833	30	5	methods	method	NOUN
aiua-12833	30	6	for	for	ADP
aiua-12833	30	7	catheterization	catheterization	NOUN
aiua-12833	30	8	when	when	SCONJ
aiua-12833	30	9	requested	request	VERB
aiua-12833	30	10	,	,	PUNCT
aiua-12833	30	11	antibiotics	antibiotic	NOUN
aiua-12833	30	12	,	,	PUNCT
aiua-12833	30	13	and	and	CCONJ
aiua-12833	30	14	supplements	supplement	NOUN
aiua-12833	30	15	are	be	AUX
aiua-12833	30	16	among	among	ADP
aiua-12833	30	17	the	the	DET
aiua-12833	30	18	preventive	preventive	ADJ
aiua-12833	30	19	strategies	strategy	NOUN
aiua-12833	30	20	for	for	ADP
aiua-12833	30	21	uti	uti	PROPN
aiua-12833	30	22	in	in	ADP
aiua-12833	30	23	pd	pd	PROPN
aiua-12833	30	24	patients	patient	NOUN
aiua-12833	30	25	(	(	PUNCT
aiua-12833	30	26	13	13	NUM
aiua-12833	30	27	)	)	PUNCT
aiua-12833	30	28	.	.	PUNCT
aiua-12833	31	1	various	various	ADJ
aiua-12833	31	2	studies	study	NOUN
aiua-12833	31	3	have	have	AUX
aiua-12833	31	4	reported	report	VERB
aiua-12833	31	5	uti	uti	PROPN
aiua-12833	31	6	as	as	ADP
aiua-12833	31	7	a	a	DET
aiua-12833	31	8	side	side	ADJ
aiua-12833	31	9	effect	effect	NOUN
aiua-12833	31	10	of	of	ADP
aiua-12833	31	11	dci	dci	PROPN
aiua-12833	31	12	drugs	drug	NOUN
aiua-12833	31	13	in	in	ADP
aiua-12833	31	14	parkinson	parkinson	NOUN
aiua-12833	31	15	's	's	PART
aiua-12833	31	16	patients	patient	NOUN
aiua-12833	31	17	(	(	PUNCT
aiua-12833	31	18	1416	1416	NUM
aiua-12833	31	19	)	)	PUNCT
aiua-12833	31	20	.	.	PUNCT
aiua-12833	32	1	however	however	ADV
aiua-12833	32	2	,	,	PUNCT
aiua-12833	32	3	given	give	VERB
aiua-12833	32	4	that	that	SCONJ
aiua-12833	32	5	this	this	DET
aiua-12833	32	6	significant	significant	ADJ
aiua-12833	32	7	complication	complication	NOUN
aiua-12833	32	8	has	have	AUX
aiua-12833	32	9	not	not	PART
aiua-12833	32	10	been	be	AUX
aiua-12833	32	11	addressed	address	VERB
aiua-12833	32	12	explicitly	explicitly	ADV
aiua-12833	32	13	in	in	ADP
aiua-12833	32	14	different	different	ADJ
aiua-12833	32	15	studies	study	NOUN
aiua-12833	32	16	,	,	PUNCT
aiua-12833	32	17	we	we	PRON
aiua-12833	32	18	aimed	aim	VERB
aiua-12833	32	19	to	to	PART
aiua-12833	32	20	conduct	conduct	VERB
aiua-12833	32	21	a	a	DET
aiua-12833	32	22	systematic	systematic	ADJ
aiua-12833	32	23	review	review	NOUN
aiua-12833	32	24	and	and	CCONJ
aiua-12833	32	25	meta	meta	NOUN
aiua-12833	32	26	-	-	PUNCT
aiua-12833	32	27	analysis	analysis	NOUN
aiua-12833	32	28	to	to	PART
aiua-12833	32	29	investigate	investigate	VERB
aiua-12833	32	30	and	and	CCONJ
aiua-12833	32	31	compare	compare	VERB
aiua-12833	32	32	the	the	DET
aiua-12833	32	33	incidence	incidence	NOUN
aiua-12833	32	34	of	of	ADP
aiua-12833	32	35	uti	uti	PROPN
aiua-12833	32	36	due	due	ADP
aiua-12833	32	37	to	to	ADP
aiua-12833	32	38	dci	dci	PROPN
aiua-12833	32	39	drugs	drug	NOUN
aiua-12833	32	40	with	with	ADP
aiua-12833	32	41	other	other	ADJ
aiua-12833	32	42	parkinson	parkinson	NOUN
aiua-12833	32	43	's	's	PART
aiua-12833	32	44	medications	medication	NOUN
aiua-12833	32	45	.	.	PUNCT
aiua-12833	33	1	materials	material	NOUN
aiua-12833	33	2	and	and	CCONJ
aiua-12833	33	3	methods	method	NOUN
aiua-12833	33	4	research	research	NOUN
aiua-12833	33	5	design	design	NOUN
aiua-12833	33	6	this	this	DET
aiua-12833	33	7	systematic	systematic	ADJ
aiua-12833	33	8	review	review	NOUN
aiua-12833	33	9	and	and	CCONJ
aiua-12833	33	10	meta	meta	ADJ
aiua-12833	33	11	-	-	PUNCT
aiua-12833	33	12	analysis	analysis	NOUN
aiua-12833	33	13	were	be	AUX
aiua-12833	33	14	registered	register	VERB
aiua-12833	33	15	with	with	ADP
aiua-12833	33	16	prospero	prospero	NOUN
aiua-12833	33	17	(	(	PUNCT
aiua-12833	33	18	registration	registration	NOUN
aiua-12833	33	19	number	number	NOUN
aiua-12833	33	20	:	:	PUNCT
aiua-12833	33	21	crd42024560930	crd42024560930	NOUN
aiua-12833	33	22	)	)	PUNCT
aiua-12833	33	23	and	and	CCONJ
aiua-12833	33	24	were	be	AUX
aiua-12833	33	25	done	do	VERB
aiua-12833	33	26	according	accord	VERB
aiua-12833	33	27	the	the	DET
aiua-12833	33	28	prisma	prisma	NOUN
aiua-12833	33	29	(	(	PUNCT
aiua-12833	33	30	preferred	prefer	VERB
aiua-12833	33	31	reporting	reporting	NOUN
aiua-12833	33	32	items	item	NOUN
aiua-12833	33	33	for	for	ADP
aiua-12833	33	34	systematic	systematic	ADJ
aiua-12833	33	35	reviews	review	NOUN
aiua-12833	33	36	and	and	CCONJ
aiua-12833	33	37	meta	meta	NOUN
aiua-12833	33	38	-	-	PUNCT
aiua-12833	33	39	analyses	analysis	NOUN
aiua-12833	33	40	)	)	PUNCT
aiua-12833	33	41	guidelines	guideline	NOUN
aiua-12833	33	42	(	(	PUNCT
aiua-12833	33	43	17	17	NUM
aiua-12833	33	44	)	)	PUNCT
aiua-12833	33	45	.	.	PUNCT
aiua-12833	34	1	additionally	additionally	ADV
aiua-12833	34	2	,	,	PUNCT
aiua-12833	34	3	this	this	DET
aiua-12833	34	4	study	study	NOUN
aiua-12833	34	5	was	be	AUX
aiua-12833	34	6	reported	report	VERB
aiua-12833	34	7	in	in	ADP
aiua-12833	34	8	compliance	compliance	NOUN
aiua-12833	34	9	with	with	ADP
aiua-12833	34	10	the	the	DET
aiua-12833	34	11	amstar	amstar	PROPN
aiua-12833	34	12	(	(	PUNCT
aiua-12833	34	13	a	a	DET
aiua-12833	34	14	measurement	measurement	NOUN
aiua-12833	34	15	tool	tool	NOUN
aiua-12833	34	16	to	to	PART
aiua-12833	34	17	assess	assess	VERB
aiua-12833	34	18	systematic	systematic	ADJ
aiua-12833	34	19	reviews	review	NOUN
aiua-12833	34	20	)	)	PUNCT
aiua-12833	34	21	methodological	methodological	ADJ
aiua-12833	34	22	quality	quality	NOUN
aiua-12833	34	23	guidelines	guideline	NOUN
aiua-12833	34	24	.	.	PUNCT
aiua-12833	35	1	research	research	NOUN
aiua-12833	35	2	question	question	NOUN
aiua-12833	35	3	does	do	AUX
aiua-12833	35	4	the	the	DET
aiua-12833	35	5	incidence	incidence	NOUN
aiua-12833	35	6	of	of	ADP
aiua-12833	35	7	uti	uti	PROPN
aiua-12833	35	8	in	in	ADP
aiua-12833	35	9	patients	patient	NOUN
aiua-12833	35	10	treatment	treatment	NOUN
aiua-12833	35	11	with	with	ADP
aiua-12833	35	12	dci	dci	PROPN
aiua-12833	35	13	drugs	drug	NOUN
aiua-12833	35	14	differ	differ	VERB
aiua-12833	35	15	compared	compare	VERB
aiua-12833	35	16	to	to	ADP
aiua-12833	35	17	patients	patient	NOUN
aiua-12833	35	18	on	on	ADP
aiua-12833	35	19	other	other	ADJ
aiua-12833	35	20	parkinson	parkinson	NOUN
aiua-12833	35	21	's	's	PART
aiua-12833	35	22	medications	medication	NOUN
aiua-12833	35	23	?	?	PUNCT
aiua-12833	36	1	research	research	NOUN
aiua-12833	36	2	criteria	criterion	NOUN
aiua-12833	36	3	and	and	CCONJ
aiua-12833	36	4	study	study	NOUN
aiua-12833	36	5	selection	selection	NOUN
aiua-12833	36	6	two	two	NUM
aiua-12833	36	7	researchers	researcher	NOUN
aiua-12833	36	8	independently	independently	ADV
aiua-12833	36	9	imported	import	VERB
aiua-12833	36	10	the	the	DET
aiua-12833	36	11	search	search	NOUN
aiua-12833	36	12	results	result	NOUN
aiua-12833	36	13	from	from	ADP
aiua-12833	36	14	each	each	DET
aiua-12833	36	15	database	database	NOUN
aiua-12833	36	16	into	into	ADP
aiua-12833	36	17	endnote	endnote	PROPN
aiua-12833	36	18	software	software	NOUN
aiua-12833	36	19	.	.	PUNCT
aiua-12833	37	1	using	use	VERB
aiua-12833	37	2	endnote	endnote	NOUN
aiua-12833	37	3	,	,	PUNCT
aiua-12833	37	4	duplicates	duplicate	NOUN
aiua-12833	37	5	were	be	AUX
aiua-12833	37	6	identified	identify	VERB
aiua-12833	37	7	and	and	CCONJ
aiua-12833	37	8	removed	remove	VERB
aiua-12833	37	9	.	.	PUNCT
aiua-12833	38	1	subsequently	subsequently	ADV
aiua-12833	38	2	,	,	PUNCT
aiua-12833	38	3	two	two	NUM
aiua-12833	38	4	researchers	researcher	NOUN
aiua-12833	38	5	screened	screen	VERB
aiua-12833	38	6	all	all	DET
aiua-12833	38	7	remaining	remain	VERB
aiua-12833	38	8	articles	article	NOUN
aiua-12833	38	9	to	to	PART
aiua-12833	38	10	identify	identify	VERB
aiua-12833	38	11	eligible	eligible	ADJ
aiua-12833	38	12	studies	study	NOUN
aiua-12833	38	13	.	.	PUNCT
aiua-12833	39	1	a	a	DET
aiua-12833	39	2	third	third	ADJ
aiua-12833	39	3	researcher	researcher	NOUN
aiua-12833	39	4	reviewed	review	VERB
aiua-12833	39	5	and	and	CCONJ
aiua-12833	39	6	resolved	resolve	VERB
aiua-12833	39	7	any	any	DET
aiua-12833	39	8	controversies	controversy	NOUN
aiua-12833	39	9	between	between	ADP
aiua-12833	39	10	the	the	DET
aiua-12833	39	11	two	two	NUM
aiua-12833	39	12	researchers	researcher	NOUN
aiua-12833	39	13	.	.	PUNCT
aiua-12833	40	1	this	this	DET
aiua-12833	40	2	study	study	NOUN
aiua-12833	40	3	's	's	PART
aiua-12833	40	4	inclusion	inclusion	NOUN
aiua-12833	40	5	criteria	criterion	NOUN
aiua-12833	40	6	were	be	AUX
aiua-12833	40	7	randomized	randomize	VERB
aiua-12833	40	8	clinical	clinical	ADJ
aiua-12833	40	9	trials	trial	NOUN
aiua-12833	40	10	(	(	PUNCT
aiua-12833	40	11	rcts	rct	NOUN
aiua-12833	40	12	)	)	PUNCT
aiua-12833	40	13	published	publish	VERB
aiua-12833	40	14	as	as	ADP
aiua-12833	40	15	full	full	ADJ
aiua-12833	40	16	articles	article	NOUN
aiua-12833	40	17	.	.	PUNCT
aiua-12833	41	1	exclusion	exclusion	NOUN
aiua-12833	41	2	criteria	criterion	NOUN
aiua-12833	41	3	included	include	VERB
aiua-12833	41	4	reviews	review	NOUN
aiua-12833	41	5	,	,	PUNCT
aiua-12833	41	6	book	book	NOUN
aiua-12833	41	7	chapters	chapter	NOUN
aiua-12833	41	8	,	,	PUNCT
aiua-12833	41	9	conference	conference	NOUN
aiua-12833	41	10	abstracts	abstract	NOUN
aiua-12833	41	11	,	,	PUNCT
aiua-12833	41	12	in	in	ADP
aiua-12833	41	13	vivo	vivo	NOUN
aiua-12833	41	14	and	and	CCONJ
aiua-12833	41	15	in	in	ADP
aiua-12833	41	16	vitro	vitro	X
aiua-12833	41	17	studies	study	NOUN
aiua-12833	41	18	,	,	PUNCT
aiua-12833	41	19	cross	cross	ADJ
aiua-12833	41	20	-	-	ADJ
aiua-12833	41	21	sectional	sectional	ADJ
aiua-12833	41	22	,	,	PUNCT
aiua-12833	41	23	case	case	NOUN
aiua-12833	41	24	-	-	PUNCT
aiua-12833	41	25	control	control	NOUN
aiua-12833	41	26	,	,	PUNCT
aiua-12833	41	27	and	and	CCONJ
aiua-12833	41	28	cohort	cohort	NOUN
aiua-12833	41	29	studies	study	NOUN
aiua-12833	41	30	.	.	PUNCT
aiua-12833	42	1	additionally	additionally	ADV
aiua-12833	42	2	,	,	PUNCT
aiua-12833	42	3	studies	study	NOUN
aiua-12833	42	4	with	with	ADP
aiua-12833	42	5	a	a	DET
aiua-12833	42	6	lack	lack	NOUN
aiua-12833	42	7	of	of	ADP
aiua-12833	42	8	full	full	ADJ
aiua-12833	42	9	text	text	NOUN
aiua-12833	42	10	and	and	CCONJ
aiua-12833	42	11	unclear	unclear	ADJ
aiua-12833	42	12	data	datum	NOUN
aiua-12833	42	13	,	,	PUNCT
aiua-12833	42	14	including	include	VERB
aiua-12833	42	15	patients	patient	NOUN
aiua-12833	42	16	with	with	ADP
aiua-12833	42	17	prostate	prostate	NOUN
aiua-12833	42	18	carcinoma	carcinoma	NOUN
aiua-12833	42	19	or	or	CCONJ
aiua-12833	42	20	uncontrolled	uncontrolled	ADJ
aiua-12833	42	21	diabetes	diabete	NOUN
aiua-12833	42	22	,	,	PUNCT
aiua-12833	42	23	patients	patient	NOUN
aiua-12833	42	24	with	with	ADP
aiua-12833	42	25	other	other	ADJ
aiua-12833	42	26	urinary	urinary	ADJ
aiua-12833	42	27	problems	problem	NOUN
aiua-12833	42	28	,	,	PUNCT
aiua-12833	42	29	or	or	CCONJ
aiua-12833	42	30	studies	study	NOUN
aiua-12833	42	31	with	with	ADP
aiua-12833	42	32	small	small	ADJ
aiua-12833	42	33	sample	sample	NOUN
aiua-12833	42	34	size	size	NOUN
aiua-12833	42	35	(	(	PUNCT
aiua-12833	42	36	n	n	CCONJ
aiua-12833	42	37	<	<	X
aiua-12833	42	38	20	20	NUM
aiua-12833	42	39	)	)	PUNCT
aiua-12833	42	40	,	,	PUNCT
aiua-12833	42	41	were	be	AUX
aiua-12833	42	42	excluded	exclude	VERB
aiua-12833	42	43	.	.	PUNCT
aiua-12833	43	1	the	the	DET
aiua-12833	43	2	relative	relative	ADJ
aiua-12833	43	3	risk	risk	NOUN
aiua-12833	43	4	(	(	PUNCT
aiua-12833	43	5	rr	rr	NOUN
aiua-12833	43	6	)	)	PUNCT
aiua-12833	43	7	was	be	AUX
aiua-12833	43	8	calculated	calculate	VERB
aiua-12833	43	9	as	as	ADP
aiua-12833	43	10	the	the	DET
aiua-12833	43	11	effect	effect	NOUN
aiua-12833	43	12	size	size	NOUN
aiua-12833	43	13	based	base	VERB
aiua-12833	43	14	on	on	ADP
aiua-12833	43	15	the	the	DET
aiua-12833	43	16	reported	report	VERB
aiua-12833	43	17	incidence	incidence	NOUN
aiua-12833	43	18	of	of	ADP
aiua-12833	43	19	uti	uti	PROPN
aiua-12833	43	20	in	in	ADP
aiua-12833	43	21	the	the	DET
aiua-12833	43	22	intervention	intervention	NOUN
aiua-12833	43	23	and	and	CCONJ
aiua-12833	43	24	control	control	NOUN
aiua-12833	43	25	groups	group	NOUN
aiua-12833	43	26	.	.	PUNCT
aiua-12833	44	1	the	the	DET
aiua-12833	44	2	intervention	intervention	PROPN
aiua-12833	44	3	group	group	NOUN
aiua-12833	44	4	comprised	comprise	VERB
aiua-12833	44	5	pd	pd	NOUN
aiua-12833	44	6	patients	patient	NOUN
aiua-12833	44	7	who	who	PRON
aiua-12833	44	8	received	receive	VERB
aiua-12833	44	9	dci	dci	PROPN
aiua-12833	44	10	drugs	drug	NOUN
aiua-12833	44	11	(	(	PUNCT
aiua-12833	44	12	carbidopa	carbidopa	NOUN
aiua-12833	44	13	or	or	CCONJ
aiua-12833	44	14	benserazide	benserazide	ADJ
aiua-12833	44	15	)	)	PUNCT
aiua-12833	44	16	alongside	alongside	ADP
aiua-12833	44	17	levodopa	levodopa	NOUN
aiua-12833	44	18	.	.	PUNCT
aiua-12833	45	1	the	the	DET
aiua-12833	45	2	control	control	PROPN
aiua-12833	45	3	group	group	NOUN
aiua-12833	45	4	included	include	VERB
aiua-12833	45	5	pd	pd	PROPN
aiua-12833	45	6	patients	patient	NOUN
aiua-12833	45	7	who	who	PRON
aiua-12833	45	8	took	take	VERB
aiua-12833	45	9	levodopa	levodopa	NOUN
aiua-12833	45	10	with	with	ADP
aiua-12833	45	11	other	other	ADJ
aiua-12833	45	12	medications	medication	NOUN
aiua-12833	45	13	(	(	PUNCT
aiua-12833	45	14	e.g.	e.g.	ADV
aiua-12833	45	15	,	,	PUNCT
aiua-12833	45	16	rotigotine	rotigotine	NOUN
aiua-12833	45	17	,	,	PUNCT
aiua-12833	45	18	safinamide	safinamide	NOUN
aiua-12833	45	19	,	,	PUNCT
aiua-12833	45	20	or	or	CCONJ
aiua-12833	45	21	entacapone	entacapone	NOUN
aiua-12833	45	22	)	)	PUNCT
aiua-12833	45	23	.	.	PUNCT
aiua-12833	46	1	we	we	PRON
aiua-12833	46	2	labeled	label	VERB
aiua-12833	46	3	them	they	PRON
aiua-12833	46	4	as	as	ADP
aiua-12833	46	5	"	"	PUNCT
aiua-12833	46	6	other	other	ADJ
aiua-12833	46	7	"	"	PUNCT
aiua-12833	46	8	to	to	PART
aiua-12833	46	9	indicate	indicate	VERB
aiua-12833	46	10	the	the	DET
aiua-12833	46	11	use	use	NOUN
aiua-12833	46	12	of	of	ADP
aiua-12833	46	13	drugs	drug	NOUN
aiua-12833	46	14	other	other	ADJ
aiua-12833	46	15	than	than	ADP
aiua-12833	46	16	the	the	DET
aiua-12833	46	17	intervention	intervention	NOUN
aiua-12833	46	18	drugs	drug	NOUN
aiua-12833	46	19	.	.	PUNCT
aiua-12833	47	1	search	search	NOUN
aiua-12833	47	2	strategy	strategy	NOUN
aiua-12833	47	3	data	datum	NOUN
aiua-12833	47	4	sources	source	NOUN
aiua-12833	47	5	we	we	PRON
aiua-12833	47	6	researched	research	VERB
aiua-12833	47	7	the	the	DET
aiua-12833	47	8	pubmed	pubmed	PROPN
aiua-12833	47	9	/	/	SYM
aiua-12833	47	10	medline	medline	PROPN
aiua-12833	47	11	,	,	PUNCT
aiua-12833	47	12	scopus	scopus	PROPN
aiua-12833	47	13	,	,	PUNCT
aiua-12833	47	14	embase	embase	NOUN
aiua-12833	47	15	,	,	PUNCT
aiua-12833	47	16	cochrane	cochrane	NOUN
aiua-12833	47	17	library	library	NOUN
aiua-12833	47	18	,	,	PUNCT
aiua-12833	47	19	and	and	CCONJ
aiua-12833	47	20	web	web	NOUN
aiua-12833	47	21	of	of	ADP
aiua-12833	47	22	science	science	NOUN
aiua-12833	47	23	databases	database	NOUN
aiua-12833	47	24	up	up	ADP
aiua-12833	47	25	to	to	ADP
aiua-12833	47	26	march	march	PROPN
aiua-12833	47	27	2024	2024	NUM
aiua-12833	47	28	.	.	PUNCT
aiua-12833	48	1	gray	gray	ADJ
aiua-12833	48	2	literature	literature	PROPN
aiua-12833	48	3	was	be	AUX
aiua-12833	48	4	also	also	ADV
aiua-12833	48	5	reviewed	review	VERB
aiua-12833	48	6	to	to	PART
aiua-12833	48	7	identify	identify	VERB
aiua-12833	48	8	additional	additional	ADJ
aiua-12833	48	9	relevant	relevant	ADJ
aiua-12833	48	10	studies	study	NOUN
aiua-12833	48	11	.	.	PUNCT
aiua-12833	49	1	the	the	DET
aiua-12833	49	2	search	search	NOUN
aiua-12833	49	3	was	be	AUX
aiua-12833	49	4	performed	perform	VERB
aiua-12833	49	5	without	without	ADP
aiua-12833	49	6	any	any	DET
aiua-12833	49	7	time	time	NOUN
aiua-12833	49	8	or	or	CCONJ
aiua-12833	49	9	language	language	NOUN
aiua-12833	49	10	restrictions	restriction	NOUN
aiua-12833	49	11	.	.	PUNCT
aiua-12833	50	1	the	the	DET
aiua-12833	50	2	mesh	mesh	NOUN
aiua-12833	50	3	(	(	PUNCT
aiua-12833	50	4	medical	medical	ADJ
aiua-12833	50	5	subject	subject	ADJ
aiua-12833	50	6	heading	heading	NOUN
aiua-12833	50	7	)	)	PUNCT
aiua-12833	50	8	and	and	CCONJ
aiua-12833	50	9	non	non	ADJ
aiua-12833	50	10	-	-	ADJ
aiua-12833	50	11	mesh	mesh	ADJ
aiua-12833	50	12	keywords	keyword	NOUN
aiua-12833	50	13	used	use	VERB
aiua-12833	50	14	included	include	VERB
aiua-12833	50	15	:	:	PUNCT
aiua-12833	50	16	“	"	PUNCT
aiua-12833	50	17	parkinson	parkinson	NOUN
aiua-12833	50	18	's	's	PART
aiua-12833	50	19	disease	disease	NOUN
aiua-12833	50	20	,	,	PUNCT
aiua-12833	50	21	parkinson	parkinson	NOUN
aiua-12833	50	22	,	,	PUNCT
aiua-12833	50	23	parkinsonism	parkinsonism	NOUN
aiua-12833	50	24	,	,	PUNCT
aiua-12833	50	25	carbidopa	carbidopa	ADV
aiua-12833	50	26	,	,	PUNCT
aiua-12833	50	27	benserazide	benserazide	ADJ
aiua-12833	50	28	,	,	PUNCT
aiua-12833	50	29	aromatic	aromatic	ADJ
aiua-12833	50	30	amino	amino	NOUN
aiua-12833	50	31	acid	acid	NOUN
aiua-12833	50	32	decarboxylase	decarboxylase	NOUN
aiua-12833	50	33	inhibitors	inhibitor	NOUN
aiua-12833	50	34	,	,	PUNCT
aiua-12833	50	35	dopa	dopa	NOUN
aiua-12833	50	36	decarboxylase	decarboxylase	NOUN
aiua-12833	50	37	inhibitor	inhibitor	NOUN
aiua-12833	50	38	,	,	PUNCT
aiua-12833	50	39	dci	dci	PROPN
aiua-12833	50	40	,	,	PUNCT
aiua-12833	50	41	urinary	urinary	ADJ
aiua-12833	50	42	tract	tract	NOUN
aiua-12833	50	43	infections	infection	NOUN
aiua-12833	50	44	,	,	PUNCT
aiua-12833	50	45	cystitis	cystitis	NOUN
aiua-12833	50	46	,	,	PUNCT
aiua-12833	50	47	pyelonephritis	pyelonephritis	NOUN
aiua-12833	50	48	,	,	PUNCT
aiua-12833	50	49	lower	low	ADJ
aiua-12833	50	50	urinary	urinary	ADJ
aiua-12833	50	51	tract	tract	NOUN
aiua-12833	50	52	symptoms	symptom	NOUN
aiua-12833	50	53	,	,	PUNCT
aiua-12833	50	54	urinary	urinary	ADJ
aiua-12833	50	55	,	,	PUNCT
aiua-12833	50	56	and	and	CCONJ
aiua-12833	50	57	urosepsis	urosepsis	ADV
aiua-12833	50	58	”	"	PUNCT
aiua-12833	50	59	.	.	PUNCT
aiua-12833	51	1	a	a	DET
aiua-12833	51	2	multi	multi	ADJ
aiua-12833	51	3	-	-	ADJ
aiua-12833	51	4	stage	stage	ADJ
aiua-12833	51	5	process	process	NOUN
aiua-12833	51	6	was	be	AUX
aiua-12833	51	7	employed	employ	VERB
aiua-12833	51	8	to	to	PART
aiua-12833	51	9	determine	determine	VERB
aiua-12833	51	10	the	the	DET
aiua-12833	51	11	search	search	NOUN
aiua-12833	51	12	keywords	keyword	NOUN
aiua-12833	51	13	and	and	CCONJ
aiua-12833	51	14	design	design	VERB
aiua-12833	51	15	the	the	DET
aiua-12833	51	16	search	search	NOUN
aiua-12833	51	17	syntax	syntax	NOUN
aiua-12833	51	18	,	,	PUNCT
aiua-12833	51	19	utilizing	utilize	VERB
aiua-12833	51	20	common	common	ADJ
aiua-12833	51	21	free	free	ADJ
aiua-12833	51	22	-	-	PUNCT
aiua-12833	51	23	text	text	NOUN
aiua-12833	51	24	keywords	keyword	NOUN
aiua-12833	51	25	and	and	CCONJ
aiua-12833	51	26	mesh	mesh	NOUN
aiua-12833	51	27	terms	term	NOUN
aiua-12833	51	28	.	.	PUNCT
aiua-12833	52	1	data	datum	NOUN
aiua-12833	52	2	extraction	extraction	NOUN
aiua-12833	52	3	the	the	DET
aiua-12833	52	4	outcome	outcome	NOUN
aiua-12833	52	5	was	be	AUX
aiua-12833	52	6	the	the	DET
aiua-12833	52	7	incidence	incidence	NOUN
aiua-12833	52	8	of	of	ADP
aiua-12833	52	9	uti	uti	PROPN
aiua-12833	52	10	complications	complication	NOUN
aiua-12833	52	11	in	in	ADP
aiua-12833	52	12	the	the	DET
aiua-12833	52	13	intervention	intervention	NOUN
aiua-12833	52	14	and	and	CCONJ
aiua-12833	52	15	control	control	NOUN
aiua-12833	52	16	groups	group	NOUN
aiua-12833	52	17	.	.	PUNCT
aiua-12833	53	1	data	datum	NOUN
aiua-12833	53	2	extracted	extract	VERB
aiua-12833	53	3	from	from	ADP
aiua-12833	53	4	each	each	DET
aiua-12833	53	5	study	study	NOUN
aiua-12833	53	6	included	include	VERB
aiua-12833	53	7	the	the	DET
aiua-12833	53	8	first	first	ADJ
aiua-12833	53	9	author	author	NOUN
aiua-12833	53	10	's	's	PART
aiua-12833	53	11	name	name	NOUN
aiua-12833	53	12	,	,	PUNCT
aiua-12833	53	13	publication	publication	NOUN
aiua-12833	53	14	date	date	NOUN
aiua-12833	53	15	,	,	PUNCT
aiua-12833	53	16	start	start	VERB
aiua-12833	53	17	date	date	NOUN
aiua-12833	53	18	of	of	ADP
aiua-12833	53	19	data	datum	NOUN
aiua-12833	53	20	collection	collection	NOUN
aiua-12833	53	21	,	,	PUNCT
aiua-12833	53	22	intervention	intervention	NOUN
aiua-12833	53	23	or	or	CCONJ
aiua-12833	53	24	control	control	NOUN
aiua-12833	53	25	designation	designation	NOUN
aiua-12833	53	26	,	,	PUNCT
aiua-12833	53	27	form	form	NOUN
aiua-12833	53	28	of	of	ADP
aiua-12833	53	29	drug	drug	NOUN
aiua-12833	53	30	administration	administration	NOUN
aiua-12833	53	31	,	,	PUNCT
aiua-12833	53	32	collaborating	collaborate	VERB
aiua-12833	53	33	countries	country	NOUN
aiua-12833	53	34	in	in	ADP
aiua-12833	53	35	data	datum	NOUN
aiua-12833	53	36	collection	collection	NOUN
aiua-12833	53	37	,	,	PUNCT
aiua-12833	53	38	sample	sample	NOUN
aiua-12833	53	39	size	size	NOUN
aiua-12833	53	40	,	,	PUNCT
aiua-12833	53	41	and	and	CCONJ
aiua-12833	53	42	incidence	incidence	NOUN
aiua-12833	53	43	of	of	ADP
aiua-12833	53	44	uti	uti	PROPN
aiua-12833	53	45	in	in	ADP
aiua-12833	53	46	both	both	DET
aiua-12833	53	47	groups	group	NOUN
aiua-12833	53	48	.	.	PUNCT
aiua-12833	54	1	quality	quality	NOUN
aiua-12833	54	2	assessment	assessment	NOUN
aiua-12833	54	3	(	(	PUNCT
aiua-12833	54	4	risk	risk	NOUN
aiua-12833	54	5	of	of	ADP
aiua-12833	54	6	bias	bias	NOUN
aiua-12833	54	7	assessment	assessment	NOUN
aiua-12833	54	8	)	)	PUNCT
aiua-12833	54	9	a	a	DET
aiua-12833	54	10	systematic	systematic	ADJ
aiua-12833	54	11	assessment	assessment	NOUN
aiua-12833	54	12	of	of	ADP
aiua-12833	54	13	bias	bias	NOUN
aiua-12833	54	14	in	in	ADP
aiua-12833	54	15	the	the	DET
aiua-12833	54	16	included	include	VERB
aiua-12833	54	17	rcts	rct	NOUN
aiua-12833	54	18	was	be	AUX
aiua-12833	54	19	conducted	conduct	VERB
aiua-12833	54	20	using	use	VERB
aiua-12833	54	21	the	the	DET
aiua-12833	54	22	cochrane	cochrane	NOUN
aiua-12833	54	23	rob	rob	PROPN
aiua-12833	54	24	2.0	2.0	NUM
aiua-12833	54	25	tool	tool	NOUN
aiua-12833	54	26	(	(	PUNCT
aiua-12833	54	27	introduced	introduce	VERB
aiua-12833	54	28	in	in	ADP
aiua-12833	54	29	2016	2016	NUM
aiua-12833	54	30	and	and	CCONJ
aiua-12833	54	31	last	last	ADJ
aiua-12833	54	32	revised	revise	VERB
aiua-12833	54	33	on	on	ADP
aiua-12833	54	34	august	august	PROPN
aiua-12833	54	35	22	22	NUM
aiua-12833	54	36	,	,	PUNCT
aiua-12833	54	37	2019	2019	NUM
aiua-12833	54	38	)	)	PUNCT
aiua-12833	54	39	to	to	PART
aiua-12833	54	40	assess	assess	VERB
aiua-12833	54	41	the	the	DET
aiua-12833	54	42	risk	risk	NOUN
aiua-12833	54	43	of	of	ADP
aiua-12833	54	44	bias	bias	NOUN
aiua-12833	54	45	in	in	ADP
aiua-12833	54	46	randomized	randomized	ADJ
aiua-12833	54	47	trials	trial	NOUN
aiua-12833	54	48	(	(	PUNCT
aiua-12833	54	49	18	18	NUM
aiua-12833	54	50	)	)	PUNCT
aiua-12833	54	51	.	.	PUNCT
aiua-12833	55	1	the	the	DET
aiua-12833	55	2	following	follow	VERB
aiua-12833	55	3	domains	domain	NOUN
aiua-12833	55	4	were	be	AUX
aiua-12833	55	5	used	use	VERB
aiua-12833	55	6	to	to	PART
aiua-12833	55	7	evaluate	evaluate	VERB
aiua-12833	55	8	each	each	DET
aiua-12833	55	9	study	study	NOUN
aiua-12833	55	10	:	:	PUNCT
aiua-12833	55	11	randomization	randomization	NOUN
aiua-12833	55	12	process	process	NOUN
aiua-12833	55	13	,	,	PUNCT
aiua-12833	55	14	deviations	deviation	NOUN
aiua-12833	55	15	from	from	ADP
aiua-12833	55	16	intended	intended	ADJ
aiua-12833	55	17	interventions	intervention	NOUN
aiua-12833	55	18	,	,	PUNCT
aiua-12833	55	19	missing	miss	VERB
aiua-12833	55	20	outcome	outcome	NOUN
aiua-12833	55	21	data	datum	NOUN
aiua-12833	55	22	,	,	PUNCT
aiua-12833	55	23	measurement	measurement	NOUN
aiua-12833	55	24	of	of	ADP
aiua-12833	55	25	the	the	DET
aiua-12833	55	26	outcome	outcome	NOUN
aiua-12833	55	27	,	,	PUNCT
aiua-12833	55	28	and	and	CCONJ
aiua-12833	55	29	selection	selection	NOUN
aiua-12833	55	30	of	of	ADP
aiua-12833	55	31	the	the	DET
aiua-12833	55	32	reported	report	VERB
aiua-12833	55	33	result	result	NOUN
aiua-12833	55	34	.	.	PUNCT
aiua-12833	56	1	studies	study	NOUN
aiua-12833	56	2	were	be	AUX
aiua-12833	56	3	categorized	categorize	VERB
aiua-12833	56	4	as	as	ADP
aiua-12833	56	5	low	low	ADJ
aiua-12833	56	6	risk	risk	NOUN
aiua-12833	56	7	of	of	ADP
aiua-12833	56	8	bias	bias	NOUN
aiua-12833	56	9	,	,	PUNCT
aiua-12833	56	10	high	high	ADJ
aiua-12833	56	11	risk	risk	NOUN
aiua-12833	56	12	of	of	ADP
aiua-12833	56	13	bias	bias	NOUN
aiua-12833	56	14	,	,	PUNCT
aiua-12833	56	15	or	or	CCONJ
aiua-12833	56	16	with	with	ADP
aiua-12833	56	17	some	some	DET
aiua-12833	56	18	concerns	concern	NOUN
aiua-12833	56	19	.	.	PUNCT
aiua-12833	57	1	two	two	NUM
aiua-12833	57	2	researchers	researcher	NOUN
aiua-12833	57	3	independently	independently	ADV
aiua-12833	57	4	performed	perform	VERB
aiua-12833	57	5	screening	screening	NOUN
aiua-12833	57	6	,	,	PUNCT
aiua-12833	57	7	study	study	NOUN
aiua-12833	57	8	selection	selection	NOUN
aiua-12833	57	9	,	,	PUNCT
aiua-12833	57	10	validation	validation	NOUN
aiua-12833	57	11	,	,	PUNCT
aiua-12833	57	12	data	datum	NOUN
aiua-12833	57	13	extraction	extraction	NOUN
aiua-12833	57	14	,	,	PUNCT
aiua-12833	57	15	and	and	CCONJ
aiua-12833	57	16	methodological	methodological	ADJ
aiua-12833	57	17	quality	quality	NOUN
aiua-12833	57	18	assessment	assessment	NOUN
aiua-12833	57	19	,	,	PUNCT
aiua-12833	57	20	with	with	ADP
aiua-12833	57	21	any	any	DET
aiua-12833	57	22	disagreements	disagreement	NOUN
aiua-12833	57	23	resolved	resolve	VERB
aiua-12833	57	24	by	by	ADP
aiua-12833	57	25	a	a	DET
aiua-12833	57	26	third	third	ADJ
aiua-12833	57	27	reviewer	reviewer	NOUN
aiua-12833	57	28	.	.	PUNCT
aiua-12833	58	1	publication	publication	NOUN
aiua-12833	58	2	bias	bias	NOUN
aiua-12833	58	3	publication	publication	NOUN
aiua-12833	58	4	bias	bias	NOUN
aiua-12833	58	5	was	be	AUX
aiua-12833	58	6	assessed	assess	VERB
aiua-12833	58	7	using	use	VERB
aiua-12833	58	8	funnel	funnel	NOUN
aiua-12833	58	9	plots	plot	NOUN
aiua-12833	58	10	and	and	CCONJ
aiua-12833	58	11	eggar	eggar	NOUN
aiua-12833	58	12	's	's	PART
aiua-12833	58	13	weighted	weight	VERB
aiua-12833	58	14	regression	regression	NOUN
aiua-12833	58	15	(	(	PUNCT
aiua-12833	58	16	19	19	NUM
aiua-12833	58	17	)	)	PUNCT
aiua-12833	58	18	.	.	PUNCT
aiua-12833	59	1	a	a	DET
aiua-12833	59	2	p	p	NOUN
aiua-12833	59	3	-	-	PUNCT
aiua-12833	59	4	value	value	NOUN
aiua-12833	59	5	greater	great	ADJ
aiua-12833	59	6	than	than	ADP
aiua-12833	59	7	0.05	0.05	NUM
aiua-12833	59	8	indicated	indicate	VERB
aiua-12833	59	9	no	no	DET
aiua-12833	59	10	publication	publication	NOUN
aiua-12833	59	11	bias	bias	NOUN
aiua-12833	59	12	.	.	PUNCT
aiua-12833	60	1	subgroup	subgroup	NOUN
aiua-12833	60	2	and	and	CCONJ
aiua-12833	60	3	sensitivity	sensitivity	NOUN
aiua-12833	60	4	analysis	analysis	NOUN
aiua-12833	60	5	sensitivity	sensitivity	NOUN
aiua-12833	60	6	analysis	analysis	NOUN
aiua-12833	60	7	was	be	AUX
aiua-12833	60	8	conducted	conduct	VERB
aiua-12833	60	9	using	use	VERB
aiua-12833	60	10	a	a	DET
aiua-12833	60	11	leave	leave	VERB
aiua-12833	60	12	-	-	PUNCT
aiua-12833	60	13	one	one	NUM
aiua-12833	60	14	-	-	PUNCT
aiua-12833	60	15	out	out	NOUN
aiua-12833	60	16	approach	approach	NOUN
aiua-12833	60	17	to	to	PART
aiua-12833	60	18	assess	assess	VERB
aiua-12833	60	19	the	the	DET
aiua-12833	60	20	impact	impact	NOUN
aiua-12833	60	21	of	of	ADP
aiua-12833	60	22	individual	individual	ADJ
aiua-12833	60	23	studies	study	NOUN
aiua-12833	60	24	on	on	ADP
aiua-12833	60	25	the	the	DET
aiua-12833	60	26	overall	overall	ADJ
aiua-12833	60	27	effect	effect	NOUN
aiua-12833	60	28	size	size	NOUN
aiua-12833	60	29	.	.	PUNCT
aiua-12833	61	1	subgroup	subgroup	NOUN
aiua-12833	61	2	analysis	analysis	NOUN
aiua-12833	61	3	was	be	AUX
aiua-12833	61	4	performed	perform	VERB
aiua-12833	61	5	based	base	VERB
aiua-12833	61	6	on	on	ADP
aiua-12833	61	7	variables	variable	NOUN
aiua-12833	61	8	such	such	ADJ
aiua-12833	61	9	as	as	ADP
aiua-12833	61	10	follow	follow	NOUN
aiua-12833	61	11	-	-	PUNCT
aiua-12833	61	12	up	up	ADP
aiua-12833	61	13	duration	duration	NOUN
aiua-12833	61	14	and	and	CCONJ
aiua-12833	61	15	type	type	NOUN
aiua-12833	61	16	of	of	ADP
aiua-12833	61	17	treatment	treatment	NOUN
aiua-12833	61	18	.	.	PUNCT
aiua-12833	62	1	statistical	statistical	ADJ
aiua-12833	62	2	analyses	analysis	NOUN
aiua-12833	62	3	data	datum	NOUN
aiua-12833	62	4	were	be	AUX
aiua-12833	62	5	entered	enter	VERB
aiua-12833	62	6	into	into	ADP
aiua-12833	62	7	a	a	DET
aiua-12833	62	8	statistical	statistical	ADJ
aiua-12833	62	9	program	program	NOUN
aiua-12833	62	10	and	and	CCONJ
aiua-12833	62	11	analyzed	analyze	VERB
aiua-12833	62	12	using	use	VERB
aiua-12833	62	13	stata	stata	PROPN
aiua-12833	62	14	17.0	17.0	NUM
aiua-12833	62	15	(	(	PUNCT
aiua-12833	62	16	stata	stata	NOUN
aiua-12833	62	17	corporation	corporation	NOUN
aiua-12833	62	18	,	,	PUNCT
aiua-12833	62	19	college	college	NOUN
aiua-12833	62	20	station	station	NOUN
aiua-12833	62	21	,	,	PUNCT
aiua-12833	62	22	tx	tx	PROPN
aiua-12833	62	23	)	)	PUNCT
aiua-12833	62	24	.	.	PUNCT
aiua-12833	63	1	a	a	DET
aiua-12833	63	2	random	random	ADJ
aiua-12833	63	3	effects	effect	NOUN
aiua-12833	63	4	model	model	NOUN
aiua-12833	63	5	was	be	AUX
aiua-12833	63	6	used	use	VERB
aiua-12833	63	7	to	to	PART
aiua-12833	63	8	account	account	VERB
aiua-12833	63	9	for	for	ADP
aiua-12833	63	10	heterogeneity	heterogeneity	NOUN
aiua-12833	63	11	between	between	ADP
aiua-12833	63	12	studies	study	NOUN
aiua-12833	63	13	.	.	PUNCT
aiua-12833	64	1	heterogeneity	heterogeneity	PROPN
aiua-12833	64	2	was	be	AUX
aiua-12833	64	3	assessed	assess	VERB
aiua-12833	64	4	using	use	VERB
aiua-12833	64	5	cochran	cochran	NOUN
aiua-12833	64	6	’s	’s	PART
aiua-12833	64	7	test	test	NOUN
aiua-12833	64	8	and	and	CCONJ
aiua-12833	64	9	the	the	DET
aiua-12833	64	10	higgins	higgins	PROPN
aiua-12833	64	11	i2	i2	PROPN
aiua-12833	64	12	test	test	NOUN
aiua-12833	64	13	,	,	PUNCT
aiua-12833	64	14	and	and	CCONJ
aiua-12833	64	15	the	the	DET
aiua-12833	64	16	differences	difference	NOUN
aiua-12833	64	17	between	between	ADP
aiua-12833	64	18	studies	study	NOUN
aiua-12833	64	19	by	by	ADP
aiua-12833	64	20	the	the	DET
aiua-12833	64	21	researchers	researcher	NOUN
aiua-12833	64	22	were	be	AUX
aiua-12833	64	23	evaluated	evaluate	VERB
aiua-12833	64	24	using	use	VERB
aiua-12833	64	25	qualitative	qualitative	ADJ
aiua-12833	64	26	evaluation	evaluation	NOUN
aiua-12833	64	27	.	.	PUNCT
aiua-12833	65	1	forest	forest	NOUN
aiua-12833	65	2	plots	plot	NOUN
aiua-12833	65	3	were	be	AUX
aiua-12833	65	4	used	use	VERB
aiua-12833	65	5	to	to	PART
aiua-12833	65	6	display	display	VERB
aiua-12833	65	7	the	the	DET
aiua-12833	65	8	effect	effect	NOUN
aiua-12833	65	9	size	size	NOUN
aiua-12833	65	10	of	of	ADP
aiua-12833	65	11	each	each	DET
aiua-12833	65	12	study	study	NOUN
aiua-12833	65	13	and	and	CCONJ
aiua-12833	65	14	pooled	pool	VERB
aiua-12833	65	15	estimates	estimate	NOUN
aiua-12833	65	16	.	.	PUNCT
aiua-12833	66	1	a	a	DET
aiua-12833	66	2	p	p	NOUN
aiua-12833	66	3	-	-	PUNCT
aiua-12833	66	4	value	value	NOUN
aiua-12833	66	5	of	of	ADP
aiua-12833	66	6	less	less	ADJ
aiua-12833	66	7	than	than	ADP
aiua-12833	66	8	0.05	0.05	NUM
aiua-12833	66	9	was	be	AUX
aiua-12833	66	10	considered	consider	VERB
aiua-12833	66	11	statistically	statistically	ADV
aiua-12833	66	12	significant	significant	ADJ
aiua-12833	66	13	.	.	PUNCT
aiua-12833	67	1	results	result	NOUN
aiua-12833	67	2	study	study	VERB
aiua-12833	67	3	selection	selection	NOUN
aiua-12833	67	4	and	and	CCONJ
aiua-12833	67	5	characteristics	characteristic	NOUN
aiua-12833	67	6	after	after	ADP
aiua-12833	67	7	searching	search	VERB
aiua-12833	67	8	all	all	DET
aiua-12833	67	9	international	international	ADJ
aiua-12833	67	10	databases	database	NOUN
aiua-12833	67	11	,	,	PUNCT
aiua-12833	67	12	1407	1407	NUM
aiua-12833	67	13	articles	article	NOUN
aiua-12833	67	14	archivio	archivio	NOUN
aiua-12833	67	15	italiano	italiano	X
aiua-12833	67	16	di	di	X
aiua-12833	67	17	urologia	urologia	PROPN
aiua-12833	67	18	e	e	PROPN
aiua-12833	67	19	andrologia	andrologia	NOUN
aiua-12833	67	20	2024	2024	NUM
aiua-12833	67	21	;	;	PUNCT
aiua-12833	67	22	96(4):12833	96(4):12833	NUM
aiua-12833	67	23	3	3	NUM
aiua-12833	67	24	dopa	dopa	NOUN
aiua-12833	67	25	decarboxylase	decarboxylase	NOUN
aiua-12833	67	26	inhibitors	inhibitor	NOUN
aiua-12833	67	27	and	and	CCONJ
aiua-12833	67	28	risk	risk	NOUN
aiua-12833	67	29	of	of	ADP
aiua-12833	67	30	urinary	urinary	ADJ
aiua-12833	67	31	tract	tract	NOUN
aiua-12833	67	32	infections	infection	NOUN
aiua-12833	67	33	in	in	ADP
aiua-12833	67	34	parkinson	parkinson	NOUN
aiua-12833	67	35	’s	’s	PART
aiua-12833	67	36	disease	disease	NOUN
aiua-12833	67	37	were	be	AUX
aiua-12833	67	38	found	find	VERB
aiua-12833	67	39	.	.	PUNCT
aiua-12833	68	1	after	after	ADP
aiua-12833	68	2	removing	remove	VERB
aiua-12833	68	3	duplicate	duplicate	ADJ
aiua-12833	68	4	articles	article	NOUN
aiua-12833	68	5	,	,	PUNCT
aiua-12833	68	6	1328	1328	NUM
aiua-12833	68	7	were	be	AUX
aiua-12833	68	8	screened	screen	VERB
aiua-12833	68	9	for	for	ADP
aiua-12833	68	10	title	title	NOUN
aiua-12833	68	11	and	and	CCONJ
aiua-12833	68	12	abstract	abstract	ADJ
aiua-12833	68	13	review	review	NOUN
aiua-12833	68	14	.	.	PUNCT
aiua-12833	69	1	following	follow	VERB
aiua-12833	69	2	the	the	DET
aiua-12833	69	3	screening	screening	NOUN
aiua-12833	69	4	phase	phase	NOUN
aiua-12833	69	5	,	,	PUNCT
aiua-12833	69	6	150	150	NUM
aiua-12833	69	7	articles	article	NOUN
aiua-12833	69	8	were	be	AUX
aiua-12833	69	9	selected	select	VERB
aiua-12833	69	10	for	for	ADP
aiua-12833	69	11	the	the	DET
aiua-12833	69	12	next	next	ADJ
aiua-12833	69	13	phase	phase	NOUN
aiua-12833	69	14	,	,	PUNCT
aiua-12833	69	15	where	where	SCONJ
aiua-12833	69	16	full	full	ADJ
aiua-12833	69	17	-	-	PUNCT
aiua-12833	69	18	text	text	NOUN
aiua-12833	69	19	articles	article	NOUN
aiua-12833	69	20	were	be	AUX
aiua-12833	69	21	assessed	assess	VERB
aiua-12833	69	22	,	,	PUNCT
aiua-12833	69	23	and	and	CCONJ
aiua-12833	69	24	nine	nine	NUM
aiua-12833	69	25	articles	article	NOUN
aiua-12833	69	26	were	be	AUX
aiua-12833	69	27	included	include	VERB
aiua-12833	69	28	in	in	ADP
aiua-12833	69	29	the	the	DET
aiua-12833	69	30	final	final	ADJ
aiua-12833	69	31	analysis	analysis	NOUN
aiua-12833	69	32	(	(	PUNCT
aiua-12833	69	33	20	20	NUM
aiua-12833	69	34	-	-	SYM
aiua-12833	69	35	28	28	NUM
aiua-12833	69	36	)	)	PUNCT
aiua-12833	69	37	.	.	PUNCT
aiua-12833	70	1	additionally	additionally	ADV
aiua-12833	70	2	,	,	PUNCT
aiua-12833	70	3	the	the	DET
aiua-12833	70	4	references	reference	NOUN
aiua-12833	70	5	of	of	ADP
aiua-12833	70	6	the	the	DET
aiua-12833	70	7	included	include	VERB
aiua-12833	70	8	articles	article	NOUN
aiua-12833	70	9	were	be	AUX
aiua-12833	70	10	examined	examine	VERB
aiua-12833	70	11	to	to	PART
aiua-12833	70	12	identify	identify	VERB
aiua-12833	70	13	and	and	CCONJ
aiua-12833	70	14	include	include	VERB
aiua-12833	70	15	related	related	ADJ
aiua-12833	70	16	studies	study	NOUN
aiua-12833	70	17	.	.	PUNCT
aiua-12833	71	1	the	the	DET
aiua-12833	71	2	study	study	NOUN
aiua-12833	71	3	selection	selection	NOUN
aiua-12833	71	4	process	process	NOUN
aiua-12833	71	5	is	be	AUX
aiua-12833	71	6	illustrated	illustrate	VERB
aiua-12833	71	7	in	in	ADP
aiua-12833	71	8	figure	figure	NOUN
aiua-12833	71	9	1	1	NUM
aiua-12833	71	10	.	.	PUNCT
aiua-12833	72	1	the	the	DET
aiua-12833	72	2	included	include	VERB
aiua-12833	72	3	studies	study	NOUN
aiua-12833	72	4	were	be	AUX
aiua-12833	72	5	up	up	ADP
aiua-12833	72	6	to	to	ADP
aiua-12833	72	7	march	march	PROPN
aiua-12833	72	8	2024	2024	NUM
aiua-12833	72	9	.	.	PUNCT
aiua-12833	73	1	nine	nine	NUM
aiua-12833	73	2	studies	study	NOUN
aiua-12833	73	3	comprising	comprise	VERB
aiua-12833	73	4	18	18	NUM
aiua-12833	73	5	records	record	NOUN
aiua-12833	73	6	within	within	ADP
aiua-12833	73	7	the	the	DET
aiua-12833	73	8	time	time	NOUN
aiua-12833	73	9	frame	frame	NOUN
aiua-12833	73	10	were	be	AUX
aiua-12833	73	11	eligible	eligible	ADJ
aiua-12833	73	12	,	,	PUNCT
aiua-12833	73	13	and	and	CCONJ
aiua-12833	73	14	they	they	PRON
aiua-12833	73	15	specifically	specifically	ADV
aiua-12833	73	16	addressed	address	VERB
aiua-12833	73	17	uti	uti	PROPN
aiua-12833	73	18	as	as	ADP
aiua-12833	73	19	a	a	DET
aiua-12833	73	20	side	side	ADJ
aiua-12833	73	21	effect	effect	NOUN
aiua-12833	73	22	of	of	ADP
aiua-12833	73	23	dci	dci	PROPN
aiua-12833	73	24	use	use	NOUN
aiua-12833	73	25	in	in	ADP
aiua-12833	73	26	parkinson	parkinson	NOUN
aiua-12833	73	27	's	's	PART
aiua-12833	73	28	disease	disease	NOUN
aiua-12833	73	29	patients	patient	NOUN
aiua-12833	73	30	.	.	PUNCT
aiua-12833	74	1	descriptive	descriptive	ADJ
aiua-12833	74	2	data	datum	NOUN
aiua-12833	74	3	of	of	ADP
aiua-12833	74	4	these	these	DET
aiua-12833	74	5	studies	study	NOUN
aiua-12833	74	6	are	be	AUX
aiua-12833	74	7	presented	present	VERB
aiua-12833	74	8	in	in	ADP
aiua-12833	74	9	table	table	NOUN
aiua-12833	74	10	1	1	NUM
aiua-12833	74	11	(	(	PUNCT
aiua-12833	74	12	20	20	NUM
aiua-12833	74	13	-	-	SYM
aiua-12833	74	14	28	28	NUM
aiua-12833	74	15	)	)	PUNCT
aiua-12833	74	16	.	.	PUNCT
aiua-12833	75	1	risk	risk	NOUN
aiua-12833	75	2	of	of	ADP
aiua-12833	75	3	bias	bias	NOUN
aiua-12833	75	4	assessment	assessment	NOUN
aiua-12833	75	5	figure	figure	NOUN
aiua-12833	75	6	2	2	NUM
aiua-12833	75	7	shows	show	VERB
aiua-12833	75	8	the	the	DET
aiua-12833	75	9	quality	quality	NOUN
aiua-12833	75	10	assessment	assessment	NOUN
aiua-12833	75	11	results	result	NOUN
aiua-12833	75	12	.	.	PUNCT
aiua-12833	76	1	based	base	VERB
aiua-12833	76	2	on	on	ADP
aiua-12833	76	3	the	the	DET
aiua-12833	76	4	quality	quality	NOUN
aiua-12833	76	5	evaluation	evaluation	NOUN
aiua-12833	76	6	checklist	checklist	NOUN
aiua-12833	76	7	used	use	VERB
aiua-12833	76	8	,	,	PUNCT
aiua-12833	76	9	7	7	NUM
aiua-12833	76	10	articles	article	NOUN
aiua-12833	76	11	were	be	AUX
aiua-12833	76	12	of	of	ADP
aiua-12833	76	13	good	good	ADJ
aiua-12833	76	14	quality	quality	NOUN
aiua-12833	76	15	(	(	PUNCT
aiua-12833	76	16	low	low	ADJ
aiua-12833	76	17	risk	risk	NOUN
aiua-12833	76	18	)	)	PUNCT
aiua-12833	76	19	,	,	PUNCT
aiua-12833	76	20	2	2	NUM
aiua-12833	76	21	articles	article	NOUN
aiua-12833	76	22	had	have	VERB
aiua-12833	76	23	some	some	DET
aiua-12833	76	24	concerns	concern	NOUN
aiua-12833	76	25	,	,	PUNCT
aiua-12833	76	26	and	and	CCONJ
aiua-12833	76	27	none	none	NOUN
aiua-12833	76	28	were	be	AUX
aiua-12833	76	29	of	of	ADP
aiua-12833	76	30	poor	poor	ADJ
aiua-12833	76	31	quality	quality	NOUN
aiua-12833	76	32	(	(	PUNCT
aiua-12833	76	33	high	high	ADJ
aiua-12833	76	34	risk	risk	NOUN
aiua-12833	76	35	)	)	PUNCT
aiua-12833	76	36	.	.	PUNCT
aiua-12833	77	1	it	it	PRON
aiua-12833	77	2	is	be	AUX
aiua-12833	77	3	noteworthy	noteworthy	ADJ
aiua-12833	77	4	that	that	SCONJ
aiua-12833	77	5	all	all	DET
aiua-12833	77	6	the	the	DET
aiua-12833	77	7	reviewed	review	VERB
aiua-12833	77	8	studies	study	NOUN
aiua-12833	77	9	were	be	AUX
aiua-12833	77	10	randomized	randomize	VERB
aiua-12833	77	11	trials	trial	NOUN
aiua-12833	77	12	.	.	PUNCT
aiua-12833	78	1	in	in	ADP
aiua-12833	78	2	7	7	NUM
aiua-12833	78	3	studies	study	NOUN
aiua-12833	78	4	,	,	PUNCT
aiua-12833	78	5	blindness	blindness	NOUN
aiua-12833	78	6	was	be	AUX
aiua-12833	78	7	double	double	ADJ
aiua-12833	78	8	-	-	PUNCT
aiua-12833	78	9	masked	mask	VERB
aiua-12833	78	10	,	,	PUNCT
aiua-12833	78	11	and	and	CCONJ
aiua-12833	78	12	five	five	NUM
aiua-12833	78	13	studies	study	NOUN
aiua-12833	78	14	were	be	AUX
aiua-12833	78	15	phase	phase	NOUN
aiua-12833	78	16	3	3	NUM
aiua-12833	78	17	trials	trial	NOUN
aiua-12833	78	18	.	.	PUNCT
aiua-12833	79	1	heterogeneity	heterogeneity	VERB
aiua-12833	79	2	the	the	DET
aiua-12833	79	3	results	result	NOUN
aiua-12833	79	4	of	of	ADP
aiua-12833	79	5	the	the	DET
aiua-12833	79	6	chi	chi	NOUN
aiua-12833	79	7	-	-	PUNCT
aiua-12833	79	8	squared	square	VERB
aiua-12833	79	9	test	test	NOUN
aiua-12833	79	10	and	and	CCONJ
aiua-12833	79	11	the	the	DET
aiua-12833	79	12	i2	i2	PROPN
aiua-12833	79	13	index	index	NOUN
aiua-12833	79	14	indicated	indicate	VERB
aiua-12833	79	15	no	no	DET
aiua-12833	79	16	heterogeneity	heterogeneity	NOUN
aiua-12833	79	17	regarding	regard	VERB
aiua-12833	79	18	side	side	NOUN
aiua-12833	79	19	effects	effect	NOUN
aiua-12833	79	20	among	among	ADP
aiua-12833	79	21	the	the	DET
aiua-12833	79	22	studies	study	NOUN
aiua-12833	79	23	(	(	PUNCT
aiua-12833	79	24	i2	i2	NOUN
aiua-12833	79	25	=	=	PUNCT
aiua-12833	79	26	7.52	7.52	NUM
aiua-12833	79	27	%	%	NOUN
aiua-12833	79	28	,	,	PUNCT
aiua-12833	79	29	q	q	NOUN
aiua-12833	79	30	-	-	PUNCT
aiua-12833	79	31	value	value	NOUN
aiua-12833	79	32	=	=	NOUN
aiua-12833	79	33	14.07	14.07	NUM
aiua-12833	79	34	,	,	PUNCT
aiua-12833	79	35	p	p	X
aiua-12833	79	36	=	=	NOUN
aiua-12833	79	37	0.661	0.661	NUM
aiua-12833	79	38	)	)	PUNCT
aiua-12833	79	39	.	.	PUNCT
aiua-12833	80	1	however	however	ADV
aiua-12833	80	2	,	,	PUNCT
aiua-12833	80	3	due	due	ADP
aiua-12833	80	4	to	to	ADP
aiua-12833	80	5	the	the	DET
aiua-12833	80	6	inherent	inherent	ADJ
aiua-12833	80	7	qualitative	qualitative	ADJ
aiua-12833	80	8	differences	difference	NOUN
aiua-12833	80	9	between	between	ADP
aiua-12833	80	10	the	the	DET
aiua-12833	80	11	studies	study	NOUN
aiua-12833	80	12	,	,	PUNCT
aiua-12833	80	13	a	a	DET
aiua-12833	80	14	random	random	ADJ
aiua-12833	80	15	effects	effect	NOUN
aiua-12833	80	16	model	model	NOUN
aiua-12833	80	17	was	be	AUX
aiua-12833	80	18	used	use	VERB
aiua-12833	80	19	for	for	ADP
aiua-12833	80	20	the	the	DET
aiua-12833	80	21	analyses	analysis	NOUN
aiua-12833	80	22	.	.	PUNCT
aiua-12833	81	1	the	the	DET
aiua-12833	81	2	results	result	NOUN
aiua-12833	81	3	of	of	ADP
aiua-12833	81	4	the	the	DET
aiua-12833	81	5	fixed	fix	VERB
aiua-12833	81	6	effects	effect	NOUN
aiua-12833	81	7	model	model	NOUN
aiua-12833	81	8	were	be	AUX
aiua-12833	81	9	also	also	ADV
aiua-12833	81	10	reported	report	VERB
aiua-12833	81	11	.	.	PUNCT
aiua-12833	82	1	the	the	DET
aiua-12833	82	2	relative	relative	ADJ
aiua-12833	82	3	risk	risk	NOUN
aiua-12833	82	4	of	of	ADP
aiua-12833	82	5	uti	uti	PROPN
aiua-12833	82	6	side	side	NOUN
aiua-12833	82	7	effects	effect	NOUN
aiua-12833	82	8	based	base	VERB
aiua-12833	82	9	on	on	ADP
aiua-12833	82	10	the	the	DET
aiua-12833	82	11	random	random	ADJ
aiua-12833	82	12	effects	effect	NOUN
aiua-12833	82	13	model	model	NOUN
aiua-12833	82	14	,	,	PUNCT
aiua-12833	82	15	the	the	DET
aiua-12833	82	16	relative	relative	ADJ
aiua-12833	82	17	risk	risk	NOUN
aiua-12833	82	18	(	(	PUNCT
aiua-12833	82	19	rr	rr	NOUN
aiua-12833	82	20	)	)	PUNCT
aiua-12833	82	21	of	of	ADP
aiua-12833	82	22	uti	uti	PROPN
aiua-12833	82	23	in	in	ADP
aiua-12833	82	24	patients	patient	NOUN
aiua-12833	82	25	taking	take	VERB
aiua-12833	82	26	dci	dci	PROPN
aiua-12833	82	27	(	(	PUNCT
aiua-12833	82	28	carbidopa	carbidopa	ADV
aiua-12833	82	29	)	)	PUNCT
aiua-12833	82	30	was	be	AUX
aiua-12833	82	31	26	26	NUM
aiua-12833	82	32	%	%	NOUN
aiua-12833	82	33	lower	low	ADJ
aiua-12833	82	34	than	than	ADP
aiua-12833	82	35	in	in	ADP
aiua-12833	82	36	patients	patient	NOUN
aiua-12833	82	37	not	not	PART
aiua-12833	82	38	taking	take	VERB
aiua-12833	82	39	it	it	PRON
aiua-12833	82	40	,	,	PUNCT
aiua-12833	82	41	and	and	CCONJ
aiua-12833	82	42	this	this	DET
aiua-12833	82	43	reduction	reduction	NOUN
aiua-12833	82	44	was	be	AUX
aiua-12833	82	45	statistically	statistically	ADV
aiua-12833	82	46	significant	significant	ADJ
aiua-12833	82	47	(	(	PUNCT
aiua-12833	82	48	rr	rr	NOUN
aiua-12833	82	49	treatment	treatment	NOUN
aiua-12833	82	50	/	/	SYM
aiua-12833	82	51	control	control	NOUN
aiua-12833	82	52	=	=	NOUN
aiua-12833	82	53	0.74	0.74	NUM
aiua-12833	82	54	,	,	PUNCT
aiua-12833	82	55	95	95	NUM
aiua-12833	82	56	%	%	NOUN
aiua-12833	82	57	ci	ci	NOUN
aiua-12833	82	58	:	:	PUNCT
aiua-12833	82	59	0.58	0.58	NUM
aiua-12833	82	60	-	-	SYM
aiua-12833	82	61	0.95	0.95	NUM
aiua-12833	82	62	,	,	PUNCT
aiua-12833	82	63	p	p	X
aiua-12833	82	64	=	=	NOUN
aiua-12833	82	65	0.019	0.019	NUM
aiua-12833	82	66	)	)	PUNCT
aiua-12833	82	67	(	(	PUNCT
aiua-12833	82	68	figure	figure	NOUN
aiua-12833	82	69	3	3	NUM
aiua-12833	82	70	)	)	PUNCT
aiua-12833	82	71	.	.	PUNCT
aiua-12833	83	1	similarly	similarly	ADV
aiua-12833	83	2	,	,	PUNCT
aiua-12833	83	3	based	base	VERB
aiua-12833	83	4	on	on	ADP
aiua-12833	83	5	the	the	DET
aiua-12833	83	6	fixed	fix	VERB
aiua-12833	83	7	effects	effect	NOUN
aiua-12833	83	8	model	model	NOUN
aiua-12833	83	9	,	,	PUNCT
aiua-12833	83	10	the	the	DET
aiua-12833	83	11	results	result	NOUN
aiua-12833	83	12	were	be	AUX
aiua-12833	83	13	consistent	consistent	ADJ
aiua-12833	83	14	,	,	PUNCT
aiua-12833	83	15	showing	show	VERB
aiua-12833	83	16	a	a	DET
aiua-12833	83	17	25	25	NUM
aiua-12833	83	18	%	%	NOUN
aiua-12833	83	19	lower	low	ADJ
aiua-12833	83	20	relative	relative	ADJ
aiua-12833	83	21	risk	risk	NOUN
aiua-12833	83	22	of	of	ADP
aiua-12833	83	23	uti	uti	PROPN
aiua-12833	83	24	in	in	ADP
aiua-12833	83	25	patients	patient	NOUN
aiua-12833	83	26	taking	take	VERB
aiua-12833	83	27	dci	dci	PROPN
aiua-12833	83	28	(	(	PUNCT
aiua-12833	83	29	carbidopa	carbidopa	ADV
aiua-12833	83	30	)	)	PUNCT
aiua-12833	83	31	compared	compare	VERB
aiua-12833	83	32	to	to	ADP
aiua-12833	83	33	those	those	PRON
aiua-12833	83	34	not	not	PART
aiua-12833	83	35	taking	take	VERB
aiua-12833	83	36	it	it	PRON
aiua-12833	83	37	(	(	PUNCT
aiua-12833	83	38	rr	rr	NOUN
aiua-12833	83	39	treatment	treatment	NOUN
aiua-12833	83	40	/	/	SYM
aiua-12833	83	41	control	control	NOUN
aiua-12833	83	42	=	=	SYM
aiua-12833	83	43	0.75	0.75	NUM
aiua-12833	83	44	,	,	PUNCT
aiua-12833	83	45	95	95	NUM
aiua-12833	83	46	%	%	NOUN
aiua-12833	83	47	ci	ci	NOUN
aiua-12833	83	48	:	:	PUNCT
aiua-12833	83	49	0.60	0.60	NUM
aiua-12833	83	50	-	-	SYM
aiua-12833	83	51	0.94	0.94	NUM
aiua-12833	83	52	,	,	PUNCT
aiua-12833	83	53	p	p	X
aiua-12833	83	54	=	=	NOUN
aiua-12833	83	55	0.012	0.012	NUM
aiua-12833	83	56	)	)	PUNCT
aiua-12833	83	57	(	(	PUNCT
aiua-12833	83	58	appendix	appendix	NOUN
aiua-12833	83	59	1	1	NUM
aiua-12833	83	60	)	)	PUNCT
aiua-12833	83	61	.	.	PUNCT
aiua-12833	84	1	subgroup	subgroup	PROPN
aiua-12833	84	2	analysis	analysis	NOUN
aiua-12833	84	3	the	the	DET
aiua-12833	84	4	subgroup	subgroup	NOUN
aiua-12833	84	5	analysis	analysis	NOUN
aiua-12833	84	6	results	result	NOUN
aiua-12833	84	7	based	base	VERB
aiua-12833	84	8	on	on	ADP
aiua-12833	84	9	the	the	DET
aiua-12833	84	10	type	type	NOUN
aiua-12833	84	11	of	of	ADP
aiua-12833	84	12	intervention	intervention	NOUN
aiua-12833	84	13	(	(	PUNCT
aiua-12833	84	14	dci	dci	PROPN
aiua-12833	84	15	group	group	NOUN
aiua-12833	84	16	vs.	vs.	ADP
aiua-12833	84	17	other	other	ADJ
aiua-12833	84	18	groups	group	NOUN
aiua-12833	84	19	)	)	PUNCT
aiua-12833	84	20	were	be	AUX
aiua-12833	84	21	consistent	consistent	ADJ
aiua-12833	84	22	.	.	PUNCT
aiua-12833	85	1	in	in	ADP
aiua-12833	85	2	the	the	DET
aiua-12833	85	3	dci	dci	PROPN
aiua-12833	85	4	group	group	NOUN
aiua-12833	85	5	,	,	PUNCT
aiua-12833	85	6	the	the	DET
aiua-12833	85	7	relative	relative	ADJ
aiua-12833	85	8	risk	risk	NOUN
aiua-12833	85	9	of	of	ADP
aiua-12833	85	10	uti	uti	PROPN
aiua-12833	85	11	was	be	AUX
aiua-12833	85	12	26	26	NUM
aiua-12833	85	13	%	%	NOUN
aiua-12833	85	14	lower	low	ADJ
aiua-12833	85	15	(	(	PUNCT
aiua-12833	85	16	rr	rr	NOUN
aiua-12833	85	17	=	=	SYM
aiua-12833	85	18	0.74	0.74	NUM
aiua-12833	85	19	,	,	PUNCT
aiua-12833	85	20	95	95	NUM
aiua-12833	85	21	%	%	NOUN
aiua-12833	85	22	ci	ci	NOUN
aiua-12833	85	23	:	:	PUNCT
aiua-12833	85	24	0.54	0.54	NUM
aiua-12833	85	25	-	-	SYM
aiua-12833	85	26	1.03	1.03	NUM
aiua-12833	85	27	)	)	PUNCT
aiua-12833	85	28	,	,	PUNCT
aiua-12833	85	29	and	and	CCONJ
aiua-12833	85	30	in	in	ADP
aiua-12833	85	31	the	the	DET
aiua-12833	85	32	other	other	ADJ
aiua-12833	85	33	group	group	NOUN
aiua-12833	85	34	,	,	PUNCT
aiua-12833	85	35	it	it	PRON
aiua-12833	85	36	was	be	AUX
aiua-12833	85	37	24	24	NUM
aiua-12833	85	38	%	%	NOUN
aiua-12833	85	39	lower	lower	ADV
aiua-12833	85	40	(	(	PUNCT
aiua-12833	85	41	rr	rr	NOUN
aiua-12833	85	42	=	=	SYM
aiua-12833	85	43	0.76	0.76	NUM
aiua-12833	85	44	,	,	PUNCT
aiua-12833	85	45	95	95	NUM
aiua-12833	85	46	%	%	NOUN
aiua-12833	85	47	ci	ci	NOUN
aiua-12833	85	48	:	:	PUNCT
aiua-12833	85	49	0.56	0.56	NUM
aiua-12833	85	50	-	-	SYM
aiua-12833	85	51	1.03	1.03	NUM
aiua-12833	85	52	)	)	PUNCT
aiua-12833	85	53	(	(	PUNCT
aiua-12833	85	54	appendix	appendix	NOUN
aiua-12833	85	55	2	2	NUM
aiua-12833	85	56	)	)	PUNCT
aiua-12833	85	57	.	.	PUNCT
aiua-12833	86	1	however	however	ADV
aiua-12833	86	2	,	,	PUNCT
aiua-12833	86	3	the	the	DET
aiua-12833	86	4	results	result	NOUN
aiua-12833	86	5	varied	vary	VERB
aiua-12833	86	6	based	base	VERB
aiua-12833	86	7	on	on	ADP
aiua-12833	86	8	the	the	DET
aiua-12833	86	9	follow	follow	NOUN
aiua-12833	86	10	-	-	PUNCT
aiua-12833	86	11	up	up	ADP
aiua-12833	86	12	duration	duration	NOUN
aiua-12833	86	13	.	.	PUNCT
aiua-12833	87	1	for	for	ADP
aiua-12833	87	2	follow	follow	NOUN
aiua-12833	87	3	-	-	PUNCT
aiua-12833	87	4	ups	up	NOUN
aiua-12833	87	5	from	from	ADP
aiua-12833	87	6	13	13	NUM
aiua-12833	87	7	to	to	PART
aiua-12833	87	8	24	24	NUM
aiua-12833	87	9	weeks	week	NOUN
aiua-12833	87	10	and	and	CCONJ
aiua-12833	87	11	over	over	ADP
aiua-12833	87	12	24	24	NUM
aiua-12833	87	13	weeks	week	NOUN
aiua-12833	87	14	,	,	PUNCT
aiua-12833	87	15	the	the	DET
aiua-12833	87	16	relative	relative	ADJ
aiua-12833	87	17	risk	risk	NOUN
aiua-12833	87	18	was	be	AUX
aiua-12833	87	19	32	32	NUM
aiua-12833	87	20	%	%	NOUN
aiua-12833	87	21	lower	low	ADJ
aiua-12833	87	22	(	(	PUNCT
aiua-12833	87	23	rr	rr	NOUN
aiua-12833	87	24	=	=	SYM
aiua-12833	87	25	0.68	0.68	NUM
aiua-12833	87	26	,	,	PUNCT
aiua-12833	87	27	95	95	NUM
aiua-12833	87	28	%	%	NOUN
aiua-12833	87	29	ci	ci	NOUN
aiua-12833	87	30	:	:	PUNCT
aiua-12833	87	31	0.46	0.46	NUM
aiua-12833	87	32	-	-	SYM
aiua-12833	87	33	1.01	1.01	NUM
aiua-12833	87	34	)	)	PUNCT
aiua-12833	87	35	and	and	CCONJ
aiua-12833	87	36	23	23	NUM
aiua-12833	87	37	%	%	NOUN
aiua-12833	87	38	lower	low	ADJ
aiua-12833	87	39	(	(	PUNCT
aiua-12833	87	40	rr	rr	NOUN
aiua-12833	87	41	=	=	SYM
aiua-12833	87	42	0.77	0.77	NUM
aiua-12833	87	43	,	,	PUNCT
aiua-12833	87	44	95	95	NUM
aiua-12833	87	45	%	%	NOUN
aiua-12833	87	46	ci	ci	NOUN
aiua-12833	87	47	:	:	PUNCT
aiua-12833	87	48	0.58	0.58	NUM
aiua-12833	87	49	-	-	SYM
aiua-12833	87	50	1.02	1.02	NUM
aiua-12833	87	51	)	)	PUNCT
aiua-12833	87	52	,	,	PUNCT
aiua-12833	87	53	respectively	respectively	ADV
aiua-12833	87	54	.	.	PUNCT
aiua-12833	88	1	for	for	ADP
aiua-12833	88	2	follow	follow	NOUN
aiua-12833	88	3	-	-	PUNCT
aiua-12833	88	4	ups	up	NOUN
aiua-12833	88	5	up	up	ADP
aiua-12833	88	6	to	to	PART
aiua-12833	88	7	12	12	NUM
aiua-12833	88	8	weeks	week	NOUN
aiua-12833	88	9	,	,	PUNCT
aiua-12833	88	10	the	the	DET
aiua-12833	88	11	relative	relative	ADJ
aiua-12833	88	12	risk	risk	NOUN
aiua-12833	88	13	was	be	AUX
aiua-12833	88	14	11	11	NUM
aiua-12833	88	15	%	%	NOUN
aiua-12833	88	16	higher	higher	ADV
aiua-12833	88	17	(	(	PUNCT
aiua-12833	88	18	rr	rr	NOUN
aiua-12833	88	19	=	=	SYM
aiua-12833	88	20	1.11	1.11	NUM
aiua-12833	88	21	,	,	PUNCT
aiua-12833	88	22	95	95	NUM
aiua-12833	88	23	%	%	NOUN
aiua-12833	88	24	ci	ci	NOUN
aiua-12833	88	25	:	:	PUNCT
aiua-12833	88	26	0.37	0.37	NUM
aiua-12833	88	27	-	-	SYM
aiua-12833	88	28	3.33	3.33	NUM
aiua-12833	88	29	)	)	PUNCT
aiua-12833	88	30	(	(	PUNCT
aiua-12833	88	31	appendix	appendix	NOUN
aiua-12833	88	32	3	3	NUM
aiua-12833	88	33	)	)	PUNCT
aiua-12833	88	34	.	.	PUNCT
aiua-12833	89	1	sensitivity	sensitivity	NOUN
aiua-12833	89	2	analysis	analysis	NOUN
aiua-12833	89	3	the	the	DET
aiua-12833	89	4	sensitivity	sensitivity	NOUN
aiua-12833	89	5	analysis	analysis	NOUN
aiua-12833	89	6	showed	show	VERB
aiua-12833	89	7	that	that	SCONJ
aiua-12833	89	8	the	the	DET
aiua-12833	89	9	effect	effect	NOUN
aiua-12833	89	10	size	size	NOUN
aiua-12833	89	11	did	do	AUX
aiua-12833	89	12	not	not	PART
aiua-12833	89	13	change	change	VERB
aiua-12833	89	14	significantly	significantly	ADV
aiua-12833	89	15	after	after	ADP
aiua-12833	89	16	excluding	exclude	VERB
aiua-12833	89	17	any	any	DET
aiua-12833	89	18	individual	individual	ADJ
aiua-12833	89	19	study	study	NOUN
aiua-12833	89	20	,	,	PUNCT
aiua-12833	89	21	and	and	CCONJ
aiua-12833	89	22	the	the	DET
aiua-12833	89	23	results	result	NOUN
aiua-12833	89	24	remained	remain	VERB
aiua-12833	89	25	statistically	statistically	ADV
aiua-12833	89	26	significant	significant	ADJ
aiua-12833	89	27	(	(	PUNCT
aiua-12833	89	28	appendix	appendix	NOUN
aiua-12833	89	29	4	4	NUM
aiua-12833	89	30	)	)	PUNCT
aiua-12833	89	31	.	.	PUNCT
aiua-12833	90	1	figure	figure	NOUN
aiua-12833	90	2	1	1	NUM
aiua-12833	90	3	.	.	PUNCT
aiua-12833	90	4	preferred	preferred	ADJ
aiua-12833	90	5	reporting	reporting	NOUN
aiua-12833	90	6	items	item	NOUN
aiua-12833	90	7	for	for	ADP
aiua-12833	90	8	a	a	DET
aiua-12833	90	9	systematic	systematic	ADJ
aiua-12833	90	10	review	review	NOUN
aiua-12833	90	11	and	and	CCONJ
aiua-12833	90	12	meta	meta	ADJ
aiua-12833	90	13	-	-	PUNCT
aiua-12833	90	14	analysis	analysis	NOUN
aiua-12833	90	15	(	(	PUNCT
aiua-12833	90	16	prisma	prisma	PROPN
aiua-12833	90	17	)	)	PUNCT
aiua-12833	90	18	2020	2020	NUM
aiua-12833	90	19	flow	flow	NOUN
aiua-12833	90	20	diagram	diagram	NOUN
aiua-12833	90	21	for	for	ADP
aiua-12833	90	22	new	new	ADJ
aiua-12833	90	23	systematic	systematic	ADJ
aiua-12833	90	24	reviews	review	NOUN
aiua-12833	90	25	,	,	PUNCT
aiua-12833	90	26	including	include	VERB
aiua-12833	90	27	database	database	NOUN
aiua-12833	90	28	,	,	PUNCT
aiua-12833	90	29	registers	register	NOUN
aiua-12833	90	30	,	,	PUNCT
aiua-12833	90	31	and	and	CCONJ
aiua-12833	90	32	other	other	ADJ
aiua-12833	90	33	source	source	NOUN
aiua-12833	90	34	searches	search	NOUN
aiua-12833	90	35	.	.	PUNCT
aiua-12833	91	1	archivio	archivio	NOUN
aiua-12833	91	2	italiano	italiano	PROPN
aiua-12833	91	3	di	di	PROPN
aiua-12833	91	4	urologia	urologia	PROPN
aiua-12833	91	5	e	e	PROPN
aiua-12833	91	6	andrologia	andrologia	NOUN
aiua-12833	91	7	2024	2024	NUM
aiua-12833	91	8	;	;	PUNCT
aiua-12833	91	9	96(4):12833	96(4):12833	NUM
aiua-12833	91	10	i.	i.	PROPN
aiua-12833	91	11	alshoaibi	alshoaibi	PROPN
aiua-12833	91	12	,	,	PUNCT
aiua-12833	91	13	b.	b.	PROPN
aiua-12833	91	14	abdo	abdo	PROPN
aiua-12833	91	15	,	,	PUNCT
aiua-12833	91	16	m.	m.	PROPN
aiua-12833	91	17	abdullah	abdullah	PROPN
aiua-12833	91	18	,	,	PUNCT
aiua-12833	91	19	et	et	PROPN
aiua-12833	91	20	al	al	PROPN
aiua-12833	91	21	.	.	PROPN
aiua-12833	91	22	4	4	NUM
aiua-12833	91	23	table	table	NOUN
aiua-12833	91	24	1	1	NUM
aiua-12833	91	25	.	.	PUNCT
aiua-12833	91	26	demographic	demographic	ADJ
aiua-12833	91	27	characteristics	characteristic	NOUN
aiua-12833	91	28	of	of	ADP
aiua-12833	91	29	the	the	DET
aiua-12833	91	30	included	include	VERB
aiua-12833	91	31	studies	study	NOUN
aiua-12833	91	32	in	in	ADP
aiua-12833	91	33	the	the	DET
aiua-12833	91	34	systematic	systematic	ADJ
aiua-12833	91	35	review	review	NOUN
aiua-12833	91	36	.	.	PUNCT
aiua-12833	92	1	d	d	PRON
aiua-12833	92	2	author	author	NOUN
aiua-12833	92	3	year	year	NOUN
aiua-12833	92	4	of	of	ADP
aiua-12833	92	5	year	year	NOUN
aiua-12833	92	6	of	of	ADP
aiua-12833	92	7	starting	start	VERB
aiua-12833	92	8	intervention	intervention	NOUN
aiua-12833	92	9	consumption	consumption	NOUN
aiua-12833	92	10	country	country	NOUN
aiua-12833	92	11	sample	sample	NOUN
aiua-12833	92	12	follow	follow	VERB
aiua-12833	92	13	-	-	PUNCT
aiua-12833	92	14	up	up	ADP
aiua-12833	92	15	publication	publication	NOUN
aiua-12833	92	16	data	datum	NOUN
aiua-12833	92	17	collection	collection	NOUN
aiua-12833	92	18	or	or	CCONJ
aiua-12833	92	19	control	control	NOUN
aiua-12833	92	20	form	form	NOUN
aiua-12833	92	21	size	size	NOUN
aiua-12833	92	22	time	time	NOUN
aiua-12833	92	23	1	1	NUM
aiua-12833	92	24	chung	chung	PROPN
aiua-12833	92	25	,	,	PUNCT
aiua-12833	92	26	et	et	PROPN
aiua-12833	92	27	al	al	PROPN
aiua-12833	92	28	(	(	PUNCT
aiua-12833	92	29	20	20	NUM
aiua-12833	92	30	)	)	PUNCT
aiua-12833	92	31	2022	2022	NUM
aiua-12833	92	32	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	92	33	intestinal	intestinal	ADJ
aiua-12833	92	34	gel	gel	NOUN
aiua-12833	92	35	9	9	NUM
aiua-12833	92	36	sites	site	NOUN
aiua-12833	92	37	in	in	ADP
aiua-12833	92	38	spain	spain	PROPN
aiua-12833	92	39	,	,	PUNCT
aiua-12833	92	40	8	8	NUM
aiua-12833	92	41	sites	site	NOUN
aiua-12833	92	42	in	in	ADP
aiua-12833	92	43	the	the	DET
aiua-12833	92	44	united	united	PROPN
aiua-12833	92	45	states	states	PROPN
aiua-12833	92	46	,	,	PUNCT
aiua-12833	92	47	7	7	NUM
aiua-12833	92	48	sites	site	NOUN
aiua-12833	92	49	in	in	ADP
aiua-12833	92	50	italy	italy	PROPN
aiua-12833	92	51	,	,	PUNCT
aiua-12833	92	52	87	87	NUM
aiua-12833	92	53	26	26	NUM
aiua-12833	92	54	weeks	week	NOUN
aiua-12833	92	55	4	4	NUM
aiua-12833	92	56	sites	site	NOUN
aiua-12833	92	57	in	in	ADP
aiua-12833	92	58	australia	australia	PROPN
aiua-12833	92	59	,	,	PUNCT
aiua-12833	92	60	3	3	NUM
aiua-12833	92	61	sites	site	NOUN
aiua-12833	92	62	in	in	ADP
aiua-12833	92	63	canada	canada	PROPN
aiua-12833	92	64	,	,	PUNCT
aiua-12833	92	65	3	3	NUM
aiua-12833	92	66	sites	site	NOUN
aiua-12833	92	67	in	in	ADP
aiua-12833	92	68	the	the	DET
aiua-12833	92	69	republic	republic	NOUN
aiua-12833	92	70	of	of	ADP
aiua-12833	92	71	korea	korea	PROPN
aiua-12833	92	72	,	,	PUNCT
aiua-12833	92	73	2	2	NUM
aiua-12833	92	74	sites	site	NOUN
aiua-12833	92	75	in	in	ADP
aiua-12833	92	76	greece	greece	PROPN
aiua-12833	92	77	,	,	PUNCT
aiua-12833	92	78	1	1	NUM
aiua-12833	92	79	site	site	NOUN
aiua-12833	92	80	in	in	ADP
aiua-12833	92	81	germany	germany	PROPN
aiua-12833	92	82	,	,	PUNCT
aiua-12833	92	83	1	1	NUM
aiua-12833	92	84	site	site	NOUN
aiua-12833	92	85	in	in	ADP
aiua-12833	92	86	sweden	sweden	PROPN
aiua-12833	92	87	1	1	NUM
aiua-12833	92	88	chung	chung	PROPN
aiua-12833	92	89	,	,	PUNCT
aiua-12833	92	90	et	et	PROPN
aiua-12833	92	91	al	al	PROPN
aiua-12833	92	92	(	(	PUNCT
aiua-12833	92	93	20	20	NUM
aiua-12833	92	94	)	)	PUNCT
aiua-12833	92	95	2022	2022	NUM
aiua-12833	92	96	other	other	ADJ
aiua-12833	92	97	tablet	tablet	NOUN
aiua-12833	92	98	or	or	CCONJ
aiua-12833	92	99	capsule	capsule	NOUN
aiua-12833	92	100	9	9	NUM
aiua-12833	92	101	sites	site	NOUN
aiua-12833	92	102	in	in	ADP
aiua-12833	92	103	spain	spain	PROPN
aiua-12833	92	104	,	,	PUNCT
aiua-12833	92	105	8	8	NUM
aiua-12833	92	106	sites	site	NOUN
aiua-12833	92	107	in	in	ADP
aiua-12833	92	108	the	the	DET
aiua-12833	92	109	united	united	PROPN
aiua-12833	92	110	states	states	PROPN
aiua-12833	92	111	,	,	PUNCT
aiua-12833	92	112	7	7	NUM
aiua-12833	92	113	sites	site	NOUN
aiua-12833	92	114	in	in	ADP
aiua-12833	92	115	italy	italy	PROPN
aiua-12833	92	116	,	,	PUNCT
aiua-12833	92	117	87	87	NUM
aiua-12833	92	118	26	26	NUM
aiua-12833	92	119	weeks	week	NOUN
aiua-12833	92	120	4	4	NUM
aiua-12833	92	121	sites	site	NOUN
aiua-12833	92	122	in	in	ADP
aiua-12833	92	123	australia	australia	PROPN
aiua-12833	92	124	,	,	PUNCT
aiua-12833	92	125	3	3	NUM
aiua-12833	92	126	sites	site	NOUN
aiua-12833	92	127	in	in	ADP
aiua-12833	92	128	canada	canada	PROPN
aiua-12833	92	129	,	,	PUNCT
aiua-12833	92	130	3	3	NUM
aiua-12833	92	131	sites	site	NOUN
aiua-12833	92	132	in	in	ADP
aiua-12833	92	133	the	the	DET
aiua-12833	92	134	republic	republic	NOUN
aiua-12833	92	135	of	of	ADP
aiua-12833	92	136	korea	korea	PROPN
aiua-12833	92	137	,	,	PUNCT
aiua-12833	92	138	2	2	NUM
aiua-12833	92	139	sites	site	NOUN
aiua-12833	92	140	in	in	ADP
aiua-12833	92	141	greece	greece	PROPN
aiua-12833	92	142	,	,	PUNCT
aiua-12833	92	143	1	1	NUM
aiua-12833	92	144	site	site	NOUN
aiua-12833	92	145	in	in	ADP
aiua-12833	92	146	germany	germany	PROPN
aiua-12833	92	147	,	,	PUNCT
aiua-12833	92	148	1	1	NUM
aiua-12833	92	149	site	site	NOUN
aiua-12833	92	150	in	in	ADP
aiua-12833	92	151	sweden	sweden	PROPN
aiua-12833	92	152	2	2	NUM
aiua-12833	92	153	fahn	fahn	NOUN
aiua-12833	92	154	,	,	PUNCT
aiua-12833	92	155	et	et	PROPN
aiua-12833	92	156	al	al	PROPN
aiua-12833	92	157	(	(	PUNCT
aiua-12833	92	158	21	21	NUM
aiua-12833	92	159	)	)	PUNCT
aiua-12833	92	160	2004	2004	NUM
aiua-12833	92	161	1998	1998	NUM
aiua-12833	93	1	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	93	2	tablet	tablet	NOUN
aiua-12833	93	3	33	33	NUM
aiua-12833	93	4	sites	site	NOUN
aiua-12833	93	5	in	in	ADP
aiua-12833	93	6	the	the	DET
aiua-12833	93	7	united	united	PROPN
aiua-12833	93	8	states	states	PROPN
aiua-12833	93	9	and	and	CCONJ
aiua-12833	93	10	5	5	NUM
aiua-12833	93	11	sites	site	NOUN
aiua-12833	93	12	in	in	ADP
aiua-12833	93	13	canada	canada	PROPN
aiua-12833	93	14	361	361	NUM
aiua-12833	93	15	40	40	NUM
aiua-12833	93	16	weeks	week	NOUN
aiua-12833	93	17	2	2	NUM
aiua-12833	93	18	fahn	fahn	NOUN
aiua-12833	93	19	,	,	PUNCT
aiua-12833	93	20	et	et	PROPN
aiua-12833	93	21	al	al	PROPN
aiua-12833	93	22	(	(	PUNCT
aiua-12833	93	23	21	21	NUM
aiua-12833	93	24	)	)	PUNCT
aiua-12833	93	25	2004	2004	NUM
aiua-12833	93	26	1998	1998	NUM
aiua-12833	93	27	other	other	ADJ
aiua-12833	93	28	tablet	tablet	NOUN
aiua-12833	93	29	33	33	NUM
aiua-12833	93	30	sites	site	NOUN
aiua-12833	93	31	in	in	ADP
aiua-12833	93	32	the	the	DET
aiua-12833	93	33	united	united	PROPN
aiua-12833	93	34	states	states	PROPN
aiua-12833	93	35	and	and	CCONJ
aiua-12833	93	36	5	5	NUM
aiua-12833	93	37	sites	site	NOUN
aiua-12833	93	38	in	in	ADP
aiua-12833	93	39	canada	canada	PROPN
aiua-12833	93	40	361	361	NUM
aiua-12833	93	41	40	40	NUM
aiua-12833	93	42	weeks	week	NOUN
aiua-12833	93	43	3	3	NUM
aiua-12833	93	44	freire	freire	NOUN
aiua-12833	93	45	-	-	PUNCT
aiua-12833	93	46	alvarez	alvarez	PROPN
aiua-12833	93	47	,	,	PUNCT
aiua-12833	93	48	et	et	PROPN
aiua-12833	93	49	al	al	PROPN
aiua-12833	93	50	(	(	PUNCT
aiua-12833	93	51	22	22	NUM
aiua-12833	93	52	)	)	PUNCT
aiua-12833	93	53	2021	2021	NUM
aiua-12833	93	54	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	93	55	intestinal	intestinal	ADJ
aiua-12833	93	56	gel	gel	NOUN
aiua-12833	93	57	9	9	NUM
aiua-12833	93	58	sites	site	NOUN
aiua-12833	93	59	in	in	ADP
aiua-12833	93	60	spain	spain	PROPN
aiua-12833	93	61	,	,	PUNCT
aiua-12833	93	62	5	5	NUM
aiua-12833	93	63	sites	site	NOUN
aiua-12833	93	64	in	in	ADP
aiua-12833	93	65	italy	italy	PROPN
aiua-12833	93	66	,	,	PUNCT
aiua-12833	93	67	4	4	NUM
aiua-12833	93	68	sites	site	NOUN
aiua-12833	93	69	in	in	ADP
aiua-12833	93	70	slovakia	slovakia	PROPN
aiua-12833	93	71	,	,	PUNCT
aiua-12833	93	72	3	3	NUM
aiua-12833	93	73	sites	site	NOUN
aiua-12833	93	74	61	61	NUM
aiua-12833	93	75	12	12	NUM
aiua-12833	93	76	weeks	week	NOUN
aiua-12833	93	77	in	in	ADP
aiua-12833	93	78	hungary	hungary	PROPN
aiua-12833	93	79	,	,	PUNCT
aiua-12833	93	80	3	3	NUM
aiua-12833	93	81	sites	site	NOUN
aiua-12833	93	82	in	in	ADP
aiua-12833	93	83	greece	greece	PROPN
aiua-12833	93	84	,	,	PUNCT
aiua-12833	93	85	2	2	NUM
aiua-12833	93	86	sites	site	NOUN
aiua-12833	93	87	in	in	ADP
aiua-12833	93	88	the	the	DET
aiua-12833	93	89	united	united	PROPN
aiua-12833	93	90	states	states	PROPN
aiua-12833	93	91	,	,	PUNCT
aiua-12833	93	92	2	2	NUM
aiua-12833	93	93	sites	site	NOUN
aiua-12833	93	94	in	in	ADP
aiua-12833	93	95	finland	finland	PROPN
aiua-12833	93	96	3	3	NUM
aiua-12833	93	97	freire	freire	PROPN
aiua-12833	93	98	-	-	PUNCT
aiua-12833	93	99	alvarez	alvarez	PROPN
aiua-12833	93	100	,	,	PUNCT
aiua-12833	93	101	et	et	PROPN
aiua-12833	93	102	al	al	PROPN
aiua-12833	93	103	(	(	PUNCT
aiua-12833	93	104	22	22	NUM
aiua-12833	93	105	)	)	PUNCT
aiua-12833	93	106	2021	2021	NUM
aiua-12833	93	107	other	other	ADJ
aiua-12833	93	108	tablet	tablet	NOUN
aiua-12833	93	109	or	or	CCONJ
aiua-12833	93	110	capsule	capsule	NOUN
aiua-12833	93	111	9	9	NUM
aiua-12833	93	112	sites	site	NOUN
aiua-12833	93	113	in	in	ADP
aiua-12833	93	114	spain	spain	PROPN
aiua-12833	93	115	,	,	PUNCT
aiua-12833	93	116	5	5	NUM
aiua-12833	93	117	sites	site	NOUN
aiua-12833	93	118	in	in	ADP
aiua-12833	93	119	italy	italy	PROPN
aiua-12833	93	120	,	,	PUNCT
aiua-12833	93	121	4	4	NUM
aiua-12833	93	122	sites	site	NOUN
aiua-12833	93	123	in	in	ADP
aiua-12833	93	124	slovakia	slovakia	PROPN
aiua-12833	93	125	,	,	PUNCT
aiua-12833	93	126	3	3	NUM
aiua-12833	93	127	sites	site	NOUN
aiua-12833	93	128	61	61	NUM
aiua-12833	93	129	12	12	NUM
aiua-12833	93	130	weeks	week	NOUN
aiua-12833	93	131	in	in	ADP
aiua-12833	93	132	hungary	hungary	PROPN
aiua-12833	93	133	,	,	PUNCT
aiua-12833	93	134	3	3	NUM
aiua-12833	93	135	sites	site	NOUN
aiua-12833	93	136	in	in	ADP
aiua-12833	93	137	greece	greece	PROPN
aiua-12833	93	138	,	,	PUNCT
aiua-12833	93	139	2	2	NUM
aiua-12833	93	140	sites	site	NOUN
aiua-12833	93	141	in	in	ADP
aiua-12833	93	142	the	the	DET
aiua-12833	93	143	united	united	PROPN
aiua-12833	93	144	states	states	PROPN
aiua-12833	93	145	,	,	PUNCT
aiua-12833	93	146	2	2	NUM
aiua-12833	93	147	sites	site	NOUN
aiua-12833	93	148	in	in	ADP
aiua-12833	93	149	finland	finland	PROPN
aiua-12833	93	150	4	4	NUM
aiua-12833	93	151	hauser	hauser	PROPN
aiua-12833	93	152	,	,	PUNCT
aiua-12833	93	153	et	et	PROPN
aiua-12833	93	154	al	al	PROPN
aiua-12833	93	155	(	(	PUNCT
aiua-12833	93	156	23	23	NUM
aiua-12833	93	157	)	)	PUNCT
aiua-12833	93	158	2013	2013	NUM
aiua-12833	93	159	2009	2009	NUM
aiua-12833	93	160	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	93	161	tablet	tablet	NOUN
aiua-12833	93	162	35	35	NUM
aiua-12833	93	163	sites	site	NOUN
aiua-12833	93	164	in	in	ADP
aiua-12833	93	165	the	the	DET
aiua-12833	93	166	united	united	PROPN
aiua-12833	93	167	states	states	PROPN
aiua-12833	93	168	,	,	PUNCT
aiua-12833	93	169	7	7	NUM
aiua-12833	93	170	sites	site	NOUN
aiua-12833	93	171	in	in	ADP
aiua-12833	93	172	ukraine	ukraine	NOUN
aiua-12833	93	173	,	,	PUNCT
aiua-12833	93	174	7	7	NUM
aiua-12833	93	175	sites	site	NOUN
aiua-12833	93	176	393	393	NUM
aiua-12833	93	177	22	22	NUM
aiua-12833	93	178	weeks	week	NOUN
aiua-12833	93	179	(	(	PUNCT
aiua-12833	93	180	extended	extend	VERB
aiua-12833	93	181	-	-	PUNCT
aiua-12833	93	182	release	release	NOUN
aiua-12833	93	183	)	)	PUNCT
aiua-12833	93	184	in	in	ADP
aiua-12833	93	185	poland	poland	PROPN
aiua-12833	93	186	,	,	PUNCT
aiua-12833	93	187	6	6	NUM
aiua-12833	93	188	sites	site	NOUN
aiua-12833	93	189	in	in	ADP
aiua-12833	93	190	spain	spain	PROPN
aiua-12833	93	191	,	,	PUNCT
aiua-12833	93	192	6	6	NUM
aiua-12833	93	193	sites	site	NOUN
aiua-12833	93	194	in	in	ADP
aiua-12833	93	195	germany	germany	PROPN
aiua-12833	93	196	,	,	PUNCT
aiua-12833	93	197	5	5	NUM
aiua-12833	93	198	sites	site	NOUN
aiua-12833	93	199	in	in	ADP
aiua-12833	93	200	france	france	PROPN
aiua-12833	93	201	,	,	PUNCT
aiua-12833	93	202	4	4	NUM
aiua-12833	93	203	sites	site	NOUN
aiua-12833	93	204	in	in	ADP
aiua-12833	93	205	romania	romania	PROPN
aiua-12833	93	206	,	,	PUNCT
aiua-12833	93	207	3	3	NUM
aiua-12833	93	208	sites	site	NOUN
aiua-12833	93	209	in	in	ADP
aiua-12833	93	210	canada	canada	PROPN
aiua-12833	93	211	4	4	NUM
aiua-12833	93	212	hauser	hauser	PROPN
aiua-12833	93	213	,	,	PUNCT
aiua-12833	93	214	et	et	PROPN
aiua-12833	93	215	al	al	PROPN
aiua-12833	93	216	(	(	PUNCT
aiua-12833	93	217	23	23	NUM
aiua-12833	93	218	)	)	PUNCT
aiua-12833	93	219	2013	2013	NUM
aiua-12833	93	220	2009	2009	NUM
aiua-12833	94	1	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	94	2	tablet	tablet	NOUN
aiua-12833	94	3	35	35	NUM
aiua-12833	94	4	sites	site	NOUN
aiua-12833	94	5	in	in	ADP
aiua-12833	94	6	the	the	DET
aiua-12833	94	7	united	united	PROPN
aiua-12833	94	8	states	states	PROPN
aiua-12833	94	9	,	,	PUNCT
aiua-12833	94	10	7	7	NUM
aiua-12833	94	11	sites	site	NOUN
aiua-12833	94	12	in	in	ADP
aiua-12833	94	13	ukraine	ukraine	NOUN
aiua-12833	94	14	,	,	PUNCT
aiua-12833	94	15	393	393	NUM
aiua-12833	94	16	22	22	NUM
aiua-12833	94	17	weeks	week	NOUN
aiua-12833	94	18	(	(	PUNCT
aiua-12833	94	19	immediate	immediate	ADJ
aiua-12833	94	20	release	release	NOUN
aiua-12833	94	21	)	)	PUNCT
aiua-12833	94	22	7	7	NUM
aiua-12833	94	23	sites	site	NOUN
aiua-12833	94	24	in	in	ADP
aiua-12833	94	25	poland	poland	PROPN
aiua-12833	94	26	,	,	PUNCT
aiua-12833	94	27	6	6	NUM
aiua-12833	94	28	sites	site	NOUN
aiua-12833	94	29	in	in	ADP
aiua-12833	94	30	spain	spain	PROPN
aiua-12833	94	31	,	,	PUNCT
aiua-12833	94	32	6	6	NUM
aiua-12833	94	33	sites	site	NOUN
aiua-12833	94	34	in	in	ADP
aiua-12833	94	35	germany	germany	PROPN
aiua-12833	94	36	,	,	PUNCT
aiua-12833	94	37	5	5	NUM
aiua-12833	94	38	sites	site	NOUN
aiua-12833	94	39	in	in	ADP
aiua-12833	94	40	france	france	PROPN
aiua-12833	94	41	,	,	PUNCT
aiua-12833	94	42	4	4	NUM
aiua-12833	94	43	sites	site	NOUN
aiua-12833	94	44	in	in	ADP
aiua-12833	94	45	romania	romania	PROPN
aiua-12833	94	46	,	,	PUNCT
aiua-12833	94	47	3	3	NUM
aiua-12833	94	48	sites	site	NOUN
aiua-12833	94	49	in	in	ADP
aiua-12833	94	50	canada	canada	PROPN
aiua-12833	94	51	5	5	NUM
aiua-12833	94	52	hauser	hauser	PROPN
aiua-12833	94	53	,	,	PUNCT
aiua-12833	94	54	et	et	PROPN
aiua-12833	94	55	al	al	PROPN
aiua-12833	94	56	(	(	PUNCT
aiua-12833	94	57	24	24	NUM
aiua-12833	94	58	)	)	PUNCT
aiua-12833	94	59	2023	2023	NUM
aiua-12833	94	60	2018	2018	NUM
aiua-12833	95	1	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	95	2	tablet	tablet	NOUN
aiua-12833	95	3	56	56	NUM
aiua-12833	95	4	sites	site	NOUN
aiua-12833	95	5	in	in	ADP
aiua-12833	95	6	the	the	DET
aiua-12833	95	7	united	united	PROPN
aiua-12833	95	8	states	states	PROPN
aiua-12833	95	9	,	,	PUNCT
aiua-12833	95	10	15	15	NUM
aiua-12833	95	11	sites	site	NOUN
aiua-12833	95	12	in	in	ADP
aiua-12833	95	13	spain	spain	PROPN
aiua-12833	95	14	,	,	PUNCT
aiua-12833	95	15	8	8	NUM
aiua-12833	95	16	sites	site	NOUN
aiua-12833	95	17	506	506	NUM
aiua-12833	95	18	20	20	NUM
aiua-12833	95	19	weeks	week	NOUN
aiua-12833	95	20	(	(	PUNCT
aiua-12833	95	21	extended	extend	VERB
aiua-12833	95	22	-	-	PUNCT
aiua-12833	95	23	release	release	NOUN
aiua-12833	95	24	)	)	PUNCT
aiua-12833	95	25	in	in	ADP
aiua-12833	95	26	germany	germany	PROPN
aiua-12833	95	27	,	,	PUNCT
aiua-12833	95	28	8	8	NUM
aiua-12833	95	29	sites	site	NOUN
aiua-12833	95	30	in	in	ADP
aiua-12833	95	31	italy	italy	PROPN
aiua-12833	95	32	,	,	PUNCT
aiua-12833	95	33	7	7	NUM
aiua-12833	95	34	sites	site	NOUN
aiua-12833	95	35	in	in	ADP
aiua-12833	95	36	poland	poland	PROPN
aiua-12833	95	37	,	,	PUNCT
aiua-12833	95	38	7	7	NUM
aiua-12833	95	39	sites	site	NOUN
aiua-12833	95	40	in	in	ADP
aiua-12833	95	41	poland	poland	PROPN
aiua-12833	95	42	,	,	PUNCT
aiua-12833	95	43	6	6	NUM
aiua-12833	95	44	sites	site	NOUN
aiua-12833	95	45	in	in	ADP
aiua-12833	95	46	czechia	czechia	NOUN
aiua-12833	95	47	,	,	PUNCT
aiua-12833	95	48	6	6	NUM
aiua-12833	95	49	sites	site	NOUN
aiua-12833	95	50	in	in	ADP
aiua-12833	95	51	germany	germany	PROPN
aiua-12833	95	52	,	,	PUNCT
aiua-12833	95	53	5	5	NUM
aiua-12833	95	54	sites	site	NOUN
aiua-12833	95	55	in	in	ADP
aiua-12833	95	56	france	france	PROPN
aiua-12833	95	57	,	,	PUNCT
aiua-12833	95	58	3	3	NUM
aiua-12833	95	59	sites	site	NOUN
aiua-12833	95	60	in	in	ADP
aiua-12833	95	61	the	the	DET
aiua-12833	95	62	united	united	PROPN
aiua-12833	95	63	kingdom	kingdom	PROPN
aiua-12833	95	64	5	5	NUM
aiua-12833	95	65	hauser	hauser	PROPN
aiua-12833	95	66	,	,	PUNCT
aiua-12833	95	67	et	et	PROPN
aiua-12833	95	68	al	al	PROPN
aiua-12833	95	69	(	(	PUNCT
aiua-12833	95	70	24	24	NUM
aiua-12833	95	71	)	)	PUNCT
aiua-12833	95	72	2023	2023	NUM
aiua-12833	95	73	2018	2018	NUM
aiua-12833	96	1	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	96	2	tablet	tablet	NOUN
aiua-12833	96	3	56	56	NUM
aiua-12833	96	4	sites	site	NOUN
aiua-12833	96	5	in	in	ADP
aiua-12833	96	6	the	the	DET
aiua-12833	96	7	united	united	PROPN
aiua-12833	96	8	states	states	PROPN
aiua-12833	96	9	,	,	PUNCT
aiua-12833	96	10	15	15	NUM
aiua-12833	96	11	sites	site	NOUN
aiua-12833	96	12	in	in	ADP
aiua-12833	96	13	spain	spain	PROPN
aiua-12833	96	14	,	,	PUNCT
aiua-12833	96	15	8	8	NUM
aiua-12833	96	16	sites	site	NOUN
aiua-12833	96	17	506	506	NUM
aiua-12833	96	18	20	20	NUM
aiua-12833	96	19	weeks	week	NOUN
aiua-12833	96	20	(	(	PUNCT
aiua-12833	96	21	immediate	immediate	ADJ
aiua-12833	96	22	release	release	NOUN
aiua-12833	96	23	)	)	PUNCT
aiua-12833	96	24	in	in	ADP
aiua-12833	96	25	germany	germany	PROPN
aiua-12833	96	26	,	,	PUNCT
aiua-12833	96	27	8	8	NUM
aiua-12833	96	28	sites	site	NOUN
aiua-12833	96	29	in	in	ADP
aiua-12833	96	30	italy	italy	PROPN
aiua-12833	96	31	,	,	PUNCT
aiua-12833	96	32	7	7	NUM
aiua-12833	96	33	sites	site	NOUN
aiua-12833	96	34	in	in	ADP
aiua-12833	96	35	poland	poland	PROPN
aiua-12833	96	36	,	,	PUNCT
aiua-12833	96	37	7	7	NUM
aiua-12833	96	38	sites	site	NOUN
aiua-12833	96	39	in	in	ADP
aiua-12833	96	40	poland	poland	PROPN
aiua-12833	96	41	,	,	PUNCT
aiua-12833	96	42	6	6	NUM
aiua-12833	96	43	sites	site	NOUN
aiua-12833	96	44	in	in	ADP
aiua-12833	96	45	czechia	czechia	NOUN
aiua-12833	96	46	,	,	PUNCT
aiua-12833	96	47	6	6	NUM
aiua-12833	96	48	sites	site	NOUN
aiua-12833	96	49	in	in	ADP
aiua-12833	96	50	germany	germany	PROPN
aiua-12833	96	51	,	,	PUNCT
aiua-12833	96	52	5	5	NUM
aiua-12833	96	53	sites	site	NOUN
aiua-12833	96	54	in	in	ADP
aiua-12833	96	55	france	france	PROPN
aiua-12833	96	56	,	,	PUNCT
aiua-12833	96	57	3	3	NUM
aiua-12833	96	58	sites	site	NOUN
aiua-12833	96	59	in	in	ADP
aiua-12833	96	60	the	the	DET
aiua-12833	96	61	united	united	PROPN
aiua-12833	96	62	kingdom	kingdom	PROPN
aiua-12833	96	63	6	6	NUM
aiua-12833	96	64	olanow	olanow	ADV
aiua-12833	96	65	,	,	PUNCT
aiua-12833	96	66	et	et	PROPN
aiua-12833	96	67	al	al	PROPN
aiua-12833	96	68	(	(	PUNCT
aiua-12833	96	69	25	25	NUM
aiua-12833	96	70	)	)	PUNCT
aiua-12833	96	71	2004	2004	NUM
aiua-12833	96	72	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	96	73	tablet	tablet	NOUN
aiua-12833	96	74	multicenter	multicenter	NOUN
aiua-12833	96	75	750	750	NUM
aiua-12833	96	76	26	26	NUM
aiua-12833	96	77	weeks	week	NOUN
aiua-12833	96	78	6	6	NUM
aiua-12833	96	79	olanow	olanow	NOUN
aiua-12833	96	80	,	,	PUNCT
aiua-12833	96	81	et	et	PROPN
aiua-12833	96	82	al	al	PROPN
aiua-12833	96	83	(	(	PUNCT
aiua-12833	96	84	25	25	NUM
aiua-12833	96	85	)	)	PUNCT
aiua-12833	96	86	2004	2004	NUM
aiua-12833	96	87	other	other	ADJ
aiua-12833	96	88	tablet	tablet	NOUN
aiua-12833	96	89	multicenter	multicenter	NOUN
aiua-12833	96	90	750	750	NUM
aiua-12833	96	91	26	26	NUM
aiua-12833	96	92	weeks	week	NOUN
aiua-12833	96	93	7	7	NUM
aiua-12833	96	94	rascol	rascol	NOUN
aiua-12833	96	95	,	,	PUNCT
aiua-12833	96	96	et	et	PROPN
aiua-12833	96	97	al	al	PROPN
aiua-12833	96	98	(	(	PUNCT
aiua-12833	96	99	26	26	NUM
aiua-12833	96	100	)	)	PUNCT
aiua-12833	96	101	2016	2016	NUM
aiua-12833	96	102	2012	2012	NUM
aiua-12833	96	103	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	96	104	tablet	tablet	NOUN
aiua-12833	96	105	10	10	NUM
aiua-12833	96	106	sites	site	NOUN
aiua-12833	96	107	in	in	ADP
aiua-12833	96	108	the	the	DET
aiua-12833	96	109	united	united	PROPN
aiua-12833	96	110	states	states	PROPN
aiua-12833	96	111	,	,	PUNCT
aiua-12833	96	112	3	3	NUM
aiua-12833	96	113	sites	site	NOUN
aiua-12833	96	114	in	in	ADP
aiua-12833	96	115	poland	poland	PROPN
aiua-12833	96	116	,	,	PUNCT
aiua-12833	96	117	2	2	NUM
aiua-12833	96	118	sites	site	NOUN
aiua-12833	96	119	68	68	NUM
aiua-12833	96	120	12	12	NUM
aiua-12833	96	121	weeks	week	NOUN
aiua-12833	96	122	in	in	ADP
aiua-12833	96	123	slovakia	slovakia	PROPN
aiua-12833	96	124	,	,	PUNCT
aiua-12833	96	125	1	1	NUM
aiua-12833	96	126	site	site	NOUN
aiua-12833	96	127	in	in	ADP
aiua-12833	96	128	germany	germany	PROPN
aiua-12833	96	129	7	7	NUM
aiua-12833	96	130	rascol	rascol	NOUN
aiua-12833	96	131	,	,	PUNCT
aiua-12833	96	132	et	et	PROPN
aiua-12833	96	133	al	al	PROPN
aiua-12833	96	134	(	(	PUNCT
aiua-12833	96	135	26	26	NUM
aiua-12833	96	136	)	)	PUNCT
aiua-12833	96	137	2016	2016	NUM
aiua-12833	96	138	2012	2012	NUM
aiua-12833	96	139	other	other	ADJ
aiua-12833	96	140	tablet	tablet	NOUN
aiua-12833	96	141	10	10	NUM
aiua-12833	96	142	sites	site	NOUN
aiua-12833	96	143	in	in	ADP
aiua-12833	96	144	the	the	DET
aiua-12833	96	145	united	united	PROPN
aiua-12833	96	146	states	states	PROPN
aiua-12833	96	147	,	,	PUNCT
aiua-12833	96	148	3	3	NUM
aiua-12833	96	149	sites	site	NOUN
aiua-12833	96	150	in	in	ADP
aiua-12833	96	151	poland	poland	PROPN
aiua-12833	96	152	,	,	PUNCT
aiua-12833	96	153	2	2	NUM
aiua-12833	96	154	sites	site	NOUN
aiua-12833	96	155	68	68	NUM
aiua-12833	96	156	12	12	NUM
aiua-12833	96	157	weeks	week	NOUN
aiua-12833	96	158	in	in	ADP
aiua-12833	96	159	slovakia	slovakia	PROPN
aiua-12833	96	160	,	,	PUNCT
aiua-12833	96	161	1	1	NUM
aiua-12833	96	162	site	site	NOUN
aiua-12833	96	163	in	in	ADP
aiua-12833	96	164	germany	germany	PROPN
aiua-12833	96	165	8	8	NUM
aiua-12833	96	166	schapira	schapira	NOUN
aiua-12833	96	167	,	,	PUNCT
aiua-12833	96	168	et	et	PROPN
aiua-12833	96	169	al	al	PROPN
aiua-12833	96	170	(	(	PUNCT
aiua-12833	96	171	27	27	NUM
aiua-12833	96	172	)	)	PUNCT
aiua-12833	96	173	2017	2017	NUM
aiua-12833	96	174	2009	2009	NUM
aiua-12833	96	175	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	96	176	tablet	tablet	NOUN
aiua-12833	96	177	/	/	SYM
aiua-12833	96	178	tablet	tablet	NOUN
aiua-12833	96	179	28	28	NUM
aiua-12833	96	180	sites	site	NOUN
aiua-12833	96	181	in	in	ADP
aiua-12833	96	182	the	the	DET
aiua-12833	96	183	united	united	PROPN
aiua-12833	96	184	states	states	PROPN
aiua-12833	96	185	,	,	PUNCT
aiua-12833	96	186	12	12	NUM
aiua-12833	96	187	sites	site	NOUN
aiua-12833	96	188	in	in	ADP
aiua-12833	96	189	germany	germany	PROPN
aiua-12833	96	190	,	,	PUNCT
aiua-12833	96	191	12	12	NUM
aiua-12833	96	192	sites	site	NOUN
aiua-12833	96	193	549	549	NUM
aiua-12833	96	194	24	24	NUM
aiua-12833	96	195	weeks	week	NOUN
aiua-12833	96	196	and/or	and/or	CCONJ
aiua-12833	96	197	in	in	ADP
aiua-12833	96	198	hungary	hungary	NOUN
aiua-12833	96	199	,	,	PUNCT
aiua-12833	96	200	8	8	NUM
aiua-12833	96	201	sites	site	NOUN
aiua-12833	96	202	in	in	ADP
aiua-12833	96	203	india	india	PROPN
aiua-12833	96	204	,	,	PUNCT
aiua-12833	96	205	6	6	NUM
aiua-12833	96	206	sites	site	NOUN
aiua-12833	96	207	in	in	ADP
aiua-12833	96	208	israel	israel	PROPN
aiua-12833	96	209	,	,	PUNCT
aiua-12833	96	210	6	6	NUM
aiua-12833	96	211	sites	site	NOUN
aiua-12833	96	212	in	in	ADP
aiua-12833	96	213	slovakia	slovakia	PROPN
aiua-12833	96	214	,	,	PUNCT
aiua-12833	96	215	levadopa+	levadopa+	PRON
aiua-12833	96	216	benserazide	benserazide	VERB
aiua-12833	96	217	6	6	NUM
aiua-12833	96	218	sites	site	NOUN
aiua-12833	96	219	in	in	ADP
aiua-12833	96	220	canada	canada	PROPN
aiua-12833	96	221	,	,	PUNCT
aiua-12833	96	222	6	6	NUM
aiua-12833	96	223	sites	site	NOUN
aiua-12833	96	224	in	in	ADP
aiua-12833	96	225	belgium	belgium	NOUN
aiua-12833	96	226	,	,	PUNCT
aiua-12833	96	227	5	5	NUM
aiua-12833	96	228	sites	site	NOUN
aiua-12833	96	229	in	in	ADP
aiua-12833	96	230	thailand	thailand	PROPN
aiua-12833	96	231	,	,	PUNCT
aiua-12833	96	232	5	5	NUM
aiua-12833	96	233	sites	site	NOUN
aiua-12833	96	234	in	in	ADP
aiua-12833	96	235	the	the	DET
aiua-12833	96	236	united	united	PROPN
aiua-12833	96	237	kingdome	kingdome	PROPN
aiua-12833	96	238	,	,	PUNCT
aiua-12833	96	239	5	5	NUM
aiua-12833	96	240	sites	site	NOUN
aiua-12833	96	241	in	in	ADP
aiua-12833	96	242	france	france	PROPN
aiua-12833	96	243	,	,	PUNCT
aiua-12833	96	244	4	4	NUM
aiua-12833	96	245	sites	site	NOUN
aiua-12833	96	246	in	in	ADP
aiua-12833	96	247	spain	spain	PROPN
aiua-12833	96	248	,	,	PUNCT
aiua-12833	96	249	3	3	NUM
aiua-12833	96	250	sites	site	NOUN
aiua-12833	96	251	in	in	ADP
aiua-12833	96	252	the	the	DET
aiua-12833	96	253	republic	republic	NOUN
aiua-12833	96	254	of	of	ADP
aiua-12833	96	255	korea	korea	PROPN
aiua-12833	96	256	,	,	PUNCT
aiua-12833	96	257	3	3	NUM
aiua-12833	96	258	sites	site	NOUN
aiua-12833	96	259	in	in	ADP
aiua-12833	96	260	taiwan	taiwan	PROPN
aiua-12833	96	261	,	,	PUNCT
aiua-12833	96	262	3	3	NUM
aiua-12833	96	263	sites	site	NOUN
aiua-12833	96	264	in	in	ADP
aiua-12833	96	265	new	new	PROPN
aiua-12833	96	266	zealand	zealand	PROPN
aiua-12833	96	267	,	,	PUNCT
aiua-12833	96	268	2	2	NUM
aiua-12833	96	269	sites	site	NOUN
aiua-12833	96	270	in	in	ADP
aiua-12833	96	271	australia	australia	PROPN
aiua-12833	96	272	,	,	PUNCT
aiua-12833	96	273	2	2	NUM
aiua-12833	96	274	sites	site	NOUN
aiua-12833	96	275	in	in	ADP
aiua-12833	96	276	austria	austria	PROPN
aiua-12833	96	277	,	,	PUNCT
aiua-12833	96	278	2	2	NUM
aiua-12833	96	279	sites	site	NOUN
aiua-12833	96	280	in	in	ADP
aiua-12833	96	281	malaysia	malaysia	PROPN
aiua-12833	96	282	,	,	PUNCT
aiua-12833	96	283	2	2	NUM
aiua-12833	96	284	sites	site	NOUN
aiua-12833	96	285	in	in	ADP
aiua-12833	96	286	switzerland	switzerland	PROPN
aiua-12833	96	287	,	,	PUNCT
aiua-12833	96	288	1	1	NUM
aiua-12833	96	289	site	site	NOUN
aiua-12833	96	290	in	in	ADP
aiua-12833	96	291	estonia	estonia	PROPN
aiua-12833	96	292	,	,	PUNCT
aiua-12833	96	293	1	1	NUM
aiua-12833	96	294	site	site	NOUN
aiua-12833	96	295	in	in	ADP
aiua-12833	96	296	the	the	DET
aiua-12833	96	297	netherlands	netherlands	PROPN
aiua-12833	96	298	8	8	NUM
aiua-12833	96	299	schapira	schapira	NOUN
aiua-12833	96	300	,	,	PUNCT
aiua-12833	96	301	et	et	PROPN
aiua-12833	96	302	al	al	PROPN
aiua-12833	96	303	(	(	PUNCT
aiua-12833	96	304	27	27	NUM
aiua-12833	96	305	)	)	PUNCT
aiua-12833	96	306	2017	2017	NUM
aiua-12833	96	307	2009	2009	NUM
aiua-12833	96	308	other	other	ADJ
aiua-12833	96	309	tablet	tablet	NOUN
aiua-12833	96	310	28	28	NUM
aiua-12833	96	311	sites	site	NOUN
aiua-12833	96	312	in	in	ADP
aiua-12833	96	313	the	the	DET
aiua-12833	96	314	united	united	PROPN
aiua-12833	96	315	states	states	PROPN
aiua-12833	96	316	,	,	PUNCT
aiua-12833	96	317	12	12	NUM
aiua-12833	96	318	sites	site	NOUN
aiua-12833	96	319	in	in	ADP
aiua-12833	96	320	germany	germany	PROPN
aiua-12833	96	321	,	,	PUNCT
aiua-12833	96	322	12	12	NUM
aiua-12833	96	323	sites	site	NOUN
aiua-12833	96	324	549	549	NUM
aiua-12833	96	325	24	24	NUM
aiua-12833	96	326	weeks	week	NOUN
aiua-12833	96	327	in	in	ADP
aiua-12833	96	328	hungary	hungary	PROPN
aiua-12833	96	329	,	,	PUNCT
aiua-12833	96	330	8	8	NUM
aiua-12833	96	331	sites	site	NOUN
aiua-12833	96	332	in	in	ADP
aiua-12833	96	333	india	india	PROPN
aiua-12833	96	334	,	,	PUNCT
aiua-12833	96	335	6	6	NUM
aiua-12833	96	336	sites	site	NOUN
aiua-12833	96	337	in	in	ADP
aiua-12833	96	338	israel	israel	PROPN
aiua-12833	96	339	,	,	PUNCT
aiua-12833	96	340	6	6	NUM
aiua-12833	96	341	sites	site	NOUN
aiua-12833	96	342	in	in	ADP
aiua-12833	96	343	slovakia	slovakia	PROPN
aiua-12833	96	344	,	,	PUNCT
aiua-12833	96	345	6	6	NUM
aiua-12833	96	346	sites	site	NOUN
aiua-12833	96	347	in	in	ADP
aiua-12833	96	348	canada	canada	PROPN
aiua-12833	96	349	,	,	PUNCT
aiua-12833	96	350	6	6	NUM
aiua-12833	96	351	sites	site	NOUN
aiua-12833	96	352	in	in	ADP
aiua-12833	96	353	belgium	belgium	NOUN
aiua-12833	96	354	,	,	PUNCT
aiua-12833	96	355	5	5	NUM
aiua-12833	96	356	sites	site	NOUN
aiua-12833	96	357	in	in	ADP
aiua-12833	96	358	thailand	thailand	PROPN
aiua-12833	96	359	,	,	PUNCT
aiua-12833	96	360	5	5	NUM
aiua-12833	96	361	sites	site	NOUN
aiua-12833	96	362	in	in	ADP
aiua-12833	96	363	the	the	DET
aiua-12833	96	364	united	united	PROPN
aiua-12833	96	365	kingdome	kingdome	PROPN
aiua-12833	96	366	,	,	PUNCT
aiua-12833	96	367	5	5	NUM
aiua-12833	96	368	sites	site	NOUN
aiua-12833	96	369	in	in	ADP
aiua-12833	96	370	france	france	PROPN
aiua-12833	96	371	,	,	PUNCT
aiua-12833	96	372	4	4	NUM
aiua-12833	96	373	sites	site	NOUN
aiua-12833	96	374	in	in	ADP
aiua-12833	96	375	spain	spain	PROPN
aiua-12833	96	376	,	,	PUNCT
aiua-12833	96	377	3	3	NUM
aiua-12833	96	378	sites	site	NOUN
aiua-12833	96	379	in	in	ADP
aiua-12833	96	380	the	the	DET
aiua-12833	96	381	republic	republic	NOUN
aiua-12833	96	382	of	of	ADP
aiua-12833	96	383	korea	korea	PROPN
aiua-12833	96	384	,	,	PUNCT
aiua-12833	96	385	3	3	NUM
aiua-12833	96	386	sites	site	NOUN
aiua-12833	96	387	in	in	ADP
aiua-12833	96	388	taiwan	taiwan	PROPN
aiua-12833	96	389	,	,	PUNCT
aiua-12833	96	390	3	3	NUM
aiua-12833	96	391	sites	site	NOUN
aiua-12833	96	392	in	in	ADP
aiua-12833	96	393	new	new	PROPN
aiua-12833	96	394	zealand	zealand	PROPN
aiua-12833	96	395	,	,	PUNCT
aiua-12833	96	396	2	2	NUM
aiua-12833	96	397	sites	site	NOUN
aiua-12833	96	398	in	in	ADP
aiua-12833	96	399	australia	australia	PROPN
aiua-12833	96	400	,	,	PUNCT
aiua-12833	96	401	2	2	NUM
aiua-12833	96	402	sites	site	NOUN
aiua-12833	96	403	in	in	ADP
aiua-12833	96	404	austria	austria	PROPN
aiua-12833	96	405	,	,	PUNCT
aiua-12833	96	406	2	2	NUM
aiua-12833	96	407	sites	site	NOUN
aiua-12833	96	408	in	in	ADP
aiua-12833	96	409	malaysia	malaysia	PROPN
aiua-12833	96	410	,	,	PUNCT
aiua-12833	96	411	2	2	NUM
aiua-12833	96	412	sites	site	NOUN
aiua-12833	96	413	in	in	ADP
aiua-12833	96	414	switzerland	switzerland	PROPN
aiua-12833	96	415	,	,	PUNCT
aiua-12833	96	416	1	1	NUM
aiua-12833	96	417	site	site	NOUN
aiua-12833	96	418	in	in	ADP
aiua-12833	96	419	estonia	estonia	PROPN
aiua-12833	96	420	,	,	PUNCT
aiua-12833	96	421	1	1	NUM
aiua-12833	96	422	site	site	NOUN
aiua-12833	96	423	in	in	ADP
aiua-12833	96	424	the	the	DET
aiua-12833	96	425	netherlands	netherlands	PROPN
aiua-12833	96	426	9	9	NUM
aiua-12833	96	427	stocchi	stocchi	NOUN
aiua-12833	96	428	,	,	PUNCT
aiua-12833	96	429	et	et	PROPN
aiua-12833	96	430	al	al	PROPN
aiua-12833	96	431	(	(	PUNCT
aiua-12833	96	432	28	28	NUM
aiua-12833	96	433	)	)	PUNCT
aiua-12833	96	434	2010	2010	NUM
aiua-12833	96	435	levadopa+carbidopa	levadopa+carbidopa	PROPN
aiua-12833	96	436	tablet	tablet	NOUN
aiua-12833	96	437	31	31	NUM
aiua-12833	96	438	sites	site	NOUN
aiua-12833	96	439	in	in	ADP
aiua-12833	96	440	the	the	DET
aiua-12833	96	441	united	united	PROPN
aiua-12833	96	442	states	states	PROPN
aiua-12833	96	443	,	,	PUNCT
aiua-12833	96	444	6	6	NUM
aiua-12833	96	445	sites	site	NOUN
aiua-12833	96	446	in	in	ADP
aiua-12833	96	447	italy	italy	PROPN
aiua-12833	96	448	,	,	PUNCT
aiua-12833	96	449	5	5	NUM
aiua-12833	96	450	sites	site	NOUN
aiua-12833	96	451	in	in	ADP
aiua-12833	96	452	germany	germany	PROPN
aiua-12833	96	453	,	,	PUNCT
aiua-12833	96	454	744	744	NUM
aiua-12833	96	455	134	134	NUM
aiua-12833	96	456	weeks	week	NOUN
aiua-12833	96	457	5	5	NUM
aiua-12833	96	458	sites	site	NOUN
aiua-12833	96	459	in	in	ADP
aiua-12833	96	460	finland	finland	PROPN
aiua-12833	96	461	,	,	PUNCT
aiua-12833	96	462	4	4	NUM
aiua-12833	96	463	sites	site	NOUN
aiua-12833	96	464	in	in	ADP
aiua-12833	96	465	sweden	sweden	PROPN
aiua-12833	96	466	,	,	PUNCT
aiua-12833	96	467	4	4	NUM
aiua-12833	96	468	sites	site	NOUN
aiua-12833	96	469	in	in	ADP
aiua-12833	96	470	france	france	PROPN
aiua-12833	96	471	,	,	PUNCT
aiua-12833	96	472	4	4	NUM
aiua-12833	96	473	sites	site	NOUN
aiua-12833	96	474	in	in	ADP
aiua-12833	96	475	the	the	DET
aiua-12833	96	476	united	united	ADJ
aiua-12833	96	477	kingdom	kingdom	NOUN
aiua-12833	96	478	,	,	PUNCT
aiua-12833	96	479	4	4	NUM
aiua-12833	96	480	sites	site	NOUN
aiua-12833	96	481	in	in	ADP
aiua-12833	96	482	canada	canada	PROPN
aiua-12833	96	483	,	,	PUNCT
aiua-12833	96	484	2	2	NUM
aiua-12833	96	485	sites	site	NOUN
aiua-12833	96	486	in	in	ADP
aiua-12833	96	487	greece	greece	PROPN
aiua-12833	96	488	,	,	PUNCT
aiua-12833	96	489	2	2	NUM
aiua-12833	96	490	sites	site	NOUN
aiua-12833	96	491	in	in	ADP
aiua-12833	96	492	belgium	belgium	NOUN
aiua-12833	96	493	,	,	PUNCT
aiua-12833	96	494	2	2	NUM
aiua-12833	96	495	sites	site	NOUN
aiua-12833	96	496	in	in	ADP
aiua-12833	96	497	spain	spain	PROPN
aiua-12833	96	498	,	,	PUNCT
aiua-12833	96	499	2	2	NUM
aiua-12833	96	500	sites	site	NOUN
aiua-12833	96	501	in	in	ADP
aiua-12833	96	502	switzerland	switzerland	PROPN
aiua-12833	96	503	,	,	PUNCT
aiua-12833	96	504	1	1	NUM
aiua-12833	96	505	site	site	NOUN
aiua-12833	96	506	in	in	ADP
aiua-12833	96	507	australia	australia	PROPN
aiua-12833	96	508	,	,	PUNCT
aiua-12833	96	509	1	1	NUM
aiua-12833	96	510	site	site	NOUN
aiua-12833	96	511	in	in	ADP
aiua-12833	96	512	turkey	turkey	NOUN
aiua-12833	96	513	9	9	NUM
aiua-12833	96	514	stocchi	stocchi	NOUN
aiua-12833	96	515	,	,	PUNCT
aiua-12833	96	516	et	et	PROPN
aiua-12833	96	517	al	al	PROPN
aiua-12833	96	518	(	(	PUNCT
aiua-12833	96	519	28	28	NUM
aiua-12833	96	520	)	)	PUNCT
aiua-12833	96	521	2010	2010	NUM
aiua-12833	96	522	other	other	ADJ
aiua-12833	96	523	tablet	tablet	NOUN
aiua-12833	96	524	31	31	NUM
aiua-12833	96	525	sites	site	NOUN
aiua-12833	96	526	in	in	ADP
aiua-12833	96	527	the	the	DET
aiua-12833	96	528	united	united	PROPN
aiua-12833	96	529	states	states	PROPN
aiua-12833	96	530	,	,	PUNCT
aiua-12833	96	531	6	6	NUM
aiua-12833	96	532	sites	site	NOUN
aiua-12833	96	533	in	in	ADP
aiua-12833	96	534	italy	italy	PROPN
aiua-12833	96	535	,	,	PUNCT
aiua-12833	96	536	5	5	NUM
aiua-12833	96	537	sites	site	NOUN
aiua-12833	96	538	in	in	ADP
aiua-12833	96	539	germany	germany	PROPN
aiua-12833	96	540	,	,	PUNCT
aiua-12833	96	541	744	744	NUM
aiua-12833	96	542	134	134	NUM
aiua-12833	96	543	weeks	week	NOUN
aiua-12833	96	544	5	5	NUM
aiua-12833	96	545	sites	site	NOUN
aiua-12833	96	546	in	in	ADP
aiua-12833	96	547	finland	finland	PROPN
aiua-12833	96	548	,	,	PUNCT
aiua-12833	96	549	4	4	NUM
aiua-12833	96	550	sites	site	NOUN
aiua-12833	96	551	in	in	ADP
aiua-12833	96	552	sweden	sweden	PROPN
aiua-12833	96	553	,	,	PUNCT
aiua-12833	96	554	4	4	NUM
aiua-12833	96	555	sites	site	NOUN
aiua-12833	96	556	in	in	ADP
aiua-12833	96	557	france	france	PROPN
aiua-12833	96	558	,	,	PUNCT
aiua-12833	96	559	4	4	NUM
aiua-12833	96	560	sites	site	NOUN
aiua-12833	96	561	in	in	ADP
aiua-12833	96	562	the	the	DET
aiua-12833	96	563	united	united	ADJ
aiua-12833	96	564	kingdom	kingdom	NOUN
aiua-12833	96	565	,	,	PUNCT
aiua-12833	96	566	4	4	NUM
aiua-12833	96	567	sites	site	NOUN
aiua-12833	96	568	in	in	ADP
aiua-12833	96	569	canada	canada	PROPN
aiua-12833	96	570	,	,	PUNCT
aiua-12833	96	571	2	2	NUM
aiua-12833	96	572	sites	site	NOUN
aiua-12833	96	573	in	in	ADP
aiua-12833	96	574	greece	greece	PROPN
aiua-12833	96	575	,	,	PUNCT
aiua-12833	96	576	2	2	NUM
aiua-12833	96	577	sites	site	NOUN
aiua-12833	96	578	in	in	ADP
aiua-12833	96	579	the	the	DET
aiua-12833	96	580	belgium	belgium	NOUN
aiua-12833	96	581	,	,	PUNCT
aiua-12833	96	582	2	2	NUM
aiua-12833	96	583	sites	site	NOUN
aiua-12833	96	584	in	in	ADP
aiua-12833	96	585	the	the	DET
aiua-12833	96	586	spain	spain	NOUN
aiua-12833	96	587	,	,	PUNCT
aiua-12833	96	588	2	2	NUM
aiua-12833	96	589	sites	site	NOUN
aiua-12833	96	590	in	in	ADP
aiua-12833	96	591	the	the	DET
aiua-12833	96	592	switzerland	switzerland	NOUN
aiua-12833	96	593	,	,	PUNCT
aiua-12833	96	594	1	1	NUM
aiua-12833	96	595	site	site	NOUN
aiua-12833	96	596	in	in	ADP
aiua-12833	96	597	the	the	DET
aiua-12833	96	598	australia	australia	PROPN
aiua-12833	96	599	,	,	PUNCT
aiua-12833	96	600	1	1	NUM
aiua-12833	96	601	site	site	NOUN
aiua-12833	96	602	in	in	ADP
aiua-12833	96	603	the	the	DET
aiua-12833	96	604	turkey	turkey	NOUN
aiua-12833	96	605	archivio	archivio	NOUN
aiua-12833	96	606	italiano	italiano	X
aiua-12833	96	607	di	di	X
aiua-12833	96	608	urologia	urologia	PROPN
aiua-12833	96	609	e	e	PROPN
aiua-12833	96	610	andrologia	andrologia	NOUN
aiua-12833	96	611	2024	2024	NUM
aiua-12833	96	612	;	;	PUNCT
aiua-12833	96	613	96(4):12833	96(4):12833	NUM
aiua-12833	96	614	5	5	NUM
aiua-12833	96	615	dopa	dopa	NOUN
aiua-12833	96	616	decarboxylase	decarboxylase	NOUN
aiua-12833	96	617	inhibitors	inhibitor	NOUN
aiua-12833	96	618	and	and	CCONJ
aiua-12833	96	619	risk	risk	NOUN
aiua-12833	96	620	of	of	ADP
aiua-12833	96	621	urinary	urinary	ADJ
aiua-12833	96	622	tract	tract	NOUN
aiua-12833	96	623	infections	infection	NOUN
aiua-12833	96	624	in	in	ADP
aiua-12833	96	625	parkinson	parkinson	NOUN
aiua-12833	96	626	’s	’s	PART
aiua-12833	96	627	disease	disease	NOUN
aiua-12833	96	628	figure	figure	NOUN
aiua-12833	96	629	2	2	NUM
aiua-12833	96	630	.	.	PUNCT
aiua-12833	96	631	risk	risk	NOUN
aiua-12833	96	632	of	of	ADP
aiua-12833	96	633	bias	bias	NOUN
aiua-12833	96	634	assessment	assessment	NOUN
aiua-12833	96	635	:	:	PUNCT
aiua-12833	96	636	(	(	PUNCT
aiua-12833	96	637	a	a	X
aiua-12833	96	638	)	)	PUNCT
aiua-12833	96	639	risk	risk	NOUN
aiua-12833	96	640	of	of	ADP
aiua-12833	96	641	bias	bias	NOUN
aiua-12833	96	642	summary	summary	NOUN
aiua-12833	96	643	of	of	ADP
aiua-12833	96	644	all	all	PRON
aiua-12833	96	645	included	include	VERB
aiua-12833	96	646	randomized	randomize	VERB
aiua-12833	96	647	clinical	clinical	ADJ
aiua-12833	96	648	trials	trial	NOUN
aiua-12833	96	649	(	(	PUNCT
aiua-12833	96	650	rcts	rct	NOUN
aiua-12833	96	651	)	)	PUNCT
aiua-12833	96	652	;	;	PUNCT
aiua-12833	96	653	(	(	PUNCT
aiua-12833	96	654	b	b	X
aiua-12833	96	655	)	)	PUNCT
aiua-12833	96	656	detailed	detailed	ADJ
aiua-12833	96	657	risk	risk	NOUN
aiua-12833	96	658	of	of	ADP
aiua-12833	96	659	bias	bias	NOUN
aiua-12833	96	660	.	.	PUNCT
aiua-12833	97	1	figure	figure	NOUN
aiua-12833	97	2	3	3	NUM
aiua-12833	97	3	.	.	PUNCT
aiua-12833	98	1	meta	meta	VERB
aiua-12833	98	2	-	-	PUNCT
aiua-12833	98	3	analysis	analysis	NOUN
aiua-12833	98	4	of	of	ADP
aiua-12833	98	5	the	the	DET
aiua-12833	98	6	relative	relative	ADJ
aiua-12833	98	7	risk	risk	NOUN
aiua-12833	98	8	of	of	ADP
aiua-12833	98	9	urinary	urinary	ADJ
aiua-12833	98	10	tract	tract	NOUN
aiua-12833	98	11	infection	infection	NOUN
aiua-12833	98	12	complications	complication	NOUN
aiua-12833	98	13	in	in	ADP
aiua-12833	98	14	parkinson	parkinson	NOUN
aiua-12833	98	15	's	's	PART
aiua-12833	98	16	disease	disease	NOUN
aiua-12833	98	17	patients	patient	NOUN
aiua-12833	98	18	;	;	PUNCT
aiua-12833	98	19	ci	ci	NOUN
aiua-12833	98	20	:	:	PUNCT
aiua-12833	98	21	confidence	confidence	NOUN
aiua-12833	98	22	interval	interval	NOUN
aiua-12833	98	23	.	.	PUNCT
aiua-12833	99	1	archivio	archivio	NOUN
aiua-12833	99	2	italiano	italiano	PROPN
aiua-12833	99	3	di	di	PROPN
aiua-12833	99	4	urologia	urologia	PROPN
aiua-12833	99	5	e	e	PROPN
aiua-12833	99	6	andrologia	andrologia	NOUN
aiua-12833	99	7	2024	2024	NUM
aiua-12833	99	8	;	;	PUNCT
aiua-12833	99	9	96(4):12833	96(4):12833	NUM
aiua-12833	99	10	i.	i.	PROPN
aiua-12833	99	11	alshoaibi	alshoaibi	PROPN
aiua-12833	99	12	,	,	PUNCT
aiua-12833	99	13	b.	b.	PROPN
aiua-12833	99	14	abdo	abdo	PROPN
aiua-12833	99	15	,	,	PUNCT
aiua-12833	99	16	m.	m.	PROPN
aiua-12833	99	17	abdullah	abdullah	PROPN
aiua-12833	99	18	,	,	PUNCT
aiua-12833	99	19	et	et	PROPN
aiua-12833	99	20	al	al	PROPN
aiua-12833	99	21	.	.	PROPN
aiua-12833	99	22	6	6	NUM
aiua-12833	99	23	appendix	appendix	NOUN
aiua-12833	99	24	1	1	NUM
aiua-12833	99	25	.	.	PUNCT
aiua-12833	100	1	meta	meta	VERB
aiua-12833	100	2	-	-	PUNCT
aiua-12833	100	3	analysis	analysis	NOUN
aiua-12833	100	4	of	of	ADP
aiua-12833	100	5	the	the	DET
aiua-12833	100	6	relative	relative	ADJ
aiua-12833	100	7	risk	risk	NOUN
aiua-12833	100	8	of	of	ADP
aiua-12833	100	9	urinary	urinary	ADJ
aiua-12833	100	10	tract	tract	NOUN
aiua-12833	100	11	infection	infection	NOUN
aiua-12833	100	12	in	in	ADP
aiua-12833	100	13	parkinson	parkinson	NOUN
aiua-12833	100	14	’s	’s	PART
aiua-12833	100	15	disease	disease	NOUN
aiua-12833	100	16	patients	patient	NOUN
aiua-12833	100	17	using	use	VERB
aiua-12833	100	18	decarboxylase	decarboxylase	NOUN
aiua-12833	100	19	inhibitors	inhibitor	NOUN
aiua-12833	100	20	(	(	PUNCT
aiua-12833	100	21	carbidopa	carbidopa	ADV
aiua-12833	100	22	)	)	PUNCT
aiua-12833	100	23	;	;	PUNCT
aiua-12833	100	24	ci	ci	NOUN
aiua-12833	100	25	:	:	PUNCT
aiua-12833	100	26	confidence	confidence	NOUN
aiua-12833	100	27	interval	interval	NOUN
aiua-12833	100	28	.	.	PUNCT
aiua-12833	101	1	appendix	appendix	NOUN
aiua-12833	101	2	2	2	NUM
aiua-12833	101	3	.	.	PUNCT
aiua-12833	101	4	subgroup	subgroup	PROPN
aiua-12833	101	5	meta	meta	ADJ
aiua-12833	101	6	-	-	PUNCT
aiua-12833	101	7	analysis	analysis	NOUN
aiua-12833	101	8	of	of	ADP
aiua-12833	101	9	the	the	DET
aiua-12833	101	10	relative	relative	ADJ
aiua-12833	101	11	risk	risk	NOUN
aiua-12833	101	12	of	of	ADP
aiua-12833	101	13	urinary	urinary	ADJ
aiua-12833	101	14	tract	tract	NOUN
aiua-12833	101	15	infection	infection	NOUN
aiua-12833	101	16	in	in	ADP
aiua-12833	101	17	parkinson	parkinson	NOUN
aiua-12833	101	18	’s	’s	PART
aiua-12833	101	19	disease	disease	NOUN
aiua-12833	101	20	patients	patient	NOUN
aiua-12833	101	21	using	use	VERB
aiua-12833	101	22	decarboxylase	decarboxylase	NOUN
aiua-12833	101	23	inhibitors	inhibitor	NOUN
aiua-12833	101	24	(	(	PUNCT
aiua-12833	101	25	carbidopa	carbidopa	ADV
aiua-12833	101	26	)	)	PUNCT
aiua-12833	101	27	based	base	VERB
aiua-12833	101	28	on	on	ADP
aiua-12833	101	29	type	type	NOUN
aiua-12833	101	30	of	of	ADP
aiua-12833	101	31	intervention	intervention	NOUN
aiua-12833	101	32	;	;	PUNCT
aiua-12833	101	33	ci	ci	NOUN
aiua-12833	101	34	:	:	PUNCT
aiua-12833	101	35	confidence	confidence	NOUN
aiua-12833	101	36	interval	interval	NOUN
aiua-12833	101	37	.	.	PUNCT
aiua-12833	102	1	appendix	appendix	VERB
aiua-12833	102	2	archivio	archivio	NOUN
aiua-12833	102	3	italiano	italiano	X
aiua-12833	102	4	di	di	X
aiua-12833	102	5	urologia	urologia	PROPN
aiua-12833	102	6	e	e	PROPN
aiua-12833	102	7	andrologia	andrologia	NOUN
aiua-12833	102	8	2024	2024	NUM
aiua-12833	102	9	;	;	PUNCT
aiua-12833	102	10	96(4):12833	96(4):12833	NUM
aiua-12833	102	11	7	7	NUM
aiua-12833	102	12	dopa	dopa	NOUN
aiua-12833	102	13	decarboxylase	decarboxylase	NOUN
aiua-12833	102	14	inhibitors	inhibitor	NOUN
aiua-12833	102	15	and	and	CCONJ
aiua-12833	102	16	risk	risk	NOUN
aiua-12833	102	17	of	of	ADP
aiua-12833	102	18	urinary	urinary	ADJ
aiua-12833	102	19	tract	tract	NOUN
aiua-12833	102	20	infections	infection	NOUN
aiua-12833	102	21	in	in	ADP
aiua-12833	102	22	parkinson	parkinson	NOUN
aiua-12833	102	23	’s	’s	PART
aiua-12833	102	24	disease	disease	NOUN
aiua-12833	102	25	appendix	appendix	VERB
aiua-12833	102	26	3	3	NUM
aiua-12833	102	27	.	.	PUNCT
aiua-12833	102	28	subgroup	subgroup	PROPN
aiua-12833	102	29	meta	meta	ADJ
aiua-12833	102	30	-	-	PUNCT
aiua-12833	102	31	analysis	analysis	NOUN
aiua-12833	102	32	of	of	ADP
aiua-12833	102	33	the	the	DET
aiua-12833	102	34	relative	relative	ADJ
aiua-12833	102	35	risk	risk	NOUN
aiua-12833	102	36	of	of	ADP
aiua-12833	102	37	urinary	urinary	ADJ
aiua-12833	102	38	tract	tract	NOUN
aiua-12833	102	39	infection	infection	NOUN
aiua-12833	102	40	in	in	ADP
aiua-12833	102	41	parkinson	parkinson	NOUN
aiua-12833	102	42	’s	’s	PART
aiua-12833	102	43	disease	disease	NOUN
aiua-12833	102	44	patients	patient	NOUN
aiua-12833	102	45	using	use	VERB
aiua-12833	102	46	decarboxylase	decarboxylase	NOUN
aiua-12833	102	47	inhibitors	inhibitor	NOUN
aiua-12833	102	48	(	(	PUNCT
aiua-12833	102	49	carbidopa	carbidopa	ADV
aiua-12833	102	50	)	)	PUNCT
aiua-12833	102	51	based	base	VERB
aiua-12833	102	52	on	on	ADP
aiua-12833	102	53	treatment	treatment	NOUN
aiua-12833	102	54	duration	duration	NOUN
aiua-12833	102	55	;	;	PUNCT
aiua-12833	102	56	ci	ci	NOUN
aiua-12833	102	57	:	:	PUNCT
aiua-12833	102	58	confidence	confidence	NOUN
aiua-12833	102	59	interval	interval	NOUN
aiua-12833	102	60	.	.	PUNCT
aiua-12833	103	1	appendix	appendix	NOUN
aiua-12833	103	2	4	4	NUM
aiua-12833	103	3	.	.	PUNCT
aiua-12833	103	4	sensitivity	sensitivity	NOUN
aiua-12833	103	5	analysis	analysis	NOUN
aiua-12833	103	6	results	result	NOUN
aiua-12833	103	7	of	of	ADP
aiua-12833	103	8	the	the	DET
aiua-12833	103	9	studies	study	NOUN
aiua-12833	103	10	included	include	VERB
aiua-12833	103	11	in	in	ADP
aiua-12833	103	12	the	the	DET
aiua-12833	103	13	meta	meta	NOUN
aiua-12833	103	14	-	-	PUNCT
aiua-12833	103	15	analysis	analysis	NOUN
aiua-12833	103	16	with	with	ADP
aiua-12833	103	17	the	the	DET
aiua-12833	103	18	exclusion	exclusion	NOUN
aiua-12833	103	19	of	of	ADP
aiua-12833	103	20	one	one	NUM
aiua-12833	103	21	study	study	NOUN
aiua-12833	103	22	;	;	PUNCT
aiua-12833	103	23	ci	ci	NOUN
aiua-12833	103	24	:	:	PUNCT
aiua-12833	103	25	confidence	confidence	NOUN
aiua-12833	103	26	interval	interval	NOUN
aiua-12833	103	27	.	.	PUNCT
aiua-12833	104	1	archivio	archivio	NOUN
aiua-12833	104	2	italiano	italiano	PROPN
aiua-12833	104	3	di	di	PROPN
aiua-12833	104	4	urologia	urologia	PROPN
aiua-12833	104	5	e	e	PROPN
aiua-12833	104	6	andrologia	andrologia	NOUN
aiua-12833	104	7	2024	2024	NUM
aiua-12833	104	8	;	;	PUNCT
aiua-12833	104	9	96(4):12833	96(4):12833	NUM
aiua-12833	104	10	i.	i.	PROPN
aiua-12833	104	11	alshoaibi	alshoaibi	PROPN
aiua-12833	104	12	,	,	PUNCT
aiua-12833	104	13	b.	b.	PROPN
aiua-12833	104	14	abdo	abdo	PROPN
aiua-12833	104	15	,	,	PUNCT
aiua-12833	104	16	m.	m.	PROPN
aiua-12833	104	17	abdullah	abdullah	PROPN
aiua-12833	104	18	,	,	PUNCT
aiua-12833	104	19	et	et	PROPN
aiua-12833	104	20	al	al	PROPN
aiua-12833	104	21	.	.	PROPN
aiua-12833	104	22	8	8	NUM
aiua-12833	104	23	publication	publication	NOUN
aiua-12833	104	24	bias	bias	NOUN
aiua-12833	104	25	finally	finally	ADV
aiua-12833	104	26	,	,	PUNCT
aiua-12833	104	27	a	a	DET
aiua-12833	104	28	funnel	funnel	NOUN
aiua-12833	104	29	plot	plot	NOUN
aiua-12833	104	30	was	be	AUX
aiua-12833	104	31	created	create	VERB
aiua-12833	104	32	to	to	PART
aiua-12833	104	33	assess	assess	VERB
aiua-12833	104	34	publication	publication	NOUN
aiua-12833	104	35	bias	bias	NOUN
aiua-12833	104	36	for	for	ADP
aiua-12833	104	37	the	the	DET
aiua-12833	104	38	uti	uti	PROPN
aiua-12833	104	39	complication	complication	NOUN
aiua-12833	104	40	of	of	ADP
aiua-12833	104	41	dci	dci	PROPN
aiua-12833	104	42	.	.	PROPN
aiua-12833	104	43	egger	egger	PROPN
aiua-12833	104	44	's	's	PART
aiua-12833	104	45	test	test	NOUN
aiua-12833	104	46	results	result	NOUN
aiua-12833	104	47	did	do	AUX
aiua-12833	104	48	not	not	PART
aiua-12833	104	49	confirm	confirm	VERB
aiua-12833	104	50	the	the	DET
aiua-12833	104	51	presence	presence	NOUN
aiua-12833	104	52	of	of	ADP
aiua-12833	104	53	publication	publication	NOUN
aiua-12833	104	54	bias	bias	NOUN
aiua-12833	104	55	for	for	ADP
aiua-12833	104	56	uti	uti	PROPN
aiua-12833	104	57	complications	complication	NOUN
aiua-12833	104	58	(	(	PUNCT
aiua-12833	104	59	bias	bias	NOUN
aiua-12833	104	60	:	:	PUNCT
aiua-12833	104	61	-0.19	-0.19	NOUN
aiua-12833	104	62	,	,	PUNCT
aiua-12833	104	63	se	se	X
aiua-12833	104	64	=	=	NOUN
aiua-12833	104	65	0.48	0.48	NUM
aiua-12833	104	66	,	,	PUNCT
aiua-12833	104	67	p	p	X
aiua-12833	104	68	=	=	NOUN
aiua-12833	104	69	0.693	0.693	NUM
aiua-12833	104	70	)	)	PUNCT
aiua-12833	104	71	(	(	PUNCT
aiua-12833	104	72	figure	figure	VERB
aiua-12833	104	73	4	4	NUM
aiua-12833	104	74	)	)	PUNCT
aiua-12833	104	75	.	.	PUNCT
aiua-12833	105	1	discussion	discussion	NOUN
aiua-12833	105	2	our	our	PRON
aiua-12833	105	3	study	study	NOUN
aiua-12833	105	4	results	result	NOUN
aiua-12833	105	5	indicated	indicate	VERB
aiua-12833	105	6	that	that	SCONJ
aiua-12833	105	7	the	the	DET
aiua-12833	105	8	use	use	NOUN
aiua-12833	105	9	of	of	ADP
aiua-12833	105	10	dci	dci	PROPN
aiua-12833	105	11	drugs	drug	NOUN
aiua-12833	105	12	in	in	ADP
aiua-12833	105	13	pd	pd	PROPN
aiua-12833	105	14	patients	patient	NOUN
aiua-12833	105	15	is	be	AUX
aiua-12833	105	16	a	a	DET
aiua-12833	105	17	protective	protective	ADJ
aiua-12833	105	18	factor	factor	NOUN
aiua-12833	105	19	against	against	ADP
aiua-12833	105	20	uti	uti	PROPN
aiua-12833	105	21	.	.	PUNCT
aiua-12833	106	1	furthermore	furthermore	ADV
aiua-12833	106	2	,	,	PUNCT
aiua-12833	106	3	the	the	DET
aiua-12833	106	4	duration	duration	NOUN
aiua-12833	106	5	of	of	ADP
aiua-12833	106	6	treatment	treatment	NOUN
aiua-12833	106	7	is	be	AUX
aiua-12833	106	8	significantly	significantly	ADV
aiua-12833	106	9	essential	essential	ADJ
aiua-12833	106	10	,	,	PUNCT
aiua-12833	106	11	because	because	SCONJ
aiua-12833	106	12	dci	dci	PROPN
aiua-12833	106	13	use	use	VERB
aiua-12833	106	14	for	for	ADP
aiua-12833	106	15	less	less	ADJ
aiua-12833	106	16	than	than	ADP
aiua-12833	106	17	12	12	NUM
aiua-12833	106	18	weeks	week	NOUN
aiua-12833	106	19	is	be	AUX
aiua-12833	106	20	associated	associate	VERB
aiua-12833	106	21	with	with	ADP
aiua-12833	106	22	an	an	DET
aiua-12833	106	23	increased	increase	VERB
aiua-12833	106	24	relative	relative	ADJ
aiua-12833	106	25	risk	risk	NOUN
aiua-12833	106	26	of	of	ADP
aiua-12833	106	27	developing	develop	VERB
aiua-12833	106	28	uti	uti	PROPN
aiua-12833	106	29	in	in	ADP
aiua-12833	106	30	pd	pd	PROPN
aiua-12833	106	31	patients	patient	NOUN
aiua-12833	106	32	whereas	whereas	SCONJ
aiua-12833	106	33	long	long	ADJ
aiua-12833	106	34	-	-	PUNCT
aiua-12833	106	35	term	term	NOUN
aiua-12833	106	36	use	use	NOUN
aiua-12833	106	37	has	have	AUX
aiua-12833	106	38	shown	show	VERB
aiua-12833	106	39	a	a	DET
aiua-12833	106	40	protective	protective	ADJ
aiua-12833	106	41	effect	effect	NOUN
aiua-12833	106	42	against	against	ADP
aiua-12833	106	43	uti	uti	PROPN
aiua-12833	106	44	.	.	PUNCT
aiua-12833	107	1	findings	finding	NOUN
aiua-12833	107	2	from	from	ADP
aiua-12833	107	3	a	a	DET
aiua-12833	107	4	prospective	prospective	ADJ
aiua-12833	107	5	cross	cross	ADJ
aiua-12833	107	6	-	-	ADJ
aiua-12833	107	7	sectional	sectional	ADJ
aiua-12833	107	8	study	study	NOUN
aiua-12833	107	9	by	by	ADP
aiua-12833	107	10	chaudhuri	chaudhuri	PROPN
aiua-12833	107	11	et	et	PROPN
aiua-12833	107	12	al	al	PROPN
aiua-12833	107	13	.	.	PROPN
aiua-12833	107	14	indicated	indicate	VERB
aiua-12833	107	15	that	that	SCONJ
aiua-12833	107	16	the	the	DET
aiua-12833	107	17	occurrence	occurrence	NOUN
aiua-12833	107	18	of	of	ADP
aiua-12833	107	19	uti	uti	PROPN
aiua-12833	107	20	in	in	ADP
aiua-12833	107	21	pd	pd	PROPN
aiua-12833	107	22	patients	patient	NOUN
aiua-12833	107	23	using	use	VERB
aiua-12833	107	24	carbidopa	carbidopa	ADJ
aiua-12833	107	25	gel	gel	NOUN
aiua-12833	107	26	is	be	AUX
aiua-12833	107	27	3	3	NUM
aiua-12833	107	28	%	%	NOUN
aiua-12833	107	29	(	(	PUNCT
aiua-12833	107	30	20	20	NUM
aiua-12833	107	31	)	)	PUNCT
aiua-12833	107	32	.	.	PUNCT
aiua-12833	108	1	additionally	additionally	ADV
aiua-12833	108	2	,	,	PUNCT
aiua-12833	108	3	a	a	DET
aiua-12833	108	4	cross	cross	ADJ
aiua-12833	108	5	-	-	ADJ
aiua-12833	108	6	sectional	sectional	ADJ
aiua-12833	108	7	survey	survey	NOUN
aiua-12833	108	8	by	by	ADP
aiua-12833	108	9	fernandez	fernandez	PROPN
aiua-12833	108	10	et	et	PROPN
aiua-12833	108	11	al	al	PROPN
aiua-12833	108	12	.	.	PROPN
aiua-12833	108	13	reported	report	VERB
aiua-12833	108	14	a	a	DET
aiua-12833	108	15	uti	uti	PROPN
aiua-12833	108	16	incidence	incidence	NOUN
aiua-12833	108	17	of	of	ADP
aiua-12833	108	18	11.4	11.4	NUM
aiua-12833	108	19	%	%	NOUN
aiua-12833	108	20	due	due	ADP
aiua-12833	108	21	to	to	ADP
aiua-12833	108	22	levodopa	levodopa	NOUN
aiua-12833	108	23	-	-	PUNCT
aiua-12833	108	24	carbidopa	carbidopa	NOUN
aiua-12833	108	25	intestinal	intestinal	ADJ
aiua-12833	108	26	gel	gel	NOUN
aiua-12833	108	27	use	use	NOUN
aiua-12833	108	28	in	in	ADP
aiua-12833	108	29	pd	pd	PROPN
aiua-12833	108	30	patients	patient	NOUN
aiua-12833	108	31	(	(	PUNCT
aiua-12833	108	32	21	21	NUM
aiua-12833	108	33	)	)	PUNCT
aiua-12833	108	34	.	.	PUNCT
aiua-12833	109	1	another	another	DET
aiua-12833	109	2	study	study	NOUN
aiua-12833	109	3	by	by	ADP
aiua-12833	109	4	fernandez	fernandez	PROPN
aiua-12833	109	5	et	et	PROPN
aiua-12833	109	6	al	al	PROPN
aiua-12833	109	7	.	.	PROPN
aiua-12833	109	8	reported	report	VERB
aiua-12833	109	9	that	that	SCONJ
aiua-12833	109	10	the	the	DET
aiua-12833	109	11	occurrence	occurrence	NOUN
aiua-12833	109	12	of	of	ADP
aiua-12833	109	13	uti	uti	PROPN
aiua-12833	109	14	in	in	ADP
aiua-12833	109	15	carbidopa	carbidopa	NOUN
aiua-12833	109	16	users	user	NOUN
aiua-12833	109	17	was	be	AUX
aiua-12833	109	18	7.8	7.8	NUM
aiua-12833	109	19	%	%	NOUN
aiua-12833	109	20	(	(	PUNCT
aiua-12833	109	21	29	29	NUM
aiua-12833	109	22	)	)	PUNCT
aiua-12833	109	23	.	.	PUNCT
aiua-12833	110	1	different	different	ADJ
aiua-12833	110	2	results	result	NOUN
aiua-12833	110	3	regarding	regard	VERB
aiua-12833	110	4	uti	uti	PROPN
aiua-12833	110	5	incidence	incidence	NOUN
aiua-12833	110	6	have	have	AUX
aiua-12833	110	7	been	be	AUX
aiua-12833	110	8	obtained	obtain	VERB
aiua-12833	110	9	in	in	ADP
aiua-12833	110	10	randomized	randomized	ADJ
aiua-12833	110	11	and	and	CCONJ
aiua-12833	110	12	controlled	control	VERB
aiua-12833	110	13	studies	study	NOUN
aiua-12833	110	14	.	.	PUNCT
aiua-12833	111	1	a	a	DET
aiua-12833	111	2	134	134	NUM
aiua-12833	111	3	-	-	PUNCT
aiua-12833	111	4	week	week	NOUN
aiua-12833	111	5	prospective	prospective	ADJ
aiua-12833	111	6	double	double	ADJ
aiua-12833	111	7	-	-	PUNCT
aiua-12833	111	8	blind	blind	ADJ
aiua-12833	111	9	trial	trial	NOUN
aiua-12833	111	10	by	by	ADP
aiua-12833	111	11	stocchi	stocchi	PROPN
aiua-12833	111	12	et	et	PROPN
aiua-12833	111	13	al	al	PROPN
aiua-12833	111	14	.	.	PROPN
aiua-12833	112	1	(	(	PUNCT
aiua-12833	112	2	28	28	NUM
aiua-12833	112	3	)	)	PUNCT
aiua-12833	112	4	reported	report	VERB
aiua-12833	112	5	that	that	SCONJ
aiua-12833	112	6	uti	uti	PROPN
aiua-12833	112	7	occurrence	occurrence	NOUN
aiua-12833	112	8	in	in	ADP
aiua-12833	112	9	patients	patient	NOUN
aiua-12833	112	10	using	use	VERB
aiua-12833	112	11	levodopa	levodopa	NOUN
aiua-12833	112	12	and	and	CCONJ
aiua-12833	112	13	carbidopa	carbidopa	NOUN
aiua-12833	112	14	was	be	AUX
aiua-12833	112	15	1	1	NUM
aiua-12833	112	16	%	%	NOUN
aiua-12833	112	17	higher	high	ADJ
aiua-12833	112	18	than	than	ADP
aiua-12833	112	19	in	in	ADP
aiua-12833	112	20	the	the	DET
aiua-12833	112	21	control	control	NOUN
aiua-12833	112	22	group	group	NOUN
aiua-12833	112	23	.	.	PUNCT
aiua-12833	113	1	conversely	conversely	ADV
aiua-12833	113	2	,	,	PUNCT
aiua-12833	113	3	in	in	ADP
aiua-12833	113	4	a	a	DET
aiua-12833	113	5	prospective	prospective	ADJ
aiua-12833	113	6	,	,	PUNCT
aiua-12833	113	7	double	double	ADV
aiua-12833	113	8	-	-	PUNCT
aiua-12833	113	9	anonymized	anonymize	VERB
aiua-12833	113	10	,	,	PUNCT
aiua-12833	113	11	placebo	placebo	NOUN
aiua-12833	113	12	-	-	PUNCT
aiua-12833	113	13	controlled	control	VERB
aiua-12833	113	14	trial	trial	NOUN
aiua-12833	113	15	,	,	PUNCT
aiua-12833	113	16	olanow	olanow	ADV
aiua-12833	113	17	et	et	PROPN
aiua-12833	113	18	al	al	PROPN
aiua-12833	113	19	.	.	PROPN
aiua-12833	114	1	(	(	PUNCT
aiua-12833	114	2	25	25	NUM
aiua-12833	114	3	)	)	PUNCT
aiua-12833	114	4	reported	report	VERB
aiua-12833	114	5	that	that	SCONJ
aiua-12833	114	6	uti	uti	PROPN
aiua-12833	114	7	occurrence	occurrence	NOUN
aiua-12833	114	8	was	be	AUX
aiua-12833	114	9	half	half	ADV
aiua-12833	114	10	as	as	ADV
aiua-12833	114	11	frequent	frequent	ADJ
aiua-12833	114	12	in	in	ADP
aiua-12833	114	13	the	the	DET
aiua-12833	114	14	levodopa	levodopa	NOUN
aiua-12833	114	15	and	and	CCONJ
aiua-12833	114	16	carbidopa	carbidopa	NOUN
aiua-12833	114	17	group	group	NOUN
aiua-12833	114	18	compared	compare	VERB
aiua-12833	114	19	to	to	ADP
aiua-12833	114	20	the	the	DET
aiua-12833	114	21	control	control	NOUN
aiua-12833	114	22	group	group	NOUN
aiua-12833	114	23	.	.	PUNCT
aiua-12833	115	1	both	both	DET
aiua-12833	115	2	studies	study	NOUN
aiua-12833	115	3	compared	compare	VERB
aiua-12833	115	4	entacapone	entacapone	NOUN
aiua-12833	115	5	in	in	ADP
aiua-12833	115	6	pd	pd	PROPN
aiua-12833	115	7	patients	patient	NOUN
aiua-12833	115	8	using	use	VERB
aiua-12833	115	9	levodopa	levodopa	NOUN
aiua-12833	115	10	and	and	CCONJ
aiua-12833	115	11	carbidopa	carbidopa	ADV
aiua-12833	115	12	,	,	PUNCT
aiua-12833	115	13	but	but	CCONJ
aiua-12833	115	14	differences	difference	NOUN
aiua-12833	115	15	in	in	ADP
aiua-12833	115	16	sample	sample	NOUN
aiua-12833	115	17	size	size	NOUN
aiua-12833	115	18	,	,	PUNCT
aiua-12833	115	19	length	length	NOUN
aiua-12833	115	20	of	of	ADP
aiua-12833	115	21	follow	follow	NOUN
aiua-12833	115	22	-	-	PUNCT
aiua-12833	115	23	up	up	NOUN
aiua-12833	115	24	,	,	PUNCT
aiua-12833	115	25	and	and	CCONJ
aiua-12833	115	26	the	the	DET
aiua-12833	115	27	duration	duration	NOUN
aiua-12833	115	28	of	of	ADP
aiua-12833	115	29	parkinson	parkinson	NOUN
aiua-12833	115	30	's	's	PART
aiua-12833	115	31	disease	disease	NOUN
aiua-12833	115	32	may	may	AUX
aiua-12833	115	33	explain	explain	VERB
aiua-12833	115	34	the	the	DET
aiua-12833	115	35	divergent	divergent	ADJ
aiua-12833	115	36	results	result	NOUN
aiua-12833	115	37	.	.	PUNCT
aiua-12833	116	1	our	our	PRON
aiua-12833	116	2	study	study	NOUN
aiua-12833	116	3	demonstrated	demonstrate	VERB
aiua-12833	116	4	that	that	SCONJ
aiua-12833	116	5	although	although	SCONJ
aiua-12833	116	6	levodopa	levodopa	NOUN
aiua-12833	116	7	with	with	ADP
aiua-12833	116	8	dci	dci	PROPN
aiua-12833	116	9	was	be	AUX
aiua-12833	116	10	associated	associate	VERB
aiua-12833	116	11	with	with	ADP
aiua-12833	116	12	a	a	DET
aiua-12833	116	13	reduced	reduced	ADJ
aiua-12833	116	14	incidence	incidence	NOUN
aiua-12833	116	15	of	of	ADP
aiua-12833	116	16	uti	uti	PROPN
aiua-12833	116	17	,	,	PUNCT
aiua-12833	116	18	it	it	PRON
aiua-12833	116	19	did	do	AUX
aiua-12833	116	20	not	not	PART
aiua-12833	116	21	significantly	significantly	ADV
aiua-12833	116	22	differ	differ	VERB
aiua-12833	116	23	from	from	ADP
aiua-12833	116	24	other	other	ADJ
aiua-12833	116	25	drugs	drug	NOUN
aiua-12833	116	26	used	use	VERB
aiua-12833	116	27	with	with	ADP
aiua-12833	116	28	levodopa	levodopa	NOUN
aiua-12833	116	29	in	in	ADP
aiua-12833	116	30	reducing	reduce	VERB
aiua-12833	116	31	uti	uti	PROPN
aiua-12833	116	32	occurrence	occurrence	NOUN
aiua-12833	116	33	.	.	PUNCT
aiua-12833	117	1	mechanistically	mechanistically	ADV
aiua-12833	117	2	,	,	PUNCT
aiua-12833	117	3	carbidopa	carbidopa	NOUN
aiua-12833	117	4	increases	increase	VERB
aiua-12833	117	5	the	the	DET
aiua-12833	117	6	conversion	conversion	NOUN
aiua-12833	117	7	of	of	ADP
aiua-12833	117	8	levodopa	levodopa	NOUN
aiua-12833	117	9	to	to	PART
aiua-12833	117	10	dopamine	dopamine	VERB
aiua-12833	117	11	in	in	ADP
aiua-12833	117	12	the	the	DET
aiua-12833	117	13	central	central	ADJ
aiua-12833	117	14	nervous	nervous	ADJ
aiua-12833	117	15	system	system	NOUN
aiua-12833	117	16	(	(	PUNCT
aiua-12833	117	17	cns	cns	NOUN
aiua-12833	117	18	)	)	PUNCT
aiua-12833	117	19	,	,	PUNCT
aiua-12833	117	20	reducing	reduce	VERB
aiua-12833	117	21	peripheral	peripheral	ADJ
aiua-12833	117	22	side	side	NOUN
aiua-12833	117	23	effects	effect	NOUN
aiua-12833	117	24	during	during	ADP
aiua-12833	117	25	pd	pd	PROPN
aiua-12833	117	26	treatment	treatment	NOUN
aiua-12833	117	27	(	(	PUNCT
aiua-12833	117	28	30	30	NUM
aiua-12833	117	29	)	)	PUNCT
aiua-12833	117	30	.	.	PUNCT
aiua-12833	118	1	although	although	SCONJ
aiua-12833	118	2	the	the	DET
aiua-12833	118	3	effects	effect	NOUN
aiua-12833	118	4	of	of	ADP
aiua-12833	118	5	levodopa	levodopa	NOUN
aiua-12833	118	6	on	on	ADP
aiua-12833	118	7	urinary	urinary	ADJ
aiua-12833	118	8	infections	infection	NOUN
aiua-12833	118	9	are	be	AUX
aiua-12833	118	10	not	not	PART
aiua-12833	118	11	well	well	ADV
aiua-12833	118	12	-	-	PUNCT
aiua-12833	118	13	defined	define	VERB
aiua-12833	118	14	,	,	PUNCT
aiua-12833	118	15	some	some	DET
aiua-12833	118	16	previous	previous	ADJ
aiua-12833	118	17	animal	animal	NOUN
aiua-12833	118	18	and	and	CCONJ
aiua-12833	118	19	human	human	ADJ
aiua-12833	118	20	studies	study	NOUN
aiua-12833	118	21	have	have	AUX
aiua-12833	118	22	shown	show	VERB
aiua-12833	118	23	that	that	DET
aiua-12833	118	24	acute	acute	ADJ
aiua-12833	118	25	activation	activation	NOUN
aiua-12833	118	26	of	of	ADP
aiua-12833	118	27	d2	d2	NOUN
aiua-12833	118	28	receptors	receptor	NOUN
aiua-12833	118	29	worsens	worsen	VERB
aiua-12833	118	30	bladder	bladder	NOUN
aiua-12833	118	31	function	function	NOUN
aiua-12833	118	32	(	(	PUNCT
aiua-12833	118	33	31	31	NUM
aiua-12833	118	34	,	,	PUNCT
aiua-12833	118	35	32	32	NUM
aiua-12833	118	36	)	)	PUNCT
aiua-12833	118	37	.	.	PUNCT
aiua-12833	119	1	conversely	conversely	ADV
aiua-12833	119	2	,	,	PUNCT
aiua-12833	119	3	a	a	DET
aiua-12833	119	4	survey	survey	NOUN
aiua-12833	119	5	of	of	ADP
aiua-12833	119	6	parkinsonian	parkinsonian	ADJ
aiua-12833	119	7	monkeys	monkey	NOUN
aiua-12833	119	8	demonstrated	demonstrate	VERB
aiua-12833	119	9	that	that	SCONJ
aiua-12833	119	10	tonic	tonic	NOUN
aiua-12833	119	11	activation	activation	NOUN
aiua-12833	119	12	of	of	ADP
aiua-12833	119	13	d1	d1	NOUN
aiua-12833	119	14	receptors	receptor	NOUN
aiua-12833	119	15	prevents	prevent	VERB
aiua-12833	119	16	bladder	bladder	NOUN
aiua-12833	119	17	voiding	voiding	NOUN
aiua-12833	119	18	(	(	PUNCT
aiua-12833	119	19	33	33	NUM
aiua-12833	119	20	)	)	PUNCT
aiua-12833	119	21	.	.	PUNCT
aiua-12833	120	1	residual	residual	ADJ
aiua-12833	120	2	urine	urine	NOUN
aiua-12833	120	3	can	can	AUX
aiua-12833	120	4	be	be	AUX
aiua-12833	120	5	associated	associate	VERB
aiua-12833	120	6	with	with	ADP
aiua-12833	120	7	urinary	urinary	ADJ
aiua-12833	120	8	infections	infection	NOUN
aiua-12833	120	9	(	(	PUNCT
aiua-12833	120	10	34	34	NUM
aiua-12833	120	11	,	,	PUNCT
aiua-12833	120	12	35	35	NUM
aiua-12833	120	13	)	)	PUNCT
aiua-12833	120	14	.	.	PUNCT
aiua-12833	121	1	therefore	therefore	ADV
aiua-12833	121	2	,	,	PUNCT
aiua-12833	121	3	by	by	ADP
aiua-12833	121	4	preventing	prevent	VERB
aiua-12833	121	5	the	the	DET
aiua-12833	121	6	peripheral	peripheral	ADJ
aiua-12833	121	7	conversion	conversion	NOUN
aiua-12833	121	8	of	of	ADP
aiua-12833	121	9	levodopa	levodopa	NOUN
aiua-12833	121	10	,	,	PUNCT
aiua-12833	121	11	carbidopa	carbidopa	NOUN
aiua-12833	121	12	causes	cause	VERB
aiua-12833	121	13	a	a	DET
aiua-12833	121	14	greater	great	ADJ
aiua-12833	121	15	amount	amount	NOUN
aiua-12833	121	16	of	of	ADP
aiua-12833	121	17	levodopa	levodopa	NOUN
aiua-12833	121	18	to	to	PART
aiua-12833	121	19	reach	reach	VERB
aiua-12833	121	20	the	the	DET
aiua-12833	121	21	brain	brain	NOUN
aiua-12833	121	22	,	,	PUNCT
aiua-12833	121	23	and	and	CCONJ
aiua-12833	121	24	as	as	ADP
aiua-12833	121	25	a	a	DET
aiua-12833	121	26	result	result	NOUN
aiua-12833	121	27	,	,	PUNCT
aiua-12833	121	28	the	the	DET
aiua-12833	121	29	dose	dose	NOUN
aiua-12833	121	30	of	of	ADP
aiua-12833	121	31	levodopa	levodopa	NOUN
aiua-12833	121	32	consumed	consume	VERB
aiua-12833	121	33	is	be	AUX
aiua-12833	121	34	reduced	reduce	VERB
aiua-12833	121	35	and	and	CCONJ
aiua-12833	121	36	its	its	PRON
aiua-12833	121	37	side	side	NOUN
aiua-12833	121	38	effects	effect	NOUN
aiua-12833	121	39	are	be	AUX
aiua-12833	121	40	avoided	avoid	VERB
aiua-12833	121	41	(	(	PUNCT
aiua-12833	121	42	36	36	NUM
aiua-12833	121	43	)	)	PUNCT
aiua-12833	121	44	.	.	PUNCT
aiua-12833	122	1	another	another	DET
aiua-12833	122	2	mechanism	mechanism	NOUN
aiua-12833	122	3	suggests	suggest	VERB
aiua-12833	122	4	that	that	SCONJ
aiua-12833	122	5	inflammatory	inflammatory	ADJ
aiua-12833	122	6	genes	gene	NOUN
aiua-12833	122	7	are	be	AUX
aiua-12833	122	8	expressed	express	VERB
aiua-12833	122	9	in	in	ADP
aiua-12833	122	10	pd	pd	PROPN
aiua-12833	122	11	,	,	PUNCT
aiua-12833	122	12	leading	lead	VERB
aiua-12833	122	13	to	to	ADP
aiua-12833	122	14	immune	immune	ADJ
aiua-12833	122	15	cell	cell	NOUN
aiua-12833	122	16	infiltration	infiltration	NOUN
aiua-12833	122	17	into	into	ADP
aiua-12833	122	18	the	the	DET
aiua-12833	122	19	brain	brain	NOUN
aiua-12833	122	20	and	and	CCONJ
aiua-12833	122	21	increased	increase	VERB
aiua-12833	122	22	activated	activate	VERB
aiua-12833	122	23	/	/	SYM
aiua-12833	122	24	memory	memory	NOUN
aiua-12833	122	25	t	t	NOUN
aiua-12833	122	26	cells	cell	NOUN
aiua-12833	122	27	(	(	PUNCT
aiua-12833	122	28	37	37	NUM
aiua-12833	122	29	)	)	PUNCT
aiua-12833	122	30	.	.	PUNCT
aiua-12833	123	1	in	in	ADP
aiua-12833	123	2	a	a	DET
aiua-12833	123	3	laboratory	laboratory	NOUN
aiua-12833	123	4	study	study	NOUN
aiua-12833	123	5	by	by	ADP
aiua-12833	123	6	zhu	zhu	PROPN
aiua-12833	123	7	et	et	PROPN
aiua-12833	123	8	al	al	PROPN
aiua-12833	123	9	.	.	PROPN
aiua-12833	124	1	(	(	PUNCT
aiua-12833	124	2	30	30	NUM
aiua-12833	124	3	)	)	PUNCT
aiua-12833	124	4	,	,	PUNCT
aiua-12833	124	5	carbidopa	carbidopa	NOUN
aiua-12833	124	6	was	be	AUX
aiua-12833	124	7	shown	show	VERB
aiua-12833	124	8	to	to	PART
aiua-12833	124	9	inhibit	inhibit	VERB
aiua-12833	124	10	t	t	NOUN
aiua-12833	124	11	cell	cell	NOUN
aiua-12833	124	12	responses	response	NOUN
aiua-12833	124	13	and	and	CCONJ
aiua-12833	124	14	autoimmunity	autoimmunity	NOUN
aiua-12833	124	15	in	in	ADP
aiua-12833	124	16	two	two	NUM
aiua-12833	124	17	animal	animal	NOUN
aiua-12833	124	18	models	model	NOUN
aiua-12833	124	19	of	of	ADP
aiua-12833	124	20	parkinson	parkinson	NOUN
aiua-12833	124	21	's	's	PART
aiua-12833	124	22	,	,	PUNCT
aiua-12833	124	23	potentially	potentially	ADV
aiua-12833	124	24	increasing	increase	VERB
aiua-12833	124	25	infection	infection	NOUN
aiua-12833	124	26	risk	risk	NOUN
aiua-12833	124	27	.	.	PUNCT
aiua-12833	125	1	they	they	PRON
aiua-12833	125	2	concluded	conclude	VERB
aiua-12833	125	3	that	that	SCONJ
aiua-12833	125	4	this	this	PRON
aiua-12833	125	5	indicates	indicate	VERB
aiua-12833	125	6	the	the	DET
aiua-12833	125	7	immunosuppressive	immunosuppressive	ADJ
aiua-12833	125	8	activity	activity	NOUN
aiua-12833	125	9	of	of	ADP
aiua-12833	125	10	this	this	DET
aiua-12833	125	11	dci	dci	PROPN
aiua-12833	125	12	.	.	PUNCT
aiua-12833	125	13	further	further	PROPN
aiua-12833	125	14	studies	study	NOUN
aiua-12833	125	15	are	be	AUX
aiua-12833	125	16	needed	need	VERB
aiua-12833	125	17	to	to	PART
aiua-12833	125	18	better	well	ADV
aiua-12833	125	19	understand	understand	VERB
aiua-12833	125	20	the	the	DET
aiua-12833	125	21	relationship	relationship	NOUN
aiua-12833	125	22	between	between	ADP
aiua-12833	125	23	carbidopa	carbidopa	ADJ
aiua-12833	125	24	and	and	CCONJ
aiua-12833	125	25	urinary	urinary	ADJ
aiua-12833	125	26	tract	tract	NOUN
aiua-12833	125	27	infection	infection	NOUN
aiua-12833	125	28	.	.	PUNCT
aiua-12833	126	1	a	a	DET
aiua-12833	126	2	cross	cross	ADJ
aiua-12833	126	3	-	-	ADJ
aiua-12833	126	4	sectional	sectional	ADJ
aiua-12833	126	5	study	study	NOUN
aiua-12833	126	6	by	by	ADP
aiua-12833	126	7	gremke	gremke	PROPN
aiua-12833	126	8	et	et	PROPN
aiua-12833	126	9	al	al	PROPN
aiua-12833	126	10	.	.	PUNCT
aiua-12833	127	1	(	(	PUNCT
aiua-12833	127	2	11	11	NUM
aiua-12833	127	3	)	)	PUNCT
aiua-12833	127	4	used	use	VERB
aiua-12833	127	5	another	another	DET
aiua-12833	127	6	dci	dci	PROPN
aiua-12833	127	7	,	,	PUNCT
aiua-12833	127	8	benserazide	benserazide	NOUN
aiua-12833	127	9	,	,	PUNCT
aiua-12833	127	10	instead	instead	ADV
aiua-12833	127	11	of	of	ADP
aiua-12833	127	12	carbidopa	carbidopa	ADV
aiua-12833	127	13	.	.	PUNCT
aiua-12833	128	1	the	the	DET
aiua-12833	128	2	study	study	NOUN
aiua-12833	128	3	(	(	PUNCT
aiua-12833	128	4	11	11	NUM
aiua-12833	128	5	)	)	PUNCT
aiua-12833	128	6	did	do	AUX
aiua-12833	128	7	not	not	PART
aiua-12833	128	8	show	show	VERB
aiua-12833	128	9	a	a	DET
aiua-12833	128	10	significant	significant	ADJ
aiua-12833	128	11	relationship	relationship	NOUN
aiua-12833	128	12	between	between	ADP
aiua-12833	128	13	the	the	DET
aiua-12833	128	14	two	two	NUM
aiua-12833	128	15	dci	dci	PROPN
aiua-12833	128	16	drugs	drug	NOUN
aiua-12833	128	17	,	,	PUNCT
aiua-12833	128	18	but	but	CCONJ
aiua-12833	128	19	benserazide	benserazide	NOUN
aiua-12833	128	20	had	have	VERB
aiua-12833	128	21	better	well	ADJ
aiua-12833	128	22	protective	protective	ADJ
aiua-12833	128	23	effects	effect	NOUN
aiua-12833	128	24	compared	compare	VERB
aiua-12833	128	25	to	to	ADP
aiua-12833	128	26	carbidopa	carbidopa	ADV
aiua-12833	128	27	.	.	PUNCT
aiua-12833	129	1	due	due	ADP
aiua-12833	129	2	to	to	ADP
aiua-12833	129	3	a	a	DET
aiua-12833	129	4	lack	lack	NOUN
aiua-12833	129	5	of	of	ADP
aiua-12833	129	6	studies	study	NOUN
aiua-12833	129	7	for	for	ADP
aiua-12833	129	8	comparison	comparison	NOUN
aiua-12833	129	9	,	,	PUNCT
aiua-12833	129	10	we	we	PRON
aiua-12833	129	11	did	do	AUX
aiua-12833	129	12	not	not	PART
aiua-12833	129	13	focus	focus	VERB
aiua-12833	129	14	on	on	ADP
aiua-12833	129	15	benserazide	benserazide	NOUN
aiua-12833	129	16	,	,	PUNCT
aiua-12833	129	17	and	and	CCONJ
aiua-12833	129	18	most	most	ADJ
aiua-12833	129	19	of	of	ADP
aiua-12833	129	20	our	our	PRON
aiua-12833	129	21	results	result	NOUN
aiua-12833	129	22	pertain	pertain	VERB
aiua-12833	129	23	to	to	PART
aiua-12833	129	24	carbidopa	carbidopa	VERB
aiua-12833	129	25	.	.	PUNCT
aiua-12833	130	1	nonetheless	nonetheless	ADV
aiua-12833	130	2	,	,	PUNCT
aiua-12833	130	3	we	we	PRON
aiua-12833	130	4	recommend	recommend	VERB
aiua-12833	130	5	future	future	ADJ
aiua-12833	130	6	studies	study	NOUN
aiua-12833	130	7	to	to	PART
aiua-12833	130	8	investigate	investigate	VERB
aiua-12833	130	9	urinary	urinary	ADJ
aiua-12833	130	10	complications	complication	NOUN
aiua-12833	130	11	,	,	PUNCT
aiua-12833	130	12	particularly	particularly	ADV
aiua-12833	130	13	uti	uti	PROPN
aiua-12833	130	14	,	,	PUNCT
aiua-12833	130	15	in	in	ADP
aiua-12833	130	16	pd	pd	PROPN
aiua-12833	130	17	patients	patient	NOUN
aiua-12833	130	18	using	use	VERB
aiua-12833	130	19	benserazide	benserazide	ADV
aiua-12833	130	20	.	.	PUNCT
aiua-12833	131	1	a	a	DET
aiua-12833	131	2	phase	phase	NOUN
aiua-12833	131	3	3	3	NUM
aiua-12833	131	4	interventional	interventional	ADJ
aiua-12833	131	5	study	study	NOUN
aiua-12833	131	6	by	by	ADP
aiua-12833	131	7	freire	freire	PROPN
aiua-12833	131	8	-	-	PUNCT
aiua-12833	131	9	alvarez	alvarez	PROPN
aiua-12833	131	10	et	et	PROPN
aiua-12833	131	11	al	al	PROPN
aiua-12833	131	12	.	.	PROPN
aiua-12833	132	1	(	(	PUNCT
aiua-12833	132	2	22	22	NUM
aiua-12833	132	3	)	)	PUNCT
aiua-12833	132	4	reported	report	VERB
aiua-12833	132	5	that	that	SCONJ
aiua-12833	132	6	uti	uti	PROPN
aiua-12833	132	7	occurrence	occurrence	NOUN
aiua-12833	132	8	in	in	ADP
aiua-12833	132	9	pd	pd	PROPN
aiua-12833	132	10	patients	patient	NOUN
aiua-12833	132	11	was	be	AUX
aiua-12833	132	12	7	7	NUM
aiua-12833	132	13	%	%	NOUN
aiua-12833	132	14	figure	figure	NOUN
aiua-12833	132	15	4	4	NUM
aiua-12833	132	16	.	.	PUNCT
aiua-12833	132	17	funnel	funnel	NOUN
aiua-12833	132	18	plot	plot	NOUN
aiua-12833	132	19	for	for	ADP
aiua-12833	132	20	the	the	DET
aiua-12833	132	21	studies	study	NOUN
aiua-12833	132	22	assessing	assess	VERB
aiua-12833	132	23	urinary	urinary	ADJ
aiua-12833	132	24	tract	tract	NOUN
aiua-12833	132	25	infection	infection	NOUN
aiua-12833	132	26	complication	complication	NOUN
aiua-12833	132	27	of	of	ADP
aiua-12833	132	28	carbidopa	carbidopa	NOUN
aiua-12833	132	29	;	;	PUNCT
aiua-12833	132	30	ci	ci	NOUN
aiua-12833	132	31	:	:	PUNCT
aiua-12833	132	32	confidence	confidence	NOUN
aiua-12833	132	33	interval	interval	NOUN
aiua-12833	132	34	.	.	PUNCT
aiua-12833	133	1	archivio	archivio	NOUN
aiua-12833	133	2	italiano	italiano	PROPN
aiua-12833	133	3	di	di	PROPN
aiua-12833	133	4	urologia	urologia	PROPN
aiua-12833	133	5	e	e	PROPN
aiua-12833	133	6	andrologia	andrologia	NOUN
aiua-12833	133	7	2024	2024	NUM
aiua-12833	133	8	;	;	PUNCT
aiua-12833	133	9	96(4):12833	96(4):12833	NUM
aiua-12833	133	10	9	9	NUM
aiua-12833	133	11	dopa	dopa	NOUN
aiua-12833	133	12	decarboxylase	decarboxylase	NOUN
aiua-12833	133	13	inhibitors	inhibitor	NOUN
aiua-12833	133	14	and	and	CCONJ
aiua-12833	133	15	risk	risk	NOUN
aiua-12833	133	16	of	of	ADP
aiua-12833	133	17	urinary	urinary	ADJ
aiua-12833	133	18	tract	tract	NOUN
aiua-12833	133	19	infections	infection	NOUN
aiua-12833	133	20	in	in	ADP
aiua-12833	133	21	parkinson	parkinson	NOUN
aiua-12833	133	22	’s	’s	PART
aiua-12833	133	23	disease	disease	NOUN
aiua-12833	133	24	higher	high	ADJ
aiua-12833	133	25	in	in	ADP
aiua-12833	133	26	the	the	DET
aiua-12833	133	27	group	group	NOUN
aiua-12833	133	28	treated	treat	VERB
aiua-12833	133	29	with	with	ADP
aiua-12833	133	30	carbidopa	carbidopa	NOUN
aiua-12833	133	31	-	-	NOUN
aiua-12833	133	32	levodopa	levodopa	NOUN
aiua-12833	133	33	for	for	ADP
aiua-12833	133	34	12	12	NUM
aiua-12833	133	35	weeks	week	NOUN
aiua-12833	133	36	compared	compare	VERB
aiua-12833	133	37	to	to	ADP
aiua-12833	133	38	the	the	DET
aiua-12833	133	39	control	control	NOUN
aiua-12833	133	40	group	group	NOUN
aiua-12833	133	41	.	.	PUNCT
aiua-12833	134	1	fernandez	fernandez	PROPN
aiua-12833	134	2	et	et	PROPN
aiua-12833	134	3	al	al	PROPN
aiua-12833	134	4	.	.	PROPN
aiua-12833	134	5	also	also	ADV
aiua-12833	134	6	noted	note	VERB
aiua-12833	134	7	an	an	DET
aiua-12833	134	8	increasing	increase	VERB
aiua-12833	134	9	trend	trend	NOUN
aiua-12833	134	10	in	in	ADP
aiua-12833	134	11	uti	uti	PROPN
aiua-12833	134	12	occurrence	occurrence	NOUN
aiua-12833	134	13	up	up	ADP
aiua-12833	134	14	to	to	ADP
aiua-12833	134	15	week	week	NOUN
aiua-12833	134	16	13	13	NUM
aiua-12833	134	17	,	,	PUNCT
aiua-12833	134	18	followed	follow	VERB
aiua-12833	134	19	by	by	ADP
aiua-12833	134	20	a	a	DET
aiua-12833	134	21	decreasing	decrease	VERB
aiua-12833	134	22	trend	trend	NOUN
aiua-12833	134	23	until	until	ADP
aiua-12833	134	24	week	week	NOUN
aiua-12833	134	25	54	54	NUM
aiua-12833	134	26	(	(	PUNCT
aiua-12833	134	27	29	29	NUM
aiua-12833	134	28	)	)	PUNCT
aiua-12833	134	29	.	.	PUNCT
aiua-12833	135	1	our	our	PRON
aiua-12833	135	2	study	study	NOUN
aiua-12833	135	3	also	also	ADV
aiua-12833	135	4	found	find	VERB
aiua-12833	135	5	that	that	SCONJ
aiua-12833	135	6	treatment	treatment	NOUN
aiua-12833	135	7	with	with	ADP
aiua-12833	135	8	levodopa	levodopa	NOUN
aiua-12833	135	9	and	and	CCONJ
aiua-12833	135	10	dci	dci	PROPN
aiua-12833	135	11	(	(	PUNCT
aiua-12833	135	12	carbidopa	carbidopa	ADV
aiua-12833	135	13	)	)	PUNCT
aiua-12833	135	14	increased	increase	VERB
aiua-12833	135	15	the	the	DET
aiua-12833	135	16	risk	risk	NOUN
aiua-12833	135	17	of	of	ADP
aiua-12833	135	18	uti	uti	PROPN
aiua-12833	135	19	within	within	ADP
aiua-12833	135	20	12	12	NUM
aiua-12833	135	21	weeks	week	NOUN
aiua-12833	135	22	,	,	PUNCT
aiua-12833	135	23	while	while	SCONJ
aiua-12833	135	24	the	the	DET
aiua-12833	135	25	risk	risk	NOUN
aiua-12833	135	26	decreased	decrease	VERB
aiua-12833	135	27	in	in	ADP
aiua-12833	135	28	the	the	DET
aiua-12833	135	29	13	13	NUM
aiua-12833	135	30	-	-	SYM
aiua-12833	135	31	24	24	NUM
aiua-12833	135	32	week	week	NOUN
aiua-12833	135	33	and	and	CCONJ
aiua-12833	135	34	¬	¬	VERB
aiua-12833	135	35	>	>	X
aiua-12833	135	36	24	24	NUM
aiua-12833	135	37	-	-	PUNCT
aiua-12833	135	38	week	week	NOUN
aiua-12833	135	39	periods	period	NOUN
aiua-12833	135	40	.	.	PUNCT
aiua-12833	136	1	an	an	DET
aiua-12833	136	2	open	open	ADJ
aiua-12833	136	3	-	-	PUNCT
aiua-12833	136	4	label	label	NOUN
aiua-12833	136	5	phase	phase	NOUN
aiua-12833	136	6	3b	3b	NUM
aiua-12833	136	7	study	study	NOUN
aiua-12833	136	8	by	by	ADP
aiua-12833	136	9	standaert	standaert	PROPN
aiua-12833	136	10	et	et	PROPN
aiua-12833	136	11	al	al	PROPN
aiua-12833	136	12	.	.	PROPN
aiua-12833	136	13	,	,	PUNCT
aiua-12833	136	14	examining	examine	VERB
aiua-12833	136	15	non	non	ADJ
aiua-12833	136	16	-	-	ADJ
aiua-12833	136	17	motor	motor	ADJ
aiua-12833	136	18	symptoms	symptom	NOUN
aiua-12833	136	19	in	in	ADP
aiua-12833	136	20	pd	pd	PROPN
aiua-12833	136	21	patients	patient	NOUN
aiua-12833	136	22	using	use	VERB
aiua-12833	136	23	carbidopa	carbidopa	ADJ
aiua-12833	136	24	gel	gel	NOUN
aiua-12833	136	25	over	over	ADP
aiua-12833	136	26	60	60	NUM
aiua-12833	136	27	weeks	week	NOUN
aiua-12833	136	28	,	,	PUNCT
aiua-12833	136	29	reported	report	VERB
aiua-12833	136	30	a	a	DET
aiua-12833	136	31	significant	significant	ADJ
aiua-12833	136	32	reduction	reduction	NOUN
aiua-12833	136	33	in	in	ADP
aiua-12833	136	34	urinary	urinary	ADJ
aiua-12833	136	35	symptoms	symptom	NOUN
aiua-12833	136	36	up	up	ADP
aiua-12833	136	37	to	to	ADP
aiua-12833	136	38	week	week	NOUN
aiua-12833	136	39	12	12	NUM
aiua-12833	136	40	,	,	PUNCT
aiua-12833	136	41	but	but	CCONJ
aiua-12833	136	42	this	this	DET
aiua-12833	136	43	reduction	reduction	NOUN
aiua-12833	136	44	was	be	AUX
aiua-12833	136	45	not	not	PART
aiua-12833	136	46	sustained	sustain	VERB
aiua-12833	136	47	.	.	PUNCT
aiua-12833	137	1	they	they	PRON
aiua-12833	137	2	used	use	VERB
aiua-12833	137	3	the	the	DET
aiua-12833	137	4	nonmotor	nonmotor	NOUN
aiua-12833	137	5	symptoms	symptom	NOUN
aiua-12833	137	6	scale	scale	NOUN
aiua-12833	137	7	(	(	PUNCT
aiua-12833	137	8	nmss	nmss	NOUN
aiua-12833	137	9	)	)	PUNCT
aiua-12833	137	10	scoring	scoring	NOUN
aiua-12833	137	11	system	system	NOUN
aiua-12833	137	12	,	,	PUNCT
aiua-12833	137	13	which	which	PRON
aiua-12833	137	14	only	only	ADV
aiua-12833	137	15	assesses	assess	VERB
aiua-12833	137	16	urgency	urgency	NOUN
aiua-12833	137	17	,	,	PUNCT
aiua-12833	137	18	frequency	frequency	NOUN
aiua-12833	137	19	,	,	PUNCT
aiua-12833	137	20	and	and	CCONJ
aiua-12833	137	21	nocturia	nocturia	PROPN
aiua-12833	137	22	,	,	PUNCT
aiua-12833	137	23	whereas	whereas	SCONJ
aiua-12833	137	24	our	our	PRON
aiua-12833	137	25	study	study	NOUN
aiua-12833	137	26	focused	focus	VERB
aiua-12833	137	27	solely	solely	ADV
aiua-12833	137	28	on	on	ADP
aiua-12833	137	29	uti	uti	PROPN
aiua-12833	137	30	occurrence	occurrence	NOUN
aiua-12833	137	31	.	.	PUNCT
aiua-12833	138	1	uti	uti	PROPN
aiua-12833	138	2	is	be	AUX
aiua-12833	138	3	a	a	DET
aiua-12833	138	4	significant	significant	ADJ
aiua-12833	138	5	cause	cause	NOUN
aiua-12833	138	6	of	of	ADP
aiua-12833	138	7	hospitalization	hospitalization	NOUN
aiua-12833	138	8	and	and	CCONJ
aiua-12833	138	9	mortality	mortality	NOUN
aiua-12833	138	10	in	in	ADP
aiua-12833	138	11	pd	pd	PROPN
aiua-12833	138	12	patients	patient	NOUN
aiua-12833	138	13	.	.	PUNCT
aiua-12833	139	1	management	management	NOUN
aiua-12833	139	2	strategies	strategy	NOUN
aiua-12833	139	3	for	for	ADP
aiua-12833	139	4	uti	uti	PROPN
aiua-12833	139	5	in	in	ADP
aiua-12833	139	6	pd	pd	PROPN
aiua-12833	139	7	patients	patient	NOUN
aiua-12833	139	8	mainly	mainly	ADV
aiua-12833	139	9	involve	involve	VERB
aiua-12833	139	10	preventive	preventive	ADJ
aiua-12833	139	11	measures	measure	NOUN
aiua-12833	139	12	,	,	PUNCT
aiua-12833	139	13	including	include	VERB
aiua-12833	139	14	vitamin	vitamin	NOUN
aiua-12833	139	15	supplements	supplement	NOUN
aiua-12833	139	16	,	,	PUNCT
aiua-12833	139	17	estrogen	estrogen	NOUN
aiua-12833	139	18	supplements	supplement	NOUN
aiua-12833	139	19	,	,	PUNCT
aiua-12833	139	20	prophylactic	prophylactic	ADJ
aiua-12833	139	21	antibiotics	antibiotic	NOUN
aiua-12833	139	22	,	,	PUNCT
aiua-12833	139	23	and	and	CCONJ
aiua-12833	139	24	hygiene	hygiene	NOUN
aiua-12833	139	25	practices	practice	NOUN
aiua-12833	139	26	in	in	ADP
aiua-12833	139	27	catheterization	catheterization	NOUN
aiua-12833	139	28	cases	case	NOUN
aiua-12833	139	29	(	(	PUNCT
aiua-12833	139	30	38	38	NUM
aiua-12833	139	31	)	)	PUNCT
aiua-12833	139	32	.	.	PUNCT
aiua-12833	140	1	given	give	VERB
aiua-12833	140	2	our	our	PRON
aiua-12833	140	3	study	study	NOUN
aiua-12833	140	4	's	's	PART
aiua-12833	140	5	finding	finding	NOUN
aiua-12833	140	6	of	of	ADP
aiua-12833	140	7	a	a	DET
aiua-12833	140	8	32	32	NUM
aiua-12833	140	9	%	%	NOUN
aiua-12833	140	10	relative	relative	ADJ
aiua-12833	140	11	risk	risk	NOUN
aiua-12833	140	12	reduction	reduction	NOUN
aiua-12833	140	13	in	in	ADP
aiua-12833	140	14	uti	uti	PROPN
aiua-12833	140	15	occurrence	occurrence	NOUN
aiua-12833	140	16	in	in	ADP
aiua-12833	140	17	pd	pd	PROPN
aiua-12833	140	18	patients	patient	NOUN
aiua-12833	140	19	using	use	VERB
aiua-12833	140	20	dci	dci	PROPN
aiua-12833	140	21	(	(	PUNCT
aiua-12833	140	22	carbidopa	carbidopa	NOUN
aiua-12833	140	23	)	)	PUNCT
aiua-12833	140	24	during	during	ADP
aiua-12833	140	25	weeks	week	NOUN
aiua-12833	140	26	13	13	NUM
aiua-12833	140	27	-	-	SYM
aiua-12833	140	28	24	24	NUM
aiua-12833	140	29	,	,	PUNCT
aiua-12833	140	30	we	we	PRON
aiua-12833	140	31	recommend	recommend	VERB
aiua-12833	140	32	future	future	ADJ
aiua-12833	140	33	studies	study	NOUN
aiua-12833	140	34	focus	focus	VERB
aiua-12833	140	35	on	on	ADP
aiua-12833	140	36	dci	dci	PROPN
aiua-12833	140	37	drugs	drug	NOUN
aiua-12833	140	38	in	in	ADP
aiua-12833	140	39	patients	patient	NOUN
aiua-12833	140	40	with	with	ADP
aiua-12833	140	41	parkinson	parkinson	NOUN
aiua-12833	140	42	's	's	PART
aiua-12833	140	43	disease	disease	NOUN
aiua-12833	140	44	who	who	PRON
aiua-12833	140	45	suffer	suffer	VERB
aiua-12833	140	46	from	from	ADP
aiua-12833	140	47	urinary	urinary	ADJ
aiua-12833	140	48	symptoms	symptom	NOUN
aiua-12833	140	49	,	,	PUNCT
aiua-12833	140	50	especially	especially	ADV
aiua-12833	140	51	uti	uti	PROPN
aiua-12833	140	52	,	,	PUNCT
aiua-12833	140	53	in	in	ADP
aiua-12833	140	54	this	this	DET
aiua-12833	140	55	treatment	treatment	NOUN
aiua-12833	140	56	period	period	NOUN
aiua-12833	140	57	so	so	SCONJ
aiua-12833	140	58	that	that	SCONJ
aiua-12833	140	59	they	they	PRON
aiua-12833	140	60	can	can	AUX
aiua-12833	140	61	benefit	benefit	VERB
aiua-12833	140	62	from	from	ADP
aiua-12833	140	63	the	the	DET
aiua-12833	140	64	maximum	maximum	ADJ
aiua-12833	140	65	protective	protective	ADJ
aiua-12833	140	66	effects	effect	NOUN
aiua-12833	140	67	of	of	ADP
aiua-12833	140	68	dci	dci	PROPN
aiua-12833	140	69	drugs	drug	NOUN
aiua-12833	140	70	,	,	PUNCT
aiua-12833	140	71	especially	especially	ADV
aiua-12833	140	72	carbidopa	carbidopa	ADV
aiua-12833	140	73	.	.	PUNCT
aiua-12833	141	1	further	further	ADJ
aiua-12833	141	2	research	research	NOUN
aiua-12833	141	3	is	be	AUX
aiua-12833	141	4	necessary	necessary	ADJ
aiua-12833	141	5	to	to	PART
aiua-12833	141	6	optimize	optimize	VERB
aiua-12833	141	7	pd	pd	PROPN
aiua-12833	141	8	treatment	treatment	NOUN
aiua-12833	141	9	,	,	PUNCT
aiua-12833	141	10	considering	consider	VERB
aiua-12833	141	11	the	the	DET
aiua-12833	141	12	associated	associated	ADJ
aiua-12833	141	13	urological	urological	ADJ
aiua-12833	141	14	complications	complication	NOUN
aiua-12833	141	15	and	and	CCONJ
aiua-12833	141	16	infections	infection	NOUN
aiua-12833	141	17	.	.	PUNCT
aiua-12833	142	1	limitations	limitation	NOUN
aiua-12833	142	2	and	and	CCONJ
aiua-12833	142	3	strengths	strength	NOUN
aiua-12833	142	4	:	:	PUNCT
aiua-12833	142	5	this	this	DET
aiua-12833	142	6	study	study	NOUN
aiua-12833	142	7	is	be	AUX
aiua-12833	142	8	the	the	DET
aiua-12833	142	9	first	first	ADJ
aiua-12833	142	10	systematic	systematic	ADJ
aiua-12833	142	11	review	review	NOUN
aiua-12833	142	12	and	and	CCONJ
aiua-12833	142	13	meta	meta	ADJ
aiua-12833	142	14	-	-	PUNCT
aiua-12833	142	15	analysis	analysis	NOUN
aiua-12833	142	16	examining	examine	VERB
aiua-12833	142	17	uti	uti	PROPN
aiua-12833	142	18	occurrence	occurrence	NOUN
aiua-12833	142	19	in	in	ADP
aiua-12833	142	20	pd	pd	PROPN
aiua-12833	142	21	patients	patient	NOUN
aiua-12833	142	22	using	use	VERB
aiua-12833	142	23	dci	dci	PROPN
aiua-12833	142	24	drugs	drug	NOUN
aiua-12833	142	25	.	.	PUNCT
aiua-12833	143	1	however	however	ADV
aiua-12833	143	2	,	,	PUNCT
aiua-12833	143	3	it	it	PRON
aiua-12833	143	4	has	have	VERB
aiua-12833	143	5	some	some	DET
aiua-12833	143	6	limitations	limitation	NOUN
aiua-12833	143	7	.	.	PUNCT
aiua-12833	144	1	firstly	firstly	ADV
aiua-12833	144	2	,	,	PUNCT
aiua-12833	144	3	many	many	ADJ
aiua-12833	144	4	studies	study	NOUN
aiua-12833	144	5	were	be	AUX
aiua-12833	144	6	excluded	exclude	VERB
aiua-12833	144	7	due	due	ADP
aiua-12833	144	8	to	to	ADP
aiua-12833	144	9	the	the	DET
aiua-12833	144	10	need	need	NOUN
aiua-12833	144	11	of	of	ADP
aiua-12833	144	12	randomization	randomization	NOUN
aiua-12833	144	13	and	and	CCONJ
aiua-12833	144	14	control	control	NOUN
aiua-12833	144	15	groups	group	NOUN
aiua-12833	144	16	.	.	PUNCT
aiua-12833	145	1	secondly	secondly	ADV
aiua-12833	145	2	,	,	PUNCT
aiua-12833	145	3	control	control	NOUN
aiua-12833	145	4	groups	group	NOUN
aiua-12833	145	5	in	in	ADP
aiua-12833	145	6	the	the	DET
aiua-12833	145	7	studies	study	NOUN
aiua-12833	145	8	were	be	AUX
aiua-12833	145	9	highly	highly	ADV
aiua-12833	145	10	heterogeneous	heterogeneous	ADJ
aiua-12833	145	11	,	,	PUNCT
aiua-12833	145	12	potentially	potentially	ADV
aiua-12833	145	13	affecting	affect	VERB
aiua-12833	145	14	the	the	DET
aiua-12833	145	15	comparison	comparison	NOUN
aiua-12833	145	16	of	of	ADP
aiua-12833	145	17	dci	dci	PROPN
aiua-12833	145	18	drug	drug	NOUN
aiua-12833	145	19	effects	effect	NOUN
aiua-12833	145	20	.	.	PUNCT
aiua-12833	146	1	thirdly	thirdly	ADV
aiua-12833	146	2	,	,	PUNCT
aiua-12833	146	3	not	not	PART
aiua-12833	146	4	all	all	DET
aiua-12833	146	5	studies	study	NOUN
aiua-12833	146	6	provided	provide	VERB
aiua-12833	146	7	detailed	detailed	ADJ
aiua-12833	146	8	information	information	NOUN
aiua-12833	146	9	on	on	ADP
aiua-12833	146	10	specific	specific	ADJ
aiua-12833	146	11	variables	variable	NOUN
aiua-12833	146	12	,	,	PUNCT
aiua-12833	146	13	so	so	ADV
aiua-12833	146	14	the	the	DET
aiua-12833	146	15	intended	intend	VERB
aiua-12833	146	16	outcome	outcome	NOUN
aiua-12833	146	17	in	in	ADP
aiua-12833	146	18	this	this	DET
aiua-12833	146	19	study	study	NOUN
aiua-12833	146	20	was	be	AUX
aiua-12833	146	21	not	not	PART
aiua-12833	146	22	reported	report	VERB
aiua-12833	146	23	in	in	ADP
aiua-12833	146	24	terms	term	NOUN
aiua-12833	146	25	of	of	ADP
aiua-12833	146	26	the	the	DET
aiua-12833	146	27	dosage	dosage	NOUN
aiua-12833	146	28	of	of	ADP
aiua-12833	146	29	the	the	DET
aiua-12833	146	30	drugs	drug	NOUN
aiua-12833	146	31	used	use	VERB
aiua-12833	146	32	,	,	PUNCT
aiua-12833	146	33	and	and	CCONJ
aiua-12833	146	34	it	it	PRON
aiua-12833	146	35	was	be	AUX
aiua-12833	146	36	impossible	impossible	ADJ
aiua-12833	146	37	to	to	PART
aiua-12833	146	38	estimate	estimate	VERB
aiua-12833	146	39	the	the	DET
aiua-12833	146	40	relative	relative	ADJ
aiua-12833	146	41	risk	risk	NOUN
aiua-12833	146	42	based	base	VERB
aiua-12833	146	43	on	on	ADP
aiua-12833	146	44	the	the	DET
aiua-12833	146	45	dosage	dosage	NOUN
aiua-12833	146	46	.	.	PUNCT
aiua-12833	147	1	conclusions	conclusion	NOUN
aiua-12833	147	2	our	our	PRON
aiua-12833	147	3	study	study	NOUN
aiua-12833	147	4	showed	show	VERB
aiua-12833	147	5	that	that	SCONJ
aiua-12833	147	6	dci	dci	PROPN
aiua-12833	147	7	use	use	NOUN
aiua-12833	147	8	,	,	PUNCT
aiua-12833	147	9	along	along	ADP
aiua-12833	147	10	with	with	ADP
aiua-12833	147	11	levodopa	levodopa	NOUN
aiua-12833	147	12	in	in	ADP
aiua-12833	147	13	pd	pd	PROPN
aiua-12833	147	14	patients	patient	NOUN
aiua-12833	147	15	,	,	PUNCT
aiua-12833	147	16	is	be	AUX
aiua-12833	147	17	associated	associate	VERB
aiua-12833	147	18	with	with	ADP
aiua-12833	147	19	a	a	DET
aiua-12833	147	20	reduced	reduce	VERB
aiua-12833	147	21	relative	relative	ADJ
aiua-12833	147	22	risk	risk	NOUN
aiua-12833	147	23	of	of	ADP
aiua-12833	147	24	uti	uti	PROPN
aiua-12833	147	25	occurrence	occurrence	NOUN
aiua-12833	147	26	.	.	PUNCT
aiua-12833	148	1	however	however	ADV
aiua-12833	148	2	,	,	PUNCT
aiua-12833	148	3	this	this	DET
aiua-12833	148	4	reduction	reduction	NOUN
aiua-12833	148	5	was	be	AUX
aiua-12833	148	6	not	not	PART
aiua-12833	148	7	specific	specific	ADJ
aiua-12833	148	8	to	to	ADP
aiua-12833	148	9	dci	dci	PROPN
aiua-12833	148	10	drugs	drug	NOUN
aiua-12833	148	11	,	,	PUNCT
aiua-12833	148	12	as	as	SCONJ
aiua-12833	148	13	other	other	ADJ
aiua-12833	148	14	medications	medication	NOUN
aiua-12833	148	15	used	use	VERB
aiua-12833	148	16	with	with	ADP
aiua-12833	148	17	levodopa	levodopa	NOUN
aiua-12833	148	18	also	also	ADV
aiua-12833	148	19	reduced	reduce	VERB
aiua-12833	148	20	uti	uti	PROPN
aiua-12833	148	21	occurrence	occurrence	NOUN
aiua-12833	148	22	.	.	PUNCT
aiua-12833	149	1	subgroup	subgroup	NOUN
aiua-12833	149	2	analysis	analysis	NOUN
aiua-12833	149	3	indicated	indicate	VERB
aiua-12833	149	4	that	that	SCONJ
aiua-12833	149	5	the	the	DET
aiua-12833	149	6	relative	relative	ADJ
aiua-12833	149	7	risk	risk	NOUN
aiua-12833	149	8	of	of	ADP
aiua-12833	149	9	uti	uti	PROPN
aiua-12833	149	10	significantly	significantly	ADV
aiua-12833	149	11	decreased	decrease	VERB
aiua-12833	149	12	starting	start	VERB
aiua-12833	149	13	from	from	ADP
aiua-12833	149	14	the	the	DET
aiua-12833	149	15	13	13	NUM
aiua-12833	149	16	to	to	PART
aiua-12833	149	17	24	24	NUM
aiua-12833	149	18	-	-	PUNCT
aiua-12833	149	19	week	week	NOUN
aiua-12833	149	20	treatment	treatment	NOUN
aiua-12833	149	21	period	period	NOUN
aiua-12833	149	22	with	with	ADP
aiua-12833	149	23	dci	dci	PROPN
aiua-12833	149	24	.	.	PUNCT
aiua-12833	150	1	these	these	DET
aiua-12833	150	2	findings	finding	NOUN
aiua-12833	150	3	can	can	AUX
aiua-12833	150	4	help	help	VERB
aiua-12833	150	5	researchers	researcher	NOUN
aiua-12833	150	6	better	well	ADV
aiua-12833	150	7	manage	manage	VERB
aiua-12833	150	8	the	the	DET
aiua-12833	150	9	primary	primary	ADJ
aiua-12833	150	10	cause	cause	NOUN
aiua-12833	150	11	of	of	ADP
aiua-12833	150	12	hospitalization	hospitalization	NOUN
aiua-12833	150	13	and	and	CCONJ
aiua-12833	150	14	mortality	mortality	NOUN
aiua-12833	150	15	in	in	ADP
aiua-12833	150	16	pd	pd	PROPN
aiua-12833	150	17	patients	patient	NOUN
aiua-12833	150	18	that	that	PRON
aiua-12833	150	19	is	be	AUX
aiua-12833	150	20	uti	uti	PROPN
aiua-12833	150	21	.	.	PUNCT
aiua-12833	151	1	additionally	additionally	ADV
aiua-12833	151	2	,	,	PUNCT
aiua-12833	151	3	researchers	researcher	NOUN
aiua-12833	151	4	can	can	AUX
aiua-12833	151	5	use	use	VERB
aiua-12833	151	6	these	these	DET
aiua-12833	151	7	findings	finding	NOUN
aiua-12833	151	8	to	to	PART
aiua-12833	151	9	design	design	VERB
aiua-12833	151	10	future	future	ADJ
aiua-12833	151	11	studies	study	NOUN
aiua-12833	151	12	more	more	ADV
aiua-12833	151	13	effectively	effectively	ADV
aiua-12833	151	14	,	,	PUNCT
aiua-12833	151	15	focusing	focus	VERB
aiua-12833	151	16	on	on	ADP
aiua-12833	151	17	the	the	DET
aiua-12833	151	18	type	type	NOUN
aiua-12833	151	19	of	of	ADP
aiua-12833	151	20	drug	drug	NOUN
aiua-12833	151	21	and	and	CCONJ
aiua-12833	151	22	treatment	treatment	NOUN
aiua-12833	151	23	duration	duration	NOUN
aiua-12833	151	24	with	with	ADP
aiua-12833	151	25	dci	dci	PROPN
aiua-12833	151	26	drugs	drug	NOUN
aiua-12833	151	27	,	,	PUNCT
aiua-12833	151	28	especially	especially	ADV
aiua-12833	151	29	carbidopa	carbidopa	ADV
aiua-12833	151	30	.	.	PUNCT
aiua-12833	152	1	acknowledgments	acknowledgment	NOUN
aiua-12833	152	2	the	the	DET
aiua-12833	152	3	authors	author	NOUN
aiua-12833	152	4	would	would	AUX
aiua-12833	152	5	like	like	VERB
aiua-12833	152	6	to	to	PART
aiua-12833	152	7	thank	thank	VERB
aiua-12833	152	8	the	the	DET
aiua-12833	152	9	general	general	ADJ
aiua-12833	152	10	manager	manager	NOUN
aiua-12833	152	11	of	of	ADP
aiua-12833	152	12	althora	althora	PROPN
aiua-12833	152	13	general	general	ADJ
aiua-12833	152	14	hospital	hospital	PROPN
aiua-12833	152	15	,	,	PUNCT
aiua-12833	152	16	ibb	ibb	NOUN
aiua-12833	152	17	,	,	PUNCT
aiua-12833	152	18	yemen	yemen	PROPN
aiua-12833	152	19	,	,	PUNCT
aiua-12833	152	20	dr	dr	PROPN
aiua-12833	152	21	.	.	PROPN
aiua-12833	152	22	abdulghani	abdulghani	PROPN
aiua-12833	152	23	ghabisha	ghabisha	PROPN
aiua-12833	152	24	,	,	PUNCT
aiua-12833	152	25	for	for	ADP
aiua-12833	152	26	editorial	editorial	ADJ
aiua-12833	152	27	assistance	assistance	NOUN
aiua-12833	152	28	.	.	PUNCT
aiua-12833	153	1	references	reference	NOUN
aiua-12833	153	2	1	1	NUM
aiua-12833	153	3	.	.	PUNCT
aiua-12833	153	4	demaagd	demaagd	PROPN
aiua-12833	153	5	g	g	PROPN
aiua-12833	153	6	,	,	PUNCT
aiua-12833	153	7	philip	philip	PROPN
aiua-12833	153	8	a.	a.	PROPN
aiua-12833	153	9	parkinson	parkinson	NOUN
aiua-12833	153	10	's	's	PART
aiua-12833	153	11	disease	disease	NOUN
aiua-12833	153	12	and	and	CCONJ
aiua-12833	153	13	its	its	PRON
aiua-12833	153	14	management	management	NOUN
aiua-12833	153	15	:	:	PUNCT
aiua-12833	153	16	part	part	NOUN
aiua-12833	153	17	1	1	NUM
aiua-12833	153	18	:	:	PUNCT
aiua-12833	153	19	disease	disease	NOUN
aiua-12833	153	20	entity	entity	NOUN
aiua-12833	153	21	,	,	PUNCT
aiua-12833	153	22	risk	risk	NOUN
aiua-12833	153	23	factors	factor	NOUN
aiua-12833	153	24	,	,	PUNCT
aiua-12833	153	25	pathophysiology	pathophysiology	NOUN
aiua-12833	153	26	,	,	PUNCT
aiua-12833	153	27	clinical	clinical	ADJ
aiua-12833	153	28	presentation	presentation	NOUN
aiua-12833	153	29	,	,	PUNCT
aiua-12833	153	30	and	and	CCONJ
aiua-12833	153	31	diagnosis	diagnosis	NOUN
aiua-12833	153	32	.	.	PUNCT
aiua-12833	154	1	p	p	X
aiua-12833	154	2	t.	t.	NOUN
aiua-12833	154	3	2015	2015	NUM
aiua-12833	154	4	;	;	PUNCT
aiua-12833	154	5	40:504	40:504	NUM
aiua-12833	154	6	-	-	SYM
aiua-12833	154	7	32	32	NUM
aiua-12833	154	8	.	.	PUNCT
aiua-12833	155	1	2	2	NUM
aiua-12833	155	2	.	.	X
aiua-12833	155	3	aarsland	aarsland	PROPN
aiua-12833	156	1	d	d	PROPN
aiua-12833	156	2	,	,	PUNCT
aiua-12833	156	3	batzu	batzu	PROPN
aiua-12833	156	4	l	l	PROPN
aiua-12833	156	5	,	,	PUNCT
aiua-12833	156	6	halliday	halliday	PROPN
aiua-12833	156	7	gm	gm	PROPN
aiua-12833	156	8	,	,	PUNCT
aiua-12833	156	9	et	et	PROPN
aiua-12833	156	10	al	al	PROPN
aiua-12833	156	11	.	.	PROPN
aiua-12833	156	12	parkinson	parkinson	PROPN
aiua-12833	156	13	disease	disease	NOUN
aiua-12833	156	14	-	-	PUNCT
aiua-12833	156	15	associated	associate	VERB
aiua-12833	156	16	cognitive	cognitive	ADJ
aiua-12833	156	17	impairment	impairment	NOUN
aiua-12833	156	18	.	.	PUNCT
aiua-12833	157	1	nat	nat	PROPN
aiua-12833	157	2	rev	rev	VERB
aiua-12833	157	3	dis	dis	PROPN
aiua-12833	157	4	primers	primer	NOUN
aiua-12833	157	5	.	.	PUNCT
aiua-12833	158	1	2021	2021	NUM
aiua-12833	158	2	;	;	PUNCT
aiua-12833	159	1	7:47	7:47	NUM
aiua-12833	159	2	.	.	PUNCT
aiua-12833	160	1	3	3	NUM
aiua-12833	160	2	.	.	X
aiua-12833	160	3	bloem	bloem	PROPN
aiua-12833	160	4	br	br	PROPN
aiua-12833	160	5	,	,	PUNCT
aiua-12833	160	6	okun	okun	PROPN
aiua-12833	160	7	ms	ms	PROPN
aiua-12833	160	8	,	,	PUNCT
aiua-12833	160	9	klein	klein	PROPN
aiua-12833	160	10	c.	c.	PROPN
aiua-12833	160	11	parkinson	parkinson	PROPN
aiua-12833	160	12	's	's	PART
aiua-12833	160	13	disease	disease	NOUN
aiua-12833	160	14	.	.	PUNCT
aiua-12833	161	1	lancet	lancet	PROPN
aiua-12833	161	2	.	.	PUNCT
aiua-12833	162	1	2021	2021	NUM
aiua-12833	162	2	;	;	PUNCT
aiua-12833	162	3	397:2284	397:2284	NUM
aiua-12833	162	4	-	-	SYM
aiua-12833	162	5	303	303	NUM
aiua-12833	162	6	.	.	NOUN
aiua-12833	163	1	4	4	X
aiua-12833	163	2	.	.	X
aiua-12833	163	3	ou	ou	PROPN
aiua-12833	163	4	z	z	PROPN
aiua-12833	163	5	,	,	PUNCT
aiua-12833	163	6	pan	pan	PROPN
aiua-12833	163	7	j	j	PROPN
aiua-12833	163	8	,	,	PUNCT
aiua-12833	163	9	tang	tang	PROPN
aiua-12833	163	10	s	s	PART
aiua-12833	163	11	,	,	PUNCT
aiua-12833	163	12	et	et	PROPN
aiua-12833	163	13	al	al	PROPN
aiua-12833	163	14	.	.	PUNCT
aiua-12833	164	1	global	global	ADJ
aiua-12833	164	2	trends	trend	NOUN
aiua-12833	164	3	in	in	ADP
aiua-12833	164	4	the	the	DET
aiua-12833	164	5	incidence	incidence	NOUN
aiua-12833	164	6	,	,	PUNCT
aiua-12833	164	7	prevalence	prevalence	NOUN
aiua-12833	164	8	,	,	PUNCT
aiua-12833	164	9	and	and	CCONJ
aiua-12833	164	10	years	year	NOUN
aiua-12833	164	11	lived	live	VERB
aiua-12833	164	12	with	with	ADP
aiua-12833	164	13	disability	disability	NOUN
aiua-12833	164	14	of	of	ADP
aiua-12833	164	15	parkinson	parkinson	NOUN
aiua-12833	164	16	's	's	PART
aiua-12833	164	17	disease	disease	NOUN
aiua-12833	164	18	in	in	ADP
aiua-12833	164	19	204	204	NUM
aiua-12833	164	20	countries	country	NOUN
aiua-12833	164	21	/	/	SYM
aiua-12833	164	22	territories	territory	NOUN
aiua-12833	164	23	from	from	ADP
aiua-12833	164	24	1990	1990	NUM
aiua-12833	164	25	to	to	ADP
aiua-12833	164	26	2019	2019	NUM
aiua-12833	164	27	.	.	PUNCT
aiua-12833	165	1	front	front	ADJ
aiua-12833	165	2	public	public	ADJ
aiua-12833	165	3	health	health	NOUN
aiua-12833	165	4	.	.	PUNCT
aiua-12833	166	1	2021	2021	NUM
aiua-12833	166	2	;	;	PUNCT
aiua-12833	166	3	9:776847	9:776847	X
aiua-12833	166	4	.	.	NOUN
aiua-12833	167	1	5	5	NUM
aiua-12833	167	2	.	.	X
aiua-12833	167	3	balestrino	balestrino	NOUN
aiua-12833	167	4	r	r	NOUN
aiua-12833	167	5	,	,	PUNCT
aiua-12833	167	6	schapira	schapira	PROPN
aiua-12833	167	7	ahv	ahv	PROPN
aiua-12833	167	8	.	.	PROPN
aiua-12833	167	9	parkinson	parkinson	PROPN
aiua-12833	167	10	disease	disease	PROPN
aiua-12833	167	11	.	.	PUNCT
aiua-12833	168	1	eur	eur	PROPN
aiua-12833	168	2	j	j	PROPN
aiua-12833	168	3	neurol	neurol	PROPN
aiua-12833	168	4	.	.	PUNCT
aiua-12833	169	1	2020	2020	NUM
aiua-12833	169	2	;	;	PUNCT
aiua-12833	169	3	27:27	27:27	NUM
aiua-12833	169	4	-	-	SYM
aiua-12833	169	5	42	42	NUM
aiua-12833	169	6	.	.	PUNCT
aiua-12833	170	1	6	6	NUM
aiua-12833	170	2	.	.	X
aiua-12833	171	1	supriya	supriya	PROPN
aiua-12833	171	2	p	p	PROPN
aiua-12833	171	3	,	,	PUNCT
aiua-12833	171	4	rajaram	rajaram	PROPN
aiua-12833	171	5	s.	s.	PROPN
aiua-12833	171	6	literature	literature	PROPN
aiua-12833	171	7	review	review	PROPN
aiua-12833	171	8	on	on	ADP
aiua-12833	171	9	history	history	NOUN
aiua-12833	171	10	and	and	CCONJ
aiua-12833	171	11	pharmacotherapy	pharmacotherapy	NOUN
aiua-12833	171	12	of	of	ADP
aiua-12833	171	13	parkinsons	parkinson	NOUN
aiua-12833	171	14	disease	disease	NOUN
aiua-12833	171	15	.	.	PUNCT
aiua-12833	172	1	j	j	PROPN
aiua-12833	172	2	pharm	pharm	PROPN
aiua-12833	172	3	res	re	VERB
aiua-12833	172	4	int	int	NOUN
aiua-12833	172	5	.	.	PUNCT
aiua-12833	173	1	2021	2021	NUM
aiua-12833	173	2	;	;	PUNCT
aiua-12833	173	3	33:839	33:839	NUM
aiua-12833	173	4	-	-	SYM
aiua-12833	173	5	49	49	NUM
aiua-12833	173	6	.	.	PUNCT
aiua-12833	174	1	7	7	X
aiua-12833	174	2	.	.	X
aiua-12833	174	3	beckers	beckers	PROPN
aiua-12833	174	4	m	m	PROPN
aiua-12833	174	5	,	,	PUNCT
aiua-12833	174	6	bloem	bloem	PROPN
aiua-12833	174	7	br	br	PROPN
aiua-12833	174	8	,	,	PUNCT
aiua-12833	174	9	verbeek	verbeek	NOUN
aiua-12833	174	10	mm	mm	PROPN
aiua-12833	174	11	.	.	PUNCT
aiua-12833	175	1	mechanisms	mechanism	NOUN
aiua-12833	175	2	of	of	ADP
aiua-12833	175	3	peripheral	peripheral	ADJ
aiua-12833	175	4	levodopa	levodopa	NOUN
aiua-12833	175	5	resistance	resistance	NOUN
aiua-12833	175	6	in	in	ADP
aiua-12833	175	7	parkinson	parkinson	NOUN
aiua-12833	175	8	's	's	PART
aiua-12833	175	9	disease	disease	NOUN
aiua-12833	175	10	.	.	PUNCT
aiua-12833	176	1	npj	npj	NOUN
aiua-12833	176	2	parkinsons	parkinson	NOUN
aiua-12833	176	3	dis	dis	PROPN
aiua-12833	176	4	.	.	PUNCT
aiua-12833	176	5	2022	2022	NUM
aiua-12833	176	6	;	;	PUNCT
aiua-12833	176	7	8:56	8:56	NUM
aiua-12833	176	8	.	.	NOUN
aiua-12833	176	9	8	8	NUM
aiua-12833	176	10	.	.	PUNCT
aiua-12833	177	1	amjad	amjad	PROPN
aiua-12833	177	2	f	f	PROPN
aiua-12833	177	3	,	,	PUNCT
aiua-12833	177	4	bhatti	bhatti	PROPN
aiua-12833	177	5	d	d	PROPN
aiua-12833	177	6	,	,	PUNCT
aiua-12833	177	7	davis	davis	PROPN
aiua-12833	177	8	tl	tl	PROPN
aiua-12833	177	9	,	,	PUNCT
aiua-12833	177	10	et	et	PROPN
aiua-12833	177	11	al	al	PROPN
aiua-12833	177	12	.	.	PUNCT
aiua-12833	178	1	current	current	ADJ
aiua-12833	178	2	practices	practice	NOUN
aiua-12833	178	3	for	for	ADP
aiua-12833	178	4	outpatient	outpatient	NOUN
aiua-12833	178	5	initiation	initiation	NOUN
aiua-12833	178	6	of	of	ADP
aiua-12833	178	7	levodopa	levodopa	NOUN
aiua-12833	178	8	-	-	PUNCT
aiua-12833	178	9	carbidopa	carbidopa	NOUN
aiua-12833	178	10	intestinal	intestinal	ADJ
aiua-12833	178	11	gel	gel	NOUN
aiua-12833	178	12	for	for	ADP
aiua-12833	178	13	management	management	NOUN
aiua-12833	178	14	of	of	ADP
aiua-12833	178	15	advanced	advanced	ADJ
aiua-12833	178	16	parkinson	parkinson	NOUN
aiua-12833	178	17	's	's	PART
aiua-12833	178	18	disease	disease	NOUN
aiua-12833	178	19	in	in	ADP
aiua-12833	178	20	the	the	DET
aiua-12833	178	21	united	united	PROPN
aiua-12833	178	22	states	states	PROPN
aiua-12833	178	23	.	.	PUNCT
aiua-12833	179	1	adv	adv	INTJ
aiua-12833	179	2	ther	ther	ADV
aiua-12833	179	3	.	.	PUNCT
aiua-12833	180	1	2019	2019	NUM
aiua-12833	180	2	;	;	PUNCT
aiua-12833	180	3	36:2233	36:2233	NUM
aiua-12833	180	4	-	-	SYM
aiua-12833	180	5	46	46	NUM
aiua-12833	180	6	.	.	NOUN
aiua-12833	181	1	9	9	NUM
aiua-12833	181	2	.	.	X
aiua-12833	181	3	montioli	montioli	NOUN
aiua-12833	181	4	r	r	PROPN
aiua-12833	181	5	,	,	PUNCT
aiua-12833	181	6	voltattorni	voltattorni	PROPN
aiua-12833	181	7	cb	cb	PROPN
aiua-12833	181	8	,	,	PUNCT
aiua-12833	181	9	bertoldi	bertoldi	NOUN
aiua-12833	181	10	m.	m.	NOUN
aiua-12833	181	11	parkinson	parkinson	NOUN
aiua-12833	181	12	's	's	PART
aiua-12833	181	13	disease	disease	NOUN
aiua-12833	181	14	:	:	PUNCT
aiua-12833	181	15	recent	recent	ADJ
aiua-12833	181	16	updates	update	NOUN
aiua-12833	181	17	in	in	ADP
aiua-12833	181	18	the	the	DET
aiua-12833	181	19	identification	identification	NOUN
aiua-12833	181	20	of	of	ADP
aiua-12833	181	21	human	human	ADJ
aiua-12833	181	22	dopa	dopa	NOUN
aiua-12833	181	23	decarboxylase	decarboxylase	NOUN
aiua-12833	181	24	inhibitors	inhibitor	NOUN
aiua-12833	181	25	.	.	PUNCT
aiua-12833	182	1	curr	curr	PROPN
aiua-12833	182	2	drug	drug	PROPN
aiua-12833	182	3	metab	metab	NOUN
aiua-12833	182	4	.	.	PUNCT
aiua-12833	183	1	2016	2016	NUM
aiua-12833	183	2	;	;	PUNCT
aiua-12833	183	3	17:513	17:513	NUM
aiua-12833	183	4	-	-	SYM
aiua-12833	183	5	8	8	NUM
aiua-12833	183	6	.	.	PUNCT
aiua-12833	183	7	10	10	NUM
aiua-12833	183	8	.	.	PUNCT
aiua-12833	184	1	chou	chou	PROPN
aiua-12833	184	2	kl	kl	PROPN
aiua-12833	184	3	.	.	PROPN
aiua-12833	184	4	adverse	adverse	ADJ
aiua-12833	184	5	events	event	NOUN
aiua-12833	184	6	from	from	ADP
aiua-12833	184	7	the	the	DET
aiua-12833	184	8	treatment	treatment	NOUN
aiua-12833	184	9	of	of	ADP
aiua-12833	184	10	parkinson	parkinson	NOUN
aiua-12833	184	11	's	's	PART
aiua-12833	184	12	disease	disease	NOUN
aiua-12833	184	13	.	.	PUNCT
aiua-12833	185	1	neurol	neurol	PROPN
aiua-12833	185	2	clin	clin	PROPN
aiua-12833	185	3	.	.	PUNCT
aiua-12833	185	4	2008	2008	NUM
aiua-12833	185	5	;	;	PUNCT
aiua-12833	185	6	26(3	26(3	NUM
aiua-12833	185	7	suppl):s65	suppl):s65	NOUN
aiua-12833	185	8	-	-	PUNCT
aiua-12833	185	9	83	83	NUM
aiua-12833	185	10	11	11	NUM
aiua-12833	185	11	.	.	PUNCT
aiua-12833	186	1	gremke	gremke	PROPN
aiua-12833	186	2	n	n	CCONJ
aiua-12833	186	3	,	,	PUNCT
aiua-12833	186	4	griewing	griewe	VERB
aiua-12833	186	5	s	s	PROPN
aiua-12833	186	6	,	,	PUNCT
aiua-12833	186	7	printz	printz	NOUN
aiua-12833	186	8	m	m	PROPN
aiua-12833	186	9	,	,	PUNCT
aiua-12833	186	10	et	et	PROPN
aiua-12833	186	11	al	al	PROPN
aiua-12833	186	12	.	.	PROPN
aiua-12833	186	13	association	association	PROPN
aiua-12833	186	14	between	between	ADP
aiua-12833	186	15	parkinson	parkinson	NOUN
aiua-12833	186	16	's	's	PART
aiua-12833	186	17	disease	disease	NOUN
aiua-12833	186	18	medication	medication	NOUN
aiua-12833	186	19	and	and	CCONJ
aiua-12833	186	20	the	the	DET
aiua-12833	186	21	risk	risk	NOUN
aiua-12833	186	22	of	of	ADP
aiua-12833	186	23	lower	low	ADJ
aiua-12833	186	24	urinary	urinary	ADJ
aiua-12833	186	25	tract	tract	NOUN
aiua-12833	186	26	infection	infection	NOUN
aiua-12833	186	27	(	(	PUNCT
aiua-12833	186	28	luti	luti	PROPN
aiua-12833	186	29	):	):	PUNCT
aiua-12833	186	30	a	a	DET
aiua-12833	186	31	retrospective	retrospective	ADJ
aiua-12833	186	32	cohort	cohort	NOUN
aiua-12833	186	33	study	study	NOUN
aiua-12833	186	34	.	.	PUNCT
aiua-12833	187	1	j	j	PROPN
aiua-12833	187	2	clin	clin	PROPN
aiua-12833	187	3	med	med	PROPN
aiua-12833	187	4	.	.	PUNCT
aiua-12833	187	5	2022	2022	NUM
aiua-12833	187	6	;	;	PUNCT
aiua-12833	187	7	11:7077	11:7077	NUM
aiua-12833	187	8	12	12	NUM
aiua-12833	187	9	.	.	PUNCT
aiua-12833	188	1	okunoye	okunoye	PROPN
aiua-12833	188	2	o	o	NOUN
aiua-12833	188	3	,	,	PUNCT
aiua-12833	188	4	kojima	kojima	PROPN
aiua-12833	188	5	g	g	PROPN
aiua-12833	188	6	,	,	PUNCT
aiua-12833	188	7	marston	marston	PROPN
aiua-12833	188	8	l	l	PROPN
aiua-12833	188	9	,	,	PUNCT
aiua-12833	189	1	et	et	PROPN
aiua-12833	189	2	al	al	PROPN
aiua-12833	189	3	.	.	PUNCT
aiua-12833	189	4	factors	factor	NOUN
aiua-12833	189	5	associated	associate	VERB
aiua-12833	189	6	with	with	ADP
aiua-12833	189	7	hospitalisation	hospitalisation	NOUN
aiua-12833	189	8	among	among	ADP
aiua-12833	189	9	people	people	NOUN
aiua-12833	189	10	with	with	ADP
aiua-12833	189	11	parkinson	parkinson	NOUN
aiua-12833	189	12	's	's	PART
aiua-12833	189	13	disease	disease	NOUN
aiua-12833	189	14	a	a	DET
aiua-12833	189	15	systematic	systematic	ADJ
aiua-12833	189	16	review	review	NOUN
aiua-12833	189	17	and	and	CCONJ
aiua-12833	189	18	meta	meta	ADJ
aiua-12833	189	19	-	-	PUNCT
aiua-12833	189	20	analysis	analysis	NOUN
aiua-12833	189	21	.	.	PUNCT
aiua-12833	190	1	parkinsonism	parkinsonism	PROPN
aiua-12833	190	2	relat	relat	PROPN
aiua-12833	190	3	disord	disord	PROPN
aiua-12833	190	4	.	.	PUNCT
aiua-12833	191	1	2020	2020	NUM
aiua-12833	191	2	;	;	PUNCT
aiua-12833	191	3	71:66	71:66	NUM
aiua-12833	191	4	-	-	SYM
aiua-12833	191	5	72	72	NUM
aiua-12833	191	6	.	.	NOUN
aiua-12833	192	1	13	13	NUM
aiua-12833	192	2	.	.	PUNCT
aiua-12833	193	1	hogg	hogg	PROPN
aiua-12833	193	2	e	e	PROPN
aiua-12833	193	3	,	,	PUNCT
aiua-12833	193	4	frank	frank	PROPN
aiua-12833	193	5	s	s	PROPN
aiua-12833	193	6	,	,	PUNCT
aiua-12833	193	7	oft	oft	ADV
aiua-12833	193	8	j	j	PROPN
aiua-12833	193	9	,	,	PUNCT
aiua-12833	193	10	et	et	PROPN
aiua-12833	193	11	al	al	PROPN
aiua-12833	193	12	.	.	PUNCT
aiua-12833	194	1	urinary	urinary	ADJ
aiua-12833	194	2	tract	tract	NOUN
aiua-12833	194	3	infection	infection	NOUN
aiua-12833	194	4	in	in	ADP
aiua-12833	194	5	parkinson	parkinson	NOUN
aiua-12833	194	6	's	's	PART
aiua-12833	194	7	disease	disease	NOUN
aiua-12833	194	8	.	.	PUNCT
aiua-12833	195	1	j	j	PROPN
aiua-12833	195	2	parkinsons	parkinson	VERB
aiua-12833	195	3	dis	dis	PROPN
aiua-12833	195	4	.	.	PUNCT
aiua-12833	195	5	2022	2022	NUM
aiua-12833	195	6	;	;	PUNCT
aiua-12833	195	7	12:743	12:743	NUM
aiua-12833	195	8	-	-	SYM
aiua-12833	195	9	57	57	NUM
aiua-12833	195	10	.	.	PUNCT
aiua-12833	196	1	14	14	NUM
aiua-12833	196	2	.	.	PUNCT
aiua-12833	197	1	fernandez	fernandez	PROPN
aiua-12833	197	2	hh	hh	PROPN
aiua-12833	197	3	,	,	PUNCT
aiua-12833	197	4	boyd	boyd	PROPN
aiua-12833	197	5	jt	jt	PROPN
aiua-12833	197	6	,	,	PUNCT
aiua-12833	197	7	fung	fung	PROPN
aiua-12833	197	8	vsc	vsc	PROPN
aiua-12833	197	9	,	,	PUNCT
aiua-12833	197	10	et	et	PROPN
aiua-12833	197	11	al	al	PROPN
aiua-12833	197	12	.	.	PUNCT
aiua-12833	198	1	long	long	ADJ
aiua-12833	198	2	-	-	PUNCT
aiua-12833	198	3	term	term	NOUN
aiua-12833	198	4	safety	safety	NOUN
aiua-12833	198	5	and	and	CCONJ
aiua-12833	198	6	efficacy	efficacy	NOUN
aiua-12833	198	7	of	of	ADP
aiua-12833	198	8	levodopa	levodopa	NOUN
aiua-12833	198	9	-	-	PUNCT
aiua-12833	198	10	carbidopa	carbidopa	NOUN
aiua-12833	198	11	intestinal	intestinal	ADJ
aiua-12833	198	12	gel	gel	NOUN
aiua-12833	198	13	in	in	ADP
aiua-12833	198	14	advanced	advanced	ADJ
aiua-12833	198	15	parkinson	parkinson	NOUN
aiua-12833	198	16	's	's	PART
aiua-12833	198	17	disease	disease	NOUN
aiua-12833	198	18	.	.	PUNCT
aiua-12833	199	1	mov	mov	NOUN
aiua-12833	199	2	disord	disord	NOUN
aiua-12833	199	3	.	.	PUNCT
aiua-12833	200	1	2018	2018	NUM
aiua-12833	200	2	;	;	PUNCT
aiua-12833	200	3	33:928	33:928	NUM
aiua-12833	200	4	-	-	SYM
aiua-12833	200	5	36	36	NUM
aiua-12833	200	6	.	.	PUNCT
aiua-12833	201	1	15	15	NUM
aiua-12833	201	2	.	.	X
aiua-12833	202	1	espay	espay	PROPN
aiua-12833	202	2	a	a	PRON
aiua-12833	202	3	,	,	PUNCT
aiua-12833	202	4	hauser	hauser	NOUN
aiua-12833	202	5	r	r	NOUN
aiua-12833	202	6	,	,	PUNCT
aiua-12833	202	7	dhall	dhall	NOUN
aiua-12833	202	8	r	r	NOUN
aiua-12833	202	9	,	,	PUNCT
aiua-12833	202	10	et	et	PROPN
aiua-12833	202	11	al	al	PROPN
aiua-12833	202	12	.	.	PUNCT
aiua-12833	203	1	long	long	ADJ
aiua-12833	203	2	-	-	PUNCT
aiua-12833	203	3	term	term	NOUN
aiua-12833	203	4	safety	safety	NOUN
aiua-12833	203	5	and	and	CCONJ
aiua-12833	203	6	efficacy	efficacy	NOUN
aiua-12833	203	7	of	of	ADP
aiua-12833	203	8	ipx203	ipx203	PROPN
aiua-12833	203	9	in	in	ADP
aiua-12833	203	10	parkinson	parkinson	NOUN
aiua-12833	203	11	’s	’s	PART
aiua-12833	203	12	disease	disease	NOUN
aiua-12833	203	13	patients	patient	NOUN
aiua-12833	203	14	with	with	ADP
aiua-12833	203	15	motor	motor	NOUN
aiua-12833	203	16	fluctuations	fluctuation	NOUN
aiua-12833	203	17	:	:	PUNCT
aiua-12833	203	18	a	a	DET
aiua-12833	203	19	9	9	NUM
aiua-12833	203	20	-	-	PUNCT
aiua-12833	203	21	month	month	NOUN
aiua-12833	203	22	open	open	ADJ
aiua-12833	203	23	-	-	PUNCT
aiua-12833	203	24	label	label	NOUN
aiua-12833	203	25	extension	extension	NOUN
aiua-12833	203	26	trial	trial	NOUN
aiua-12833	203	27	(	(	PUNCT
aiua-12833	203	28	s32.006	s32.006	ADJ
aiua-12833	203	29	)	)	PUNCT
aiua-12833	203	30	.	.	PUNCT
aiua-12833	204	1	neurology	neurology	NOUN
aiua-12833	204	2	.	.	PUNCT
aiua-12833	205	1	2023	2023	NUM
aiua-12833	205	2	;	;	PUNCT
aiua-12833	206	1	100(17	100(17	NUM
aiua-12833	206	2	suppl	suppl	ADJ
aiua-12833	206	3	2):2472	2):2472	PROPN
aiua-12833	206	4	.	.	PROPN
aiua-12833	207	1	16	16	NUM
aiua-12833	207	2	.	.	PUNCT
aiua-12833	207	3	boyd	boyd	PROPN
aiua-12833	207	4	jt	jt	PROPN
aiua-12833	207	5	,	,	PUNCT
aiua-12833	207	6	zadikoff	zadikoff	PROPN
aiua-12833	207	7	c	c	AUX
aiua-12833	207	8	,	,	PUNCT
aiua-12833	207	9	benesh	benesh	VERB
aiua-12833	207	10	ja	ja	PROPN
aiua-12833	207	11	,	,	PUNCT
aiua-12833	207	12	et	et	PROPN
aiua-12833	207	13	al	al	PROPN
aiua-12833	207	14	.	.	PUNCT
aiua-12833	208	1	a	a	DET
aiua-12833	208	2	post	post	X
aiua-12833	208	3	hoc	hoc	X
aiua-12833	208	4	comparison	comparison	NOUN
aiua-12833	208	5	of	of	ADP
aiua-12833	208	6	levodopa	levodopa	NOUN
aiua-12833	208	7	-	-	PUNCT
aiua-12833	208	8	carbidopa	carbidopa	NOUN
aiua-12833	208	9	intestinal	intestinal	ADJ
aiua-12833	208	10	gel	gel	NOUN
aiua-12833	208	11	daytime	daytime	NOUN
aiua-12833	208	12	monotherapy	monotherapy	NOUN
aiua-12833	208	13	vs	vs	ADP
aiua-12833	208	14	polytherapy	polytherapy	NOUN
aiua-12833	208	15	safety	safety	NOUN
aiua-12833	208	16	and	and	CCONJ
aiua-12833	208	17	efficacy	efficacy	NOUN
aiua-12833	208	18	in	in	ADP
aiua-12833	208	19	patients	patient	NOUN
aiua-12833	208	20	with	with	ADP
aiua-12833	208	21	advanced	advanced	ADJ
aiua-12833	208	22	parkinson	parkinson	NOUN
aiua-12833	208	23	's	's	PART
aiua-12833	208	24	disease	disease	NOUN
aiua-12833	208	25	:	:	PUNCT
aiua-12833	208	26	results	result	NOUN
aiua-12833	208	27	from	from	ADP
aiua-12833	208	28	6	6	NUM
aiua-12833	208	29	phase	phase	NOUN
aiua-12833	208	30	3/3b	3/3b	NUM
aiua-12833	208	31	open	open	ADJ
aiua-12833	208	32	-	-	PUNCT
aiua-12833	208	33	label	label	NOUN
aiua-12833	208	34	studies	study	NOUN
aiua-12833	208	35	.	.	PUNCT
aiua-12833	209	1	clin	clin	PROPN
aiua-12833	209	2	park	park	PROPN
aiua-12833	209	3	relat	relat	PROPN
aiua-12833	209	4	disord	disord	PROPN
aiua-12833	209	5	.	.	PUNCT
aiua-12833	210	1	2020	2020	NUM
aiua-12833	210	2	;	;	PUNCT
aiua-12833	211	1	2:25	2:25	NUM
aiua-12833	211	2	-	-	SYM
aiua-12833	211	3	34	34	NUM
aiua-12833	211	4	.	.	PUNCT
aiua-12833	211	5	17	17	NUM
aiua-12833	211	6	.	.	PUNCT
aiua-12833	211	7	page	page	NOUN
aiua-12833	211	8	mj	mj	PROPN
aiua-12833	211	9	,	,	PUNCT
aiua-12833	211	10	mckenzie	mckenzie	PROPN
aiua-12833	211	11	je	je	PROPN
aiua-12833	211	12	,	,	PUNCT
aiua-12833	211	13	bossuyt	bossuyt	NOUN
aiua-12833	211	14	pm	pm	NOUN
aiua-12833	211	15	,	,	PUNCT
aiua-12833	211	16	et	et	PROPN
aiua-12833	211	17	al	al	PROPN
aiua-12833	211	18	.	.	PUNCT
aiua-12833	211	19	updating	update	VERB
aiua-12833	211	20	guidance	guidance	NOUN
aiua-12833	211	21	for	for	ADP
aiua-12833	211	22	reporting	report	VERB
aiua-12833	211	23	systematic	systematic	ADJ
aiua-12833	211	24	reviews	review	NOUN
aiua-12833	211	25	:	:	PUNCT
aiua-12833	211	26	development	development	NOUN
aiua-12833	211	27	of	of	ADP
aiua-12833	211	28	the	the	DET
aiua-12833	211	29	prisma	prisma	PROPN
aiua-12833	211	30	2020	2020	NUM
aiua-12833	211	31	statement	statement	NOUN
aiua-12833	211	32	.	.	PUNCT
aiua-12833	212	1	j	j	PROPN
aiua-12833	212	2	clin	clin	PROPN
aiua-12833	212	3	epidemiol	epidemiol	PROPN
aiua-12833	212	4	.	.	PROPN
aiua-12833	212	5	2021	2021	NUM
aiua-12833	212	6	;	;	PUNCT
aiua-12833	212	7	134:103	134:103	NOUN
aiua-12833	212	8	-	-	SYM
aiua-12833	212	9	12	12	NUM
aiua-12833	212	10	.	.	PUNCT
aiua-12833	213	1	archivio	archivio	NOUN
aiua-12833	213	2	italiano	italiano	X
aiua-12833	213	3	di	di	PROPN
aiua-12833	213	4	urologia	urologia	PROPN
aiua-12833	213	5	e	e	PROPN
aiua-12833	213	6	andrologia	andrologia	NOUN
aiua-12833	213	7	2024	2024	NUM
aiua-12833	213	8	;	;	PUNCT
aiua-12833	213	9	96(4):12833	96(4):12833	NUM
aiua-12833	213	10	i.	i.	PROPN
aiua-12833	213	11	alshoaibi	alshoaibi	PROPN
aiua-12833	213	12	,	,	PUNCT
aiua-12833	213	13	b.	b.	PROPN
aiua-12833	213	14	abdo	abdo	PROPN
aiua-12833	213	15	,	,	PUNCT
aiua-12833	213	16	m.	m.	PROPN
aiua-12833	213	17	abdullah	abdullah	PROPN
aiua-12833	213	18	,	,	PUNCT
aiua-12833	213	19	et	et	PROPN
aiua-12833	213	20	al	al	PROPN
aiua-12833	213	21	.	.	PROPN
aiua-12833	214	1	10	10	NUM
aiua-12833	214	2	18	18	NUM
aiua-12833	214	3	.	.	PUNCT
aiua-12833	215	1	sterne	sterne	PROPN
aiua-12833	215	2	jac	jac	PROPN
aiua-12833	215	3	,	,	PUNCT
aiua-12833	215	4	savovic	savovic	PROPN
aiua-12833	215	5	j	j	PROPN
aiua-12833	215	6	,	,	PUNCT
aiua-12833	215	7	page	page	NOUN
aiua-12833	215	8	mj	mj	PROPN
aiua-12833	215	9	,	,	PUNCT
aiua-12833	215	10	et	et	PROPN
aiua-12833	215	11	al	al	PROPN
aiua-12833	215	12	.	.	PROPN
aiua-12833	215	13	rob	rob	PROPN
aiua-12833	216	1	2	2	NUM
aiua-12833	216	2	:	:	PUNCT
aiua-12833	216	3	a	a	DET
aiua-12833	216	4	revised	revise	VERB
aiua-12833	216	5	tool	tool	NOUN
aiua-12833	216	6	for	for	ADP
aiua-12833	216	7	assessing	assess	VERB
aiua-12833	216	8	risk	risk	NOUN
aiua-12833	216	9	of	of	ADP
aiua-12833	216	10	bias	bias	NOUN
aiua-12833	216	11	in	in	ADP
aiua-12833	216	12	randomised	randomised	ADJ
aiua-12833	216	13	trials	trial	NOUN
aiua-12833	216	14	.	.	PUNCT
aiua-12833	217	1	bmj	bmj	PROPN
aiua-12833	217	2	.	.	PROPN
aiua-12833	217	3	2019	2019	NUM
aiua-12833	217	4	;	;	PUNCT
aiua-12833	217	5	366	366	NUM
aiua-12833	217	6	:	:	PUNCT
aiua-12833	217	7	l4898	l4898	PROPN
aiua-12833	217	8	.	.	PUNCT
aiua-12833	218	1	19	19	NUM
aiua-12833	218	2	.	.	PUNCT
aiua-12833	218	3	begg	begg	PROPN
aiua-12833	218	4	cb	cb	PROPN
aiua-12833	218	5	,	,	PUNCT
aiua-12833	218	6	berlin	berlin	PROPN
aiua-12833	218	7	ja	ja	PROPN
aiua-12833	218	8	.	.	PROPN
aiua-12833	218	9	publication	publication	NOUN
aiua-12833	218	10	bias	bias	NOUN
aiua-12833	218	11	and	and	CCONJ
aiua-12833	218	12	dissemination	dissemination	NOUN
aiua-12833	218	13	of	of	ADP
aiua-12833	218	14	clinical	clinical	ADJ
aiua-12833	218	15	research	research	NOUN
aiua-12833	218	16	.	.	PUNCT
aiua-12833	219	1	j	j	PROPN
aiua-12833	219	2	natl	natl	PROPN
aiua-12833	219	3	cancer	cancer	PROPN
aiua-12833	219	4	inst	inst	PROPN
aiua-12833	219	5	.	.	PUNCT
aiua-12833	219	6	1989	1989	NUM
aiua-12833	219	7	;	;	PUNCT
aiua-12833	219	8	81:107	81:107	NUM
aiua-12833	219	9	-	-	SYM
aiua-12833	219	10	15	15	NUM
aiua-12833	219	11	.	.	NOUN
aiua-12833	219	12	20	20	NUM
aiua-12833	219	13	.	.	PUNCT
aiua-12833	220	1	chung	chung	PROPN
aiua-12833	220	2	sj	sj	PROPN
aiua-12833	220	3	,	,	PUNCT
aiua-12833	220	4	calopa	calopa	NOUN
aiua-12833	220	5	m	m	PROPN
aiua-12833	220	6	,	,	PUNCT
aiua-12833	220	7	ceravolo	ceravolo	ADJ
aiua-12833	220	8	mg	mg	PROPN
aiua-12833	220	9	,	,	PUNCT
aiua-12833	220	10	et	et	PROPN
aiua-12833	220	11	al	al	PROPN
aiua-12833	220	12	.	.	PUNCT
aiua-12833	221	1	effects	effect	NOUN
aiua-12833	221	2	of	of	ADP
aiua-12833	221	3	levodopacarbidopa	levodopacarbidopa	ADJ
aiua-12833	221	4	intestinal	intestinal	ADJ
aiua-12833	221	5	gel	gel	NOUN
aiua-12833	221	6	compared	compare	VERB
aiua-12833	221	7	with	with	ADP
aiua-12833	221	8	optimized	optimize	VERB
aiua-12833	221	9	medical	medical	ADJ
aiua-12833	221	10	treatment	treatment	NOUN
aiua-12833	221	11	on	on	ADP
aiua-12833	221	12	nonmotor	nonmotor	NOUN
aiua-12833	221	13	symptoms	symptom	NOUN
aiua-12833	221	14	in	in	ADP
aiua-12833	221	15	advanced	advanced	ADJ
aiua-12833	221	16	parkinson	parkinson	NOUN
aiua-12833	221	17	's	's	PART
aiua-12833	221	18	disease	disease	NOUN
aiua-12833	221	19	:	:	PUNCT
aiua-12833	221	20	insights	insight	NOUN
aiua-12833	221	21	study	study	VERB
aiua-12833	221	22	.	.	PUNCT
aiua-12833	222	1	parkinsons	parkinson	NOUN
aiua-12833	222	2	dis	dis	PROPN
aiua-12833	222	3	.	.	PUNCT
aiua-12833	222	4	2022	2022	NUM
aiua-12833	222	5	;	;	PUNCT
aiua-12833	222	6	2022:1216975	2022:1216975	NUM
aiua-12833	222	7	.	.	NOUN
aiua-12833	222	8	21	21	NUM
aiua-12833	222	9	.	.	PUNCT
aiua-12833	223	1	fahn	fahn	PROPN
aiua-12833	223	2	s	s	PROPN
aiua-12833	223	3	,	,	PUNCT
aiua-12833	223	4	oakes	oakes	PROPN
aiua-12833	223	5	d	d	PROPN
aiua-12833	223	6	,	,	PUNCT
aiua-12833	223	7	shoulson	shoulson	PROPN
aiua-12833	223	8	i	i	PROPN
aiua-12833	223	9	,	,	PUNCT
aiua-12833	223	10	et	et	PROPN
aiua-12833	223	11	al	al	PROPN
aiua-12833	223	12	.	.	PUNCT
aiua-12833	223	13	levodopa	levodopa	NOUN
aiua-12833	223	14	and	and	CCONJ
aiua-12833	223	15	the	the	DET
aiua-12833	223	16	progression	progression	NOUN
aiua-12833	223	17	of	of	ADP
aiua-12833	223	18	parkinson	parkinson	NOUN
aiua-12833	223	19	's	's	PART
aiua-12833	223	20	disease	disease	NOUN
aiua-12833	223	21	.	.	PUNCT
aiua-12833	224	1	n	n	PROPN
aiua-12833	224	2	engl	engl	PROPN
aiua-12833	224	3	j	j	PROPN
aiua-12833	224	4	med	med	PROPN
aiua-12833	224	5	.	.	PUNCT
aiua-12833	224	6	2004	2004	NUM
aiua-12833	224	7	;	;	PUNCT
aiua-12833	225	1	351:2498	351:2498	NUM
aiua-12833	225	2	-	-	SYM
aiua-12833	225	3	508	508	NUM
aiua-12833	225	4	.	.	PUNCT
aiua-12833	226	1	22	22	NUM
aiua-12833	226	2	.	.	PUNCT
aiua-12833	226	3	freire	freire	PROPN
aiua-12833	226	4	-	-	PUNCT
aiua-12833	226	5	alvarez	alvarez	PROPN
aiua-12833	226	6	e	e	PROPN
aiua-12833	226	7	,	,	PUNCT
aiua-12833	226	8	kurca	kurca	NOUN
aiua-12833	226	9	e	e	PROPN
aiua-12833	226	10	,	,	PUNCT
aiua-12833	226	11	lopez	lopez	PROPN
aiua-12833	226	12	manzanares	manzanares	PROPN
aiua-12833	226	13	l	l	PROPN
aiua-12833	226	14	,	,	PUNCT
aiua-12833	226	15	et	et	PROPN
aiua-12833	226	16	al	al	PROPN
aiua-12833	226	17	.	.	PROPN
aiua-12833	227	1	levodopacarbidopa	levodopacarbidopa	PROPN
aiua-12833	227	2	intestinal	intestinal	ADJ
aiua-12833	227	3	gel	gel	NOUN
aiua-12833	227	4	reduces	reduce	VERB
aiua-12833	227	5	dyskinesia	dyskinesia	NOUN
aiua-12833	227	6	in	in	ADP
aiua-12833	227	7	parkinson	parkinson	NOUN
aiua-12833	227	8	's	's	PART
aiua-12833	227	9	disease	disease	NOUN
aiua-12833	227	10	in	in	ADP
aiua-12833	227	11	a	a	DET
aiua-12833	227	12	randomized	randomized	ADJ
aiua-12833	227	13	trial	trial	NOUN
aiua-12833	227	14	.	.	PUNCT
aiua-12833	228	1	mov	mov	NOUN
aiua-12833	228	2	disord	disord	NOUN
aiua-12833	228	3	.	.	PUNCT
aiua-12833	229	1	2021	2021	NUM
aiua-12833	229	2	;	;	PUNCT
aiua-12833	229	3	36:2615	36:2615	NUM
aiua-12833	229	4	-	-	SYM
aiua-12833	229	5	23	23	NUM
aiua-12833	229	6	.	.	PUNCT
aiua-12833	230	1	23	23	NUM
aiua-12833	230	2	.	.	PUNCT
aiua-12833	231	1	hauser	hauser	PROPN
aiua-12833	231	2	ra	ra	PROPN
aiua-12833	231	3	,	,	PUNCT
aiua-12833	231	4	hsu	hsu	PROPN
aiua-12833	231	5	a	a	PROPN
aiua-12833	231	6	,	,	PUNCT
aiua-12833	231	7	kell	kell	PROPN
aiua-12833	231	8	s	s	PROPN
aiua-12833	231	9	,	,	PUNCT
aiua-12833	231	10	et	et	PROPN
aiua-12833	231	11	al	al	PROPN
aiua-12833	231	12	.	.	PROPN
aiua-12833	231	13	extended	extend	VERB
aiua-12833	231	14	-	-	PUNCT
aiua-12833	231	15	release	release	NOUN
aiua-12833	231	16	carbidopa	carbidopa	NOUN
aiua-12833	231	17	-	-	PUNCT
aiua-12833	231	18	levodopa	levodopa	NOUN
aiua-12833	231	19	(	(	PUNCT
aiua-12833	231	20	ipx066	ipx066	PROPN
aiua-12833	231	21	)	)	PUNCT
aiua-12833	231	22	compared	compare	VERB
aiua-12833	231	23	with	with	ADP
aiua-12833	231	24	immediate	immediate	ADJ
aiua-12833	231	25	-	-	PUNCT
aiua-12833	231	26	release	release	NOUN
aiua-12833	231	27	carbidopa	carbidopa	NOUN
aiua-12833	231	28	-	-	NOUN
aiua-12833	231	29	levodopa	levodopa	NOUN
aiua-12833	231	30	in	in	ADP
aiua-12833	231	31	patients	patient	NOUN
aiua-12833	231	32	with	with	ADP
aiua-12833	231	33	parkinson	parkinson	NOUN
aiua-12833	231	34	's	's	PART
aiua-12833	231	35	disease	disease	NOUN
aiua-12833	231	36	and	and	CCONJ
aiua-12833	231	37	motor	motor	NOUN
aiua-12833	231	38	fluctuations	fluctuation	NOUN
aiua-12833	231	39	:	:	PUNCT
aiua-12833	231	40	a	a	DET
aiua-12833	231	41	phase	phase	NOUN
aiua-12833	231	42	3	3	NUM
aiua-12833	231	43	randomised	randomise	VERB
aiua-12833	231	44	,	,	PUNCT
aiua-12833	231	45	double	double	ADJ
aiua-12833	231	46	-	-	PUNCT
aiua-12833	231	47	blind	blind	ADJ
aiua-12833	231	48	trial	trial	NOUN
aiua-12833	231	49	.	.	PUNCT
aiua-12833	232	1	lancet	lancet	PROPN
aiua-12833	232	2	neurol	neurol	PROPN
aiua-12833	232	3	.	.	PUNCT
aiua-12833	233	1	2013	2013	NUM
aiua-12833	233	2	;	;	PUNCT
aiua-12833	233	3	12:346	12:346	NUM
aiua-12833	233	4	-	-	SYM
aiua-12833	233	5	56	56	NUM
aiua-12833	233	6	.	.	NOUN
aiua-12833	233	7	24	24	NUM
aiua-12833	233	8	.	.	PUNCT
aiua-12833	234	1	hauser	hauser	PROPN
aiua-12833	234	2	ra	ra	PROPN
aiua-12833	234	3	,	,	PUNCT
aiua-12833	234	4	espay	espay	PROPN
aiua-12833	234	5	aj	aj	PROPN
aiua-12833	234	6	,	,	PUNCT
aiua-12833	234	7	ellenbogen	ellenbogen	PROPN
aiua-12833	234	8	al	al	PROPN
aiua-12833	234	9	,	,	PUNCT
aiua-12833	234	10	et	et	PROPN
aiua-12833	234	11	al	al	PROPN
aiua-12833	234	12	.	.	PUNCT
aiua-12833	235	1	ipx203	ipx203	PROPN
aiua-12833	235	2	vs	vs	ADP
aiua-12833	235	3	immediate	immediate	ADJ
aiua-12833	235	4	-	-	PUNCT
aiua-12833	235	5	release	release	NOUN
aiua-12833	235	6	carbidopa	carbidopa	NOUN
aiua-12833	235	7	-	-	NOUN
aiua-12833	235	8	levodopa	levodopa	NOUN
aiua-12833	235	9	for	for	ADP
aiua-12833	235	10	the	the	DET
aiua-12833	235	11	treatment	treatment	NOUN
aiua-12833	235	12	of	of	ADP
aiua-12833	235	13	motor	motor	NOUN
aiua-12833	235	14	fluctuations	fluctuation	NOUN
aiua-12833	235	15	in	in	ADP
aiua-12833	235	16	parkinson	parkinson	NOUN
aiua-12833	235	17	disease	disease	NOUN
aiua-12833	235	18	:	:	PUNCT
aiua-12833	235	19	the	the	DET
aiua-12833	235	20	rise	rise	NOUN
aiua-12833	235	21	-	-	PUNCT
aiua-12833	235	22	pd	pd	NOUN
aiua-12833	235	23	randomized	randomize	VERB
aiua-12833	235	24	clinical	clinical	ADJ
aiua-12833	235	25	trial	trial	NOUN
aiua-12833	235	26	.	.	PUNCT
aiua-12833	236	1	jama	jama	PROPN
aiua-12833	236	2	neurol	neurol	PROPN
aiua-12833	236	3	.	.	PUNCT
aiua-12833	237	1	2023	2023	NUM
aiua-12833	237	2	;	;	PUNCT
aiua-12833	237	3	80:1062	80:1062	NOUN
aiua-12833	237	4	-	-	SYM
aiua-12833	237	5	9	9	NUM
aiua-12833	237	6	.	.	NUM
aiua-12833	237	7	25	25	NUM
aiua-12833	237	8	.	.	PUNCT
aiua-12833	238	1	olanow	olanow	PROPN
aiua-12833	238	2	cw	cw	PROPN
aiua-12833	238	3	,	,	PUNCT
aiua-12833	238	4	kieburtz	kieburtz	PROPN
aiua-12833	238	5	k	k	PROPN
aiua-12833	238	6	,	,	PUNCT
aiua-12833	238	7	stern	stern	PROPN
aiua-12833	238	8	m	m	PROPN
aiua-12833	238	9	,	,	PUNCT
aiua-12833	238	10	et	et	PROPN
aiua-12833	238	11	al	al	PROPN
aiua-12833	238	12	.	.	PROPN
aiua-12833	239	1	double	double	ADJ
aiua-12833	239	2	-	-	PUNCT
aiua-12833	239	3	blind	blind	ADJ
aiua-12833	239	4	,	,	PUNCT
aiua-12833	239	5	placebocontrolled	placebocontrolle	VERB
aiua-12833	239	6	study	study	NOUN
aiua-12833	239	7	of	of	ADP
aiua-12833	239	8	entacapone	entacapone	NOUN
aiua-12833	239	9	in	in	ADP
aiua-12833	239	10	levodopa	levodopa	NOUN
aiua-12833	239	11	-	-	PUNCT
aiua-12833	239	12	treated	treat	VERB
aiua-12833	239	13	patients	patient	NOUN
aiua-12833	239	14	with	with	ADP
aiua-12833	239	15	stable	stable	ADJ
aiua-12833	239	16	parkinson	parkinson	NOUN
aiua-12833	239	17	disease	disease	NOUN
aiua-12833	239	18	.	.	PUNCT
aiua-12833	240	1	arch	arch	ADJ
aiua-12833	240	2	neurol	neurol	PROPN
aiua-12833	240	3	.	.	PUNCT
aiua-12833	241	1	2004	2004	NUM
aiua-12833	241	2	;	;	PUNCT
aiua-12833	241	3	61:1563	61:1563	NOUN
aiua-12833	241	4	-	-	PUNCT
aiua-12833	241	5	8	8	NUM
aiua-12833	241	6	.	.	NOUN
aiua-12833	242	1	26	26	NUM
aiua-12833	242	2	.	.	PUNCT
aiua-12833	243	1	rascol	rascol	ADJ
aiua-12833	243	2	o	o	NOUN
aiua-12833	243	3	,	,	PUNCT
aiua-12833	243	4	zesiewicz	zesiewicz	PROPN
aiua-12833	243	5	t	t	PROPN
aiua-12833	243	6	,	,	PUNCT
aiua-12833	243	7	chaudhuri	chaudhuri	PROPN
aiua-12833	243	8	kr	kr	PROPN
aiua-12833	243	9	,	,	PUNCT
aiua-12833	243	10	et	et	PROPN
aiua-12833	243	11	al	al	PROPN
aiua-12833	243	12	.	.	PUNCT
aiua-12833	244	1	a	a	DET
aiua-12833	244	2	randomized	randomized	ADJ
aiua-12833	244	3	controlled	control	VERB
aiua-12833	244	4	exploratory	exploratory	ADJ
aiua-12833	244	5	pilot	pilot	NOUN
aiua-12833	244	6	study	study	NOUN
aiua-12833	244	7	to	to	PART
aiua-12833	244	8	evaluate	evaluate	VERB
aiua-12833	244	9	the	the	DET
aiua-12833	244	10	effect	effect	NOUN
aiua-12833	244	11	of	of	ADP
aiua-12833	244	12	rotigotine	rotigotine	NOUN
aiua-12833	244	13	transdermal	transdermal	ADJ
aiua-12833	244	14	patch	patch	NOUN
aiua-12833	244	15	on	on	ADP
aiua-12833	244	16	parkinson	parkinson	NOUN
aiua-12833	244	17	's	's	PART
aiua-12833	244	18	disease	disease	NOUN
aiua-12833	244	19	-	-	PUNCT
aiua-12833	244	20	associated	associate	VERB
aiua-12833	244	21	chronic	chronic	ADJ
aiua-12833	244	22	pain	pain	NOUN
aiua-12833	244	23	.	.	PUNCT
aiua-12833	245	1	j	j	PROPN
aiua-12833	245	2	clin	clin	PROPN
aiua-12833	245	3	pharmacol	pharmacol	PROPN
aiua-12833	245	4	.	.	PROPN
aiua-12833	246	1	2016	2016	NUM
aiua-12833	246	2	;	;	PUNCT
aiua-12833	246	3	56:852	56:852	NUM
aiua-12833	246	4	-	-	SYM
aiua-12833	246	5	61	61	NUM
aiua-12833	246	6	.	.	PUNCT
aiua-12833	247	1	27	27	NUM
aiua-12833	247	2	.	.	PUNCT
aiua-12833	248	1	schapira	schapira	PROPN
aiua-12833	248	2	ah	ah	INTJ
aiua-12833	248	3	,	,	PUNCT
aiua-12833	248	4	fox	fox	PROPN
aiua-12833	248	5	sh	sh	PROPN
aiua-12833	248	6	,	,	PUNCT
aiua-12833	248	7	hauser	hauser	PROPN
aiua-12833	248	8	ra	ra	PROPN
aiua-12833	248	9	,	,	PUNCT
aiua-12833	248	10	et	et	PROPN
aiua-12833	248	11	al	al	PROPN
aiua-12833	248	12	.	.	PROPN
aiua-12833	248	13	assessment	assessment	NOUN
aiua-12833	248	14	of	of	ADP
aiua-12833	248	15	safety	safety	NOUN
aiua-12833	248	16	and	and	CCONJ
aiua-12833	248	17	efficacy	efficacy	NOUN
aiua-12833	248	18	of	of	ADP
aiua-12833	248	19	safinamide	safinamide	NOUN
aiua-12833	248	20	as	as	ADP
aiua-12833	248	21	a	a	DET
aiua-12833	248	22	levodopa	levodopa	NOUN
aiua-12833	248	23	adjunct	adjunct	VERB
aiua-12833	248	24	in	in	ADP
aiua-12833	248	25	patients	patient	NOUN
aiua-12833	248	26	with	with	ADP
aiua-12833	248	27	parkinson	parkinson	NOUN
aiua-12833	248	28	disease	disease	NOUN
aiua-12833	248	29	and	and	CCONJ
aiua-12833	248	30	motor	motor	NOUN
aiua-12833	248	31	fluctuations	fluctuation	NOUN
aiua-12833	248	32	:	:	PUNCT
aiua-12833	248	33	a	a	DET
aiua-12833	248	34	randomized	randomized	ADJ
aiua-12833	248	35	clinical	clinical	ADJ
aiua-12833	248	36	trial	trial	NOUN
aiua-12833	248	37	.	.	PUNCT
aiua-12833	249	1	jama	jama	PROPN
aiua-12833	249	2	neurology	neurology	PROPN
aiua-12833	249	3	.	.	PUNCT
aiua-12833	250	1	2017	2017	NUM
aiua-12833	250	2	;	;	PUNCT
aiua-12833	250	3	74:216	74:216	NUM
aiua-12833	250	4	-	-	SYM
aiua-12833	250	5	24	24	NUM
aiua-12833	250	6	.	.	PUNCT
aiua-12833	250	7	28	28	NUM
aiua-12833	250	8	.	.	PUNCT
aiua-12833	251	1	stocchi	stocchi	PROPN
aiua-12833	251	2	f	f	PROPN
aiua-12833	251	3	,	,	PUNCT
aiua-12833	251	4	rascol	rascol	ADJ
aiua-12833	251	5	o	o	NOUN
aiua-12833	251	6	,	,	PUNCT
aiua-12833	251	7	kieburtz	kieburtz	PROPN
aiua-12833	251	8	k	k	PROPN
aiua-12833	251	9	,	,	PUNCT
aiua-12833	251	10	et	et	PROPN
aiua-12833	251	11	al	al	PROPN
aiua-12833	251	12	.	.	PUNCT
aiua-12833	251	13	initiating	initiate	VERB
aiua-12833	251	14	levodopa	levodopa	NOUN
aiua-12833	251	15	/	/	SYM
aiua-12833	251	16	carbidopa	carbidopa	NOUN
aiua-12833	251	17	therapy	therapy	NOUN
aiua-12833	251	18	with	with	ADP
aiua-12833	251	19	and	and	CCONJ
aiua-12833	251	20	without	without	ADP
aiua-12833	251	21	entacapone	entacapone	NOUN
aiua-12833	251	22	in	in	ADP
aiua-12833	251	23	early	early	ADJ
aiua-12833	251	24	parkinson	parkinson	NOUN
aiua-12833	251	25	disease	disease	NOUN
aiua-12833	251	26	:	:	PUNCT
aiua-12833	251	27	the	the	DET
aiua-12833	251	28	stride	stride	ADJ
aiua-12833	251	29	-	-	PUNCT
aiua-12833	251	30	pd	pd	NOUN
aiua-12833	251	31	study	study	NOUN
aiua-12833	251	32	.	.	PUNCT
aiua-12833	252	1	ann	ann	PROPN
aiua-12833	252	2	neurol	neurol	PROPN
aiua-12833	252	3	.	.	PUNCT
aiua-12833	253	1	2010	2010	NUM
aiua-12833	253	2	;	;	PUNCT
aiua-12833	253	3	68:18	68:18	NUM
aiua-12833	253	4	-	-	SYM
aiua-12833	253	5	27	27	NUM
aiua-12833	253	6	.	.	PUNCT
aiua-12833	254	1	29	29	NUM
aiua-12833	254	2	.	.	PUNCT
aiua-12833	255	1	fernandez	fernandez	PROPN
aiua-12833	255	2	hh	hh	PROPN
aiua-12833	255	3	,	,	PUNCT
aiua-12833	255	4	vanagunas	vanaguna	NOUN
aiua-12833	255	5	a	a	PRON
aiua-12833	255	6	,	,	PUNCT
aiua-12833	255	7	odin	odin	VERB
aiua-12833	255	8	p	p	NOUN
aiua-12833	255	9	,	,	PUNCT
aiua-12833	255	10	et	et	PROPN
aiua-12833	255	11	al	al	PROPN
aiua-12833	255	12	.	.	PUNCT
aiua-12833	255	13	levodopa	levodopa	NOUN
aiua-12833	255	14	-	-	PUNCT
aiua-12833	255	15	carbidopa	carbidopa	NOUN
aiua-12833	255	16	intestinal	intestinal	ADJ
aiua-12833	255	17	gel	gel	NOUN
aiua-12833	255	18	in	in	ADP
aiua-12833	255	19	advanced	advanced	ADJ
aiua-12833	255	20	parkinson	parkinson	NOUN
aiua-12833	255	21	's	's	PART
aiua-12833	255	22	disease	disease	NOUN
aiua-12833	255	23	open	open	ADJ
aiua-12833	255	24	-	-	PUNCT
aiua-12833	255	25	label	label	NOUN
aiua-12833	255	26	study	study	NOUN
aiua-12833	255	27	:	:	PUNCT
aiua-12833	255	28	interim	interim	ADJ
aiua-12833	255	29	results	result	NOUN
aiua-12833	255	30	.	.	PUNCT
aiua-12833	256	1	parkinsonism	parkinsonism	PROPN
aiua-12833	256	2	relat	relat	PROPN
aiua-12833	256	3	disord	disord	PROPN
aiua-12833	256	4	.	.	PUNCT
aiua-12833	257	1	2013	2013	NUM
aiua-12833	257	2	;	;	PUNCT
aiua-12833	257	3	19:339	19:339	NUM
aiua-12833	257	4	-	-	SYM
aiua-12833	257	5	45	45	NUM
aiua-12833	257	6	.	.	PUNCT
aiua-12833	257	7	30	30	NUM
aiua-12833	257	8	.	.	PUNCT
aiua-12833	258	1	zhu	zhu	PROPN
aiua-12833	258	2	h	h	PROPN
aiua-12833	258	3	,	,	PUNCT
aiua-12833	258	4	lemos	lemos	PROPN
aiua-12833	258	5	h	h	PROPN
aiua-12833	258	6	,	,	PUNCT
aiua-12833	258	7	bhatt	bhatt	PROPN
aiua-12833	258	8	b	b	PROPN
aiua-12833	258	9	,	,	PUNCT
aiua-12833	258	10	et	et	PROPN
aiua-12833	258	11	al	al	PROPN
aiua-12833	258	12	.	.	PROPN
aiua-12833	258	13	carbidopa	carbidopa	PROPN
aiua-12833	258	14	,	,	PUNCT
aiua-12833	258	15	a	a	DET
aiua-12833	258	16	drug	drug	NOUN
aiua-12833	258	17	in	in	ADP
aiua-12833	258	18	use	use	NOUN
aiua-12833	258	19	for	for	ADP
aiua-12833	258	20	management	management	NOUN
aiua-12833	258	21	of	of	ADP
aiua-12833	258	22	parkinson	parkinson	NOUN
aiua-12833	258	23	disease	disease	NOUN
aiua-12833	258	24	inhibits	inhibit	VERB
aiua-12833	258	25	t	t	NOUN
aiua-12833	258	26	cell	cell	NOUN
aiua-12833	258	27	activation	activation	NOUN
aiua-12833	258	28	and	and	CCONJ
aiua-12833	258	29	autoimmunity	autoimmunity	NOUN
aiua-12833	258	30	.	.	PUNCT
aiua-12833	259	1	plos	plos	PROPN
aiua-12833	259	2	one	one	NUM
aiua-12833	259	3	.	.	PUNCT
aiua-12833	259	4	2017	2017	NUM
aiua-12833	259	5	;	;	PUNCT
aiua-12833	259	6	12	12	NUM
aiua-12833	259	7	:	:	PUNCT
aiua-12833	259	8	e0183484	e0183484	NOUN
aiua-12833	259	9	.	.	PUNCT
aiua-12833	260	1	31	31	NUM
aiua-12833	260	2	.	.	PUNCT
aiua-12833	260	3	uchiyama	uchiyama	PROPN
aiua-12833	260	4	t	t	PROPN
aiua-12833	260	5	,	,	PUNCT
aiua-12833	260	6	sakakibara	sakakibara	PROPN
aiua-12833	260	7	r	r	PROPN
aiua-12833	260	8	,	,	PUNCT
aiua-12833	260	9	hattori	hattori	PROPN
aiua-12833	260	10	t	t	PROPN
aiua-12833	260	11	,	,	PUNCT
aiua-12833	260	12	yamanishi	yamanishi	NOUN
aiua-12833	260	13	t.	t.	PROPN
aiua-12833	260	14	short	short	ADJ
aiua-12833	260	15	-	-	PUNCT
aiua-12833	260	16	term	term	NOUN
aiua-12833	260	17	effect	effect	NOUN
aiua-12833	260	18	of	of	ADP
aiua-12833	260	19	a	a	DET
aiua-12833	260	20	single	single	ADJ
aiua-12833	260	21	levodopa	levodopa	NOUN
aiua-12833	260	22	dose	dose	NOUN
aiua-12833	260	23	on	on	ADP
aiua-12833	260	24	micturition	micturition	NOUN
aiua-12833	260	25	disturbance	disturbance	NOUN
aiua-12833	260	26	in	in	ADP
aiua-12833	260	27	parkinson	parkinson	NOUN
aiua-12833	260	28	's	's	PART
aiua-12833	260	29	disease	disease	NOUN
aiua-12833	260	30	patients	patient	NOUN
aiua-12833	260	31	with	with	ADP
aiua-12833	260	32	the	the	DET
aiua-12833	260	33	wearing	wear	VERB
aiua-12833	260	34	-	-	PUNCT
aiua-12833	260	35	off	off	ADP
aiua-12833	260	36	phenomenon	phenomenon	NOUN
aiua-12833	260	37	.	.	PUNCT
aiua-12833	261	1	mov	mov	NOUN
aiua-12833	261	2	disord	disord	NOUN
aiua-12833	261	3	.	.	PUNCT
aiua-12833	262	1	2003	2003	NUM
aiua-12833	262	2	;	;	PUNCT
aiua-12833	262	3	18:573	18:573	NUM
aiua-12833	262	4	-	-	SYM
aiua-12833	262	5	8	8	NUM
aiua-12833	262	6	.	.	PUNCT
aiua-12833	263	1	32	32	NUM
aiua-12833	263	2	.	.	PUNCT
aiua-12833	264	1	brusa	brusa	NOUN
aiua-12833	264	2	l	l	NOUN
aiua-12833	264	3	,	,	PUNCT
aiua-12833	264	4	petta	petta	ADJ
aiua-12833	264	5	f	f	NOUN
aiua-12833	264	6	,	,	PUNCT
aiua-12833	264	7	pisani	pisani	PROPN
aiua-12833	264	8	a	a	X
aiua-12833	264	9	,	,	PUNCT
aiua-12833	264	10	et	et	PROPN
aiua-12833	264	11	al	al	PROPN
aiua-12833	264	12	.	.	PROPN
aiua-12833	264	13	central	central	ADJ
aiua-12833	264	14	acute	acute	PROPN
aiua-12833	264	15	d2	d2	PROPN
aiua-12833	264	16	stimulation	stimulation	NOUN
aiua-12833	264	17	worsens	worsen	VERB
aiua-12833	264	18	bladder	bladder	NOUN
aiua-12833	264	19	function	function	NOUN
aiua-12833	264	20	in	in	ADP
aiua-12833	264	21	patients	patient	NOUN
aiua-12833	264	22	with	with	ADP
aiua-12833	264	23	mild	mild	ADJ
aiua-12833	264	24	parkinson	parkinson	NOUN
aiua-12833	264	25	's	's	PART
aiua-12833	264	26	disease	disease	NOUN
aiua-12833	264	27	.	.	PUNCT
aiua-12833	265	1	j	j	PROPN
aiua-12833	265	2	urol	urol	PROPN
aiua-12833	265	3	.	.	PUNCT
aiua-12833	266	1	2006	2006	NUM
aiua-12833	266	2	;	;	PUNCT
aiua-12833	266	3	175:202	175:202	NOUN
aiua-12833	266	4	-	-	PUNCT
aiua-12833	266	5	6	6	NUM
aiua-12833	266	6	33	33	NUM
aiua-12833	266	7	.	.	PUNCT
aiua-12833	267	1	yoshimura	yoshimura	PROPN
aiua-12833	267	2	n	n	CCONJ
aiua-12833	267	3	,	,	PUNCT
aiua-12833	267	4	mizuta	mizuta	PROPN
aiua-12833	267	5	e	e	PROPN
aiua-12833	267	6	,	,	PUNCT
aiua-12833	267	7	yoshida	yoshida	PROPN
aiua-12833	267	8	o	o	PROPN
aiua-12833	267	9	,	,	PUNCT
aiua-12833	267	10	kuno	kuno	PROPN
aiua-12833	267	11	s.	s.	PROPN
aiua-12833	267	12	therapeutic	therapeutic	ADJ
aiua-12833	267	13	effects	effect	NOUN
aiua-12833	267	14	of	of	ADP
aiua-12833	267	15	dopamine	dopamine	NOUN
aiua-12833	267	16	d1	d1	NOUN
aiua-12833	267	17	/	/	SYM
aiua-12833	267	18	d2	d2	NOUN
aiua-12833	267	19	receptor	receptor	NOUN
aiua-12833	267	20	agonists	agonist	NOUN
aiua-12833	267	21	on	on	ADP
aiua-12833	267	22	detrusor	detrusor	NOUN
aiua-12833	267	23	hyperreflexia	hyperreflexia	NOUN
aiua-12833	267	24	in	in	ADP
aiua-12833	267	25	1methyl-4	1methyl-4	NUM
aiua-12833	267	26	-	-	PUNCT
aiua-12833	267	27	phenyl-1,2,3,6	phenyl-1,2,3,6	NOUN
aiua-12833	267	28	-	-	PUNCT
aiua-12833	267	29	tetrahydropyridine	tetrahydropyridine	ADV
aiua-12833	267	30	-	-	PUNCT
aiua-12833	267	31	lesioned	lesione	VERB
aiua-12833	267	32	parkinsonian	parkinsonian	ADJ
aiua-12833	267	33	cynomolgus	cynomolgus	ADJ
aiua-12833	267	34	monkeys	monkey	NOUN
aiua-12833	267	35	.	.	PUNCT
aiua-12833	268	1	j	j	PROPN
aiua-12833	268	2	pharmacol	pharmacol	PROPN
aiua-12833	268	3	exp	exp	NOUN
aiua-12833	268	4	ther	ther	ADV
aiua-12833	268	5	.	.	PUNCT
aiua-12833	269	1	1998	1998	NUM
aiua-12833	269	2	;	;	PUNCT
aiua-12833	269	3	286:228	286:228	NUM
aiua-12833	269	4	-	-	SYM
aiua-12833	269	5	33	33	NUM
aiua-12833	269	6	.	.	PUNCT
aiua-12833	270	1	34	34	NUM
aiua-12833	270	2	.	.	PUNCT
aiua-12833	271	1	byron	byron	PROPN
aiua-12833	271	2	jk	jk	PROPN
aiua-12833	271	3	.	.	PUNCT
aiua-12833	271	4	urinary	urinary	ADJ
aiua-12833	271	5	tract	tract	NOUN
aiua-12833	271	6	infection	infection	NOUN
aiua-12833	271	7	.	.	PUNCT
aiua-12833	272	1	vet	vet	NOUN
aiua-12833	272	2	clin	clin	PROPN
aiua-12833	272	3	north	north	PROPN
aiua-12833	272	4	am	be	AUX
aiua-12833	272	5	small	small	ADJ
aiua-12833	272	6	anim	anim	NOUN
aiua-12833	272	7	pract	pract	NOUN
aiua-12833	272	8	.	.	PUNCT
aiua-12833	273	1	2019	2019	NUM
aiua-12833	273	2	;	;	PUNCT
aiua-12833	273	3	49:211	49:211	NUM
aiua-12833	273	4	-	-	SYM
aiua-12833	273	5	21	21	NUM
aiua-12833	273	6	.	.	PUNCT
aiua-12833	274	1	35	35	NUM
aiua-12833	274	2	.	.	PUNCT
aiua-12833	275	1	storme	storme	PROPN
aiua-12833	275	2	o	o	PROPN
aiua-12833	275	3	,	,	PUNCT
aiua-12833	275	4	tiran	tiran	PROPN
aiua-12833	275	5	saucedo	saucedo	PROPN
aiua-12833	275	6	j	j	PROPN
aiua-12833	275	7	,	,	PUNCT
aiua-12833	275	8	garcia	garcia	PROPN
aiua-12833	275	9	-	-	PUNCT
aiua-12833	275	10	mora	mora	PROPN
aiua-12833	275	11	a	a	X
aiua-12833	275	12	,	,	PUNCT
aiua-12833	275	13	et	et	PROPN
aiua-12833	275	14	al	al	PROPN
aiua-12833	275	15	.	.	PUNCT
aiua-12833	275	16	risk	risk	NOUN
aiua-12833	275	17	factors	factor	NOUN
aiua-12833	275	18	and	and	CCONJ
aiua-12833	275	19	predisposing	predispose	VERB
aiua-12833	275	20	conditions	condition	NOUN
aiua-12833	275	21	for	for	ADP
aiua-12833	275	22	urinary	urinary	ADJ
aiua-12833	275	23	tract	tract	NOUN
aiua-12833	275	24	infection	infection	NOUN
aiua-12833	275	25	.	.	PUNCT
aiua-12833	276	1	ther	ther	INTJ
aiua-12833	276	2	adv	adv	INTJ
aiua-12833	276	3	urol	urol	PROPN
aiua-12833	276	4	.	.	PROPN
aiua-12833	276	5	2019	2019	NUM
aiua-12833	276	6	;	;	PUNCT
aiua-12833	276	7	11:1756287218814382	11:1756287218814382	NUM
aiua-12833	276	8	.	.	NOUN
aiua-12833	276	9	36	36	NUM
aiua-12833	276	10	.	.	PUNCT
aiua-12833	277	1	gilbert	gilbert	PROPN
aiua-12833	277	2	ja	ja	PROPN
aiua-12833	277	3	,	,	PUNCT
aiua-12833	277	4	frederick	frederick	PROPN
aiua-12833	277	5	lm	lm	PROPN
aiua-12833	277	6	,	,	PUNCT
aiua-12833	277	7	ames	ames	PROPN
aiua-12833	277	8	mm	mm	PROPN
aiua-12833	277	9	.	.	PUNCT
aiua-12833	278	1	the	the	DET
aiua-12833	278	2	aromatic	aromatic	ADJ
aiua-12833	278	3	-	-	PUNCT
aiua-12833	278	4	l	l	NOUN
aiua-12833	278	5	-	-	ADJ
aiua-12833	278	6	amino	amino	ADJ
aiua-12833	278	7	acid	acid	NOUN
aiua-12833	278	8	decarboxylase	decarboxylase	NOUN
aiua-12833	278	9	inhibitor	inhibitor	NOUN
aiua-12833	278	10	carbidopa	carbidopa	NOUN
aiua-12833	278	11	is	be	AUX
aiua-12833	278	12	selectively	selectively	ADV
aiua-12833	278	13	cytotoxic	cytotoxic	ADJ
aiua-12833	278	14	to	to	ADP
aiua-12833	278	15	human	human	ADJ
aiua-12833	278	16	pulmonary	pulmonary	ADJ
aiua-12833	278	17	carcinoid	carcinoid	NOUN
aiua-12833	278	18	and	and	CCONJ
aiua-12833	278	19	small	small	ADJ
aiua-12833	278	20	cell	cell	NOUN
aiua-12833	278	21	lung	lung	NOUN
aiua-12833	278	22	carcinoma	carcinoma	NOUN
aiua-12833	278	23	cells	cell	NOUN
aiua-12833	278	24	.	.	PUNCT
aiua-12833	279	1	clin	clin	PROPN
aiua-12833	279	2	cancer	cancer	NOUN
aiua-12833	279	3	res	re	NOUN
aiua-12833	279	4	.	.	PROPN
aiua-12833	279	5	2000	2000	NUM
aiua-12833	279	6	;	;	PUNCT
aiua-12833	279	7	6:4365	6:4365	X
aiua-12833	279	8	-	-	SYM
aiua-12833	279	9	72	72	NUM
aiua-12833	279	10	.	.	PUNCT
aiua-12833	280	1	37	37	NUM
aiua-12833	280	2	.	.	PUNCT
aiua-12833	281	1	tan	tan	PROPN
aiua-12833	281	2	ek	ek	PROPN
aiua-12833	281	3	,	,	PUNCT
aiua-12833	281	4	chao	chao	PROPN
aiua-12833	281	5	yx	yx	PROPN
aiua-12833	281	6	,	,	PUNCT
aiua-12833	281	7	west	west	PROPN
aiua-12833	281	8	a	a	X
aiua-12833	281	9	,	,	PUNCT
aiua-12833	281	10	et	et	PROPN
aiua-12833	281	11	al	al	PROPN
aiua-12833	281	12	.	.	PROPN
aiua-12833	281	13	parkinson	parkinson	NOUN
aiua-12833	281	14	disease	disease	NOUN
aiua-12833	281	15	and	and	CCONJ
aiua-12833	281	16	the	the	DET
aiua-12833	281	17	immune	immune	ADJ
aiua-12833	281	18	system	system	NOUN
aiua-12833	281	19	associations	association	NOUN
aiua-12833	281	20	,	,	PUNCT
aiua-12833	281	21	mechanisms	mechanism	NOUN
aiua-12833	281	22	and	and	CCONJ
aiua-12833	281	23	therapeutics	therapeutic	NOUN
aiua-12833	281	24	.	.	PUNCT
aiua-12833	282	1	nat	nat	PROPN
aiua-12833	282	2	rev	rev	VERB
aiua-12833	282	3	neurol	neurol	PROPN
aiua-12833	282	4	.	.	PUNCT
aiua-12833	283	1	2020	2020	NUM
aiua-12833	283	2	;	;	PUNCT
aiua-12833	283	3	16:303	16:303	NUM
aiua-12833	283	4	-	-	SYM
aiua-12833	283	5	18	18	NUM
aiua-12833	283	6	.	.	PUNCT
aiua-12833	284	1	38	38	NUM
aiua-12833	284	2	.	.	PUNCT
aiua-12833	285	1	aslam	aslam	PROPN
aiua-12833	285	2	s	s	PROPN
aiua-12833	285	3	,	,	PUNCT
aiua-12833	285	4	albo	albo	PROPN
aiua-12833	285	5	m	m	PROPN
aiua-12833	285	6	,	,	PUNCT
aiua-12833	285	7	brubaker	brubaker	PROPN
aiua-12833	285	8	l.	l.	PROPN
aiua-12833	285	9	recurrent	recurrent	PROPN
aiua-12833	285	10	urinary	urinary	ADJ
aiua-12833	285	11	tract	tract	NOUN
aiua-12833	285	12	infections	infection	NOUN
aiua-12833	285	13	in	in	ADP
aiua-12833	285	14	adult	adult	NOUN
aiua-12833	285	15	women	woman	NOUN
aiua-12833	285	16	.	.	PUNCT
aiua-12833	286	1	jama	jama	PROPN
aiua-12833	286	2	.	.	PUNCT
aiua-12833	287	1	2020	2020	NUM
aiua-12833	287	2	;	;	PUNCT
aiua-12833	287	3	323:658	323:658	NUM
aiua-12833	287	4	-	-	SYM
aiua-12833	287	5	9	9	NUM
aiua-12833	287	6	.	.	PUNCT
aiua-12833	288	1	correspondence	correspondence	NOUN
aiua-12833	288	2	ismaeel	ismaeel	PROPN
aiua-12833	288	3	alshoaibi	alshoaibi	PROPN
aiua-12833	288	4	,	,	PUNCT
aiua-12833	289	1	md	md	PROPN
aiua-12833	289	2	drismsho@gmail.com	drismsho@gmail.com	PROPN
aiua-12833	290	1	basheer	basheer	PROPN
aiua-12833	290	2	abdo	abdo	PROPN
aiua-12833	290	3	abdobasheer500@gmail.com	abdobasheer500@gmail.com	PROPN
aiua-12833	291	1	mohammed	mohammed	PROPN
aiua-12833	291	2	abdullah	abdullah	PROPN
aiua-12833	291	3	,	,	PUNCT
aiua-12833	291	4	md	md	PROPN
aiua-12833	291	5	dr.moh.moqbel@gmail.com	dr.moh.moqbel@gmail.com	PROPN
aiua-12833	291	6	khaled	khaled	PROPN
aiua-12833	291	7	alzanen	alzanen	PROPN
aiua-12833	291	8	,	,	PUNCT
aiua-12833	291	9	md	md	PROPN
aiua-12833	291	10	khaledhamoud409@gmail.com	khaledhamoud409@gmail.com	PROPN
aiua-12833	291	11	mohammed	mohammed	PROPN
aiua-12833	291	12	alhakamy	alhakamy	PROPN
aiua-12833	291	13	,	,	PUNCT
aiua-12833	291	14	md	md	PROPN
aiua-12833	291	15	wwkkh2018@gmail.com	wwkkh2018@gmail.com	PROPN
aiua-12833	291	16	mamoon	mamoon	PROPN
aiua-12833	291	17	al	al	PROPN
aiua-12833	291	18	-	-	PUNCT
aiua-12833	291	19	namer	namer	PROPN
aiua-12833	291	20	,	,	PUNCT
aiua-12833	291	21	md	md	PROPN
aiua-12833	291	22	m_namer@yaho.com	m_namer@yaho.com	PROPN
aiua-12833	291	23	afrah	afrah	PROPN
aiua-12833	291	24	salem	salem	PROPN
aiua-12833	291	25	,	,	PUNCT
aiua-12833	291	26	md	md	PROPN
aiua-12833	291	27	salemafrah111@gmail.com	salemafrah111@gmail.com	PROPN
aiua-12833	291	28	mohammed	mohammed	PROPN
aiua-12833	291	29	almogahed	almogahe	VERB
aiua-12833	291	30	,	,	PUNCT
aiua-12833	291	31	md	md	PROPN
aiua-12833	291	32	mugahedmoham123@gmail.com	mugahedmoham123@gmail.com	PROPN
aiua-12833	291	33	department	department	PROPN
aiua-12833	291	34	of	of	ADP
aiua-12833	291	35	internal	internal	ADJ
aiua-12833	291	36	medicine	medicine	NOUN
aiua-12833	291	37	,	,	PUNCT
aiua-12833	291	38	school	school	NOUN
aiua-12833	291	39	of	of	ADP
aiua-12833	291	40	medicine	medicine	NOUN
aiua-12833	291	41	,	,	PUNCT
aiua-12833	291	42	ibb	ibb	PROPN
aiua-12833	291	43	university	university	NOUN
aiua-12833	291	44	,	,	PUNCT
aiua-12833	291	45	ibb	ibb	NOUN
aiua-12833	291	46	,	,	PUNCT
aiua-12833	291	47	yemen	yemen	PROPN
aiua-12833	291	48	abdulghani	abdulghani	VERB
aiua-12833	291	49	al	al	PROPN
aiua-12833	291	50	-	-	PUNCT
aiua-12833	291	51	hagri	hagri	PROPN
aiua-12833	291	52	,	,	PUNCT
aiua-12833	291	53	md	md	PROPN
aiua-12833	291	54	alhagriabdulghani@gmail.com	alhagriabdulghani@gmail.com	PROPN
aiua-12833	291	55	student	student	PROPN
aiua-12833	291	56	research	research	PROPN
aiua-12833	291	57	committee	committee	NOUN
aiua-12833	291	58	,	,	PUNCT
aiua-12833	291	59	faculty	faculty	NOUN
aiua-12833	291	60	of	of	ADP
aiua-12833	291	61	medicine	medicine	NOUN
aiua-12833	291	62	and	and	CCONJ
aiua-12833	291	63	health	health	NOUN
aiua-12833	291	64	sciences	science	NOUN
aiua-12833	291	65	,	,	PUNCT
aiua-12833	291	66	sana'a	sana'a	DET
aiua-12833	291	67	university	university	NOUN
aiua-12833	291	68	,	,	PUNCT
aiua-12833	291	69	sana'a	sana'a	PROPN
aiua-12833	291	70	,	,	PUNCT
aiua-12833	291	71	yemen	yemen	PROPN
aiua-12833	291	72	urology	urology	NOUN
aiua-12833	291	73	office	office	NOUN
aiua-12833	291	74	,	,	PUNCT
aiua-12833	291	75	althora	althora	PROPN
aiua-12833	291	76	general	general	ADJ
aiua-12833	291	77	hospital	hospital	NOUN
aiua-12833	291	78	,	,	PUNCT
aiua-12833	291	79	alodine	alodine	ADJ
aiua-12833	291	80	street	street	PROPN
aiua-12833	291	81	,	,	PUNCT
aiua-12833	291	82	ibb	ibb	PROPN
aiua-12833	291	83	(	(	PUNCT
aiua-12833	291	84	yemen	yemen	PROPN
aiua-12833	291	85	)	)	PUNCT
aiua-12833	291	86	morshed	morshe	VERB
aiua-12833	291	87	salah	salah	PROPN
aiua-12833	291	88	,	,	PUNCT
aiua-12833	291	89	md	md	PROPN
aiua-12833	291	90	morshed.salah@gmail.com	morshed.salah@gmail.com	PROPN
aiua-12833	291	91	urology	urology	NOUN
aiua-12833	291	92	section	section	NOUN
aiua-12833	291	93	,	,	PUNCT
aiua-12833	291	94	surgery	surgery	NOUN
aiua-12833	291	95	department	department	NOUN
aiua-12833	291	96	,	,	PUNCT
aiua-12833	291	97	hazm	hazm	PROPN
aiua-12833	291	98	mebaireek	mebaireek	PROPN
aiua-12833	291	99	general	general	ADJ
aiua-12833	291	100	hospital	hospital	NOUN
aiua-12833	291	101	,	,	PUNCT
aiua-12833	291	102	hamad	hamad	PROPN
aiua-12833	291	103	medical	medical	PROPN
aiua-12833	291	104	corporation	corporation	PROPN
aiua-12833	291	105	,	,	PUNCT
aiua-12833	291	106	doha	doha	PROPN
aiua-12833	291	107	,	,	PUNCT
aiua-12833	291	108	qatar	qatar	PROPN
aiua-12833	291	109	.	.	PUNCT
aiua-12833	292	1	ibrahim	ibrahim	PROPN
aiua-12833	292	2	alnadhari	alnadhari	PROPN
aiua-12833	292	3	,	,	PUNCT
aiua-12833	292	4	md	md	PROPN
aiua-12833	292	5	ibrahimah1978@yahoo.com	ibrahimah1978@yahoo.com	PROPN
aiua-12833	292	6	department	department	PROPN
aiua-12833	292	7	of	of	ADP
aiua-12833	292	8	surgery	surgery	NOUN
aiua-12833	292	9	,	,	PUNCT
aiua-12833	292	10	school	school	NOUN
aiua-12833	292	11	of	of	ADP
aiua-12833	292	12	medicine	medicine	NOUN
aiua-12833	292	13	,	,	PUNCT
aiua-12833	292	14	qatar	qatar	PROPN
aiua-12833	292	15	university	university	PROPN
aiua-12833	292	16	,	,	PUNCT
aiua-12833	292	17	doha	doha	PROPN
aiua-12833	292	18	,	,	PUNCT
aiua-12833	292	19	qatar	qatar	PROPN
aiua-12833	292	20	al	al	PROPN
aiua-12833	292	21	wakra	wakra	PROPN
aiua-12833	292	22	hospital	hospital	PROPN
aiua-12833	292	23	,	,	PUNCT
aiua-12833	292	24	hamad	hamad	PROPN
aiua-12833	292	25	medical	medical	PROPN
aiua-12833	292	26	corporation	corporation	PROPN
aiua-12833	292	27	,	,	PUNCT
aiua-12833	292	28	al	al	PROPN
aiua-12833	292	29	wakra	wakra	PROPN
aiua-12833	292	30	,	,	PUNCT
aiua-12833	292	31	(	(	PUNCT
aiua-12833	292	32	qatar	qatar	NOUN
aiua-12833	292	33	)	)	PUNCT
aiua-12833	292	34	faisal	faisal	PROPN
aiua-12833	292	35	ahmed	ahmed	PROPN
aiua-12833	292	36	,	,	PUNCT
aiua-12833	292	37	md	md	PROPN
aiua-12833	292	38	(	(	PUNCT
aiua-12833	292	39	corresponding	correspond	VERB
aiua-12833	292	40	author	author	NOUN
aiua-12833	292	41	)	)	PUNCT
aiua-12833	292	42	fmaaa2006@yahoo.com	fmaaa2006@yahoo.com	PROPN
aiua-12833	293	1	department	department	PROPN
aiua-12833	293	2	of	of	ADP
aiua-12833	293	3	urology	urology	NOUN
aiua-12833	293	4	,	,	PUNCT
aiua-12833	293	5	school	school	NOUN
aiua-12833	293	6	of	of	ADP
aiua-12833	293	7	medicine	medicine	NOUN
aiua-12833	293	8	,	,	PUNCT
aiua-12833	293	9	ibb	ibb	PROPN
aiua-12833	293	10	university	university	NOUN
aiua-12833	293	11	,	,	PUNCT
aiua-12833	293	12	ibb	ibb	NOUN
aiua-12833	293	13	,	,	PUNCT
aiua-12833	293	14	yemen	yemen	PROPN
aiua-12833	293	15	conflict	conflict	NOUN
aiua-12833	293	16	of	of	ADP
aiua-12833	293	17	interest	interest	NOUN
aiua-12833	293	18	:	:	PUNCT
aiua-12833	293	19	the	the	DET
aiua-12833	293	20	authors	author	NOUN
aiua-12833	293	21	declare	declare	VERB
aiua-12833	293	22	no	no	DET
aiua-12833	293	23	potential	potential	ADJ
aiua-12833	293	24	conflict	conflict	NOUN
aiua-12833	293	25	of	of	ADP
aiua-12833	293	26	interest	interest	NOUN
aiua-12833	293	27	.	.	PUNCT